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nA b s t r a c t .
The work herein describes an investigation into the 
synthesis, analysis and decomposition of some labelled amino 
acids and peptides. The work was carried out to investigate 
the potential of a novel biochemical method for labelling 
amino acids with hydrogen isotopes and to study the effects 
of pH on the storage of tritiated amino acid derivatives in 
aqueous solutions.
Chapter One describes the synthesis, analysis and 
radiation decomposition of tritiated amino acids and 
peptides. Methods for the preparation of N-acyl-2,3- 
didehydroamino acids and N ~ a c y 1-2,3 “didehydropeptides via 
azlactone and azido carboxylic acid intermediates are given. 
The catalytic reduction of the unsaturated precursors using 
hydrogen-tritium mixtures has been investigated. The 
radiation decomposition of N-acetyl-C4,5-*H^-leucine 
( 3.7 5 C i / m m o l ), N-acetyl-C2,3-®iy-phenylalani ne (18.2Ci/mmol) 
and N-benzoyl-[2,3-*H^-phenylalan ine (12Ci/mmol) in buffer 
solutions are reported. Analysis of the samples by tritium 
nmr spectroscopy and radio-tlc analysis revealed that in 
all cases the majority of radiation decomposition was 
not at the site of tritium labelling.
Chapter Two describes the deuteration of amino acids 
using Pseudomonas putida cells as a catalyst. Attempts to 
use semi-purified extracts of methionine-r-lyase as a 
catalyst for the deuterium labelling of amino acids were 
unsuccessful. The immobilization of the bacteria cells 
using Biofix C2 support is reported. A wide range of amino 
acids have been investigated and the results of labelling 
studies using free and immobilized cells are compared. 
Labelling studies using semi-aqueous and non-aquedus solvent 
media, including the deuteration of glycine esters in 
dimethylsulphoxide and dimethylformamide, have been 
reported.
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CHAPTER ONE
The Synthesis, Analysis and Radiation Decomposition 
of Tritiated Amino Acids and Peptides.
1.1 Introduction
1.1.1 G e n e r a l .
Amino acids and their polymeric derivatives peptides 
and proteins play an important role in biology. They are 
essential to all life and are involved in a wide variety of 
functions. Attempts to understand their action have led to 
chemists and biochemists using a range of labels to mark 
these compounds. The label that is chosen must be easy to 
detect, easy to incorporate and preferably chemically 
stable. The labelled molecule should under ideal 
circumstances mimic the behaviour of the unmarked compound 
it is representing. Indeed, it is only isotopes of hydrogen, 
carbon, nitrogen, oxygen and sulphur that can be 
incorporated into amino acids and peptides without altering 
their chemical structure.
There are two types of isotopes, namely those that are 
stable and those that are radioactive. A wide range of 
spectroscopic and other techniques can be used to detect 
both categories of isotopes. However, the major advantage 
of radioisotopes over their stable counterparts is that they 
can be detected at tracer level. The most commonly used 
radioisotopes used for labelling amino acids and peptides 
are tritium, carbon-14, iodine-125 and sulphur-35.
Only deuterium and tritium have been used in the 
present research. Both these hydrogen isotopes are
8relatively chealp compared to isotopes of other elements. In 
addition* they have several advantages that make them more 
attractive than others to use. Since the isotopes are 
Simply being used to replace hydrogen in a molecule then 
they can be used as tracers for both hydrogen and carbon.
The aims of the work described herein were:
(a) To prepare some N-acyIdidehydroamino acids and N- 
acyldidehydropeptides.
(b) The optimisation of the catalyst: substrate ratio for 
the reduction of N-acyIdidehydroamino acids with 
hydrogen-tritium mixtures.
(c) To study the effects of varying the solvent for the 
labelling of N-acyldidehydroamino acids by catalytic 
reduct ion.
(d) The catalytic reduction of some N-acyIdidehydropeptides 
using h y d rogen-tritium mixtures.
(e) To study the radiation decomposition of tritiated N- 
acylamino acids by tritium nuclear magnetic resonance 
(®H nmr) spectroscopy* liquid scintillation counting 
and radio thin layer chromatography (tic).
1.1.2 Pro p e r t i e s  of tritium.
Tritium is a r a d i o a c t i v e  isotope of hydrogen and has an 
atomic mass of three The general properties of
tritium are shown in Table 1. 1. The decay process is shown 
in Figure 1.1. The (^--particle (or negatron as it is 
sometimes called) is an energetic electron that migrates 
from the nucleus and leaves behind an isotope with an 
increased atomic number. fî--Part ic les are caused by the 
instability of the nucleus due to the presence of too many 
neutrons.
Figure 1. 1 Decay process of atoms.
Tritium has a natural abundance of less than 10“ ^® and 
is produced in the upper atmosphere as a result of nuclear 
reactions caused by cosmic radiation. Tritium can be 
artificially prepared by several methods, as shown in Figure 
1.2, Tritium may be incorporated into water by oxidation or 
reduction. Tritium is used for synthesis either in the 
form of a diatomic gas, as a pure isotope or as a hydrogen 
isotopomeric mixture, t r i t i a t e d  water or as a metal tritide. 
Hence, there is a range of methods that can be employed to 
incorporate tritium into molecules. Some of these will be 
discussed in section 1.1.6.
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Mass
Radiation emitted
Half-life
Maximum energy 
of particle
Decay product 
( s t a b l e )
Maximum specific 
activity
Method of measurement 
(efficiency)
Range of particles: 
in air 
in water
Volume of ®Ha gas 
at STP
Table 1.1: Some properties of t r i t i u m .
3
# - - P a r t i c le 
12.43 years
18.6 Kev
Helium (»He)
28.76 Ci/mA
Liquid scintillation 
(40%)
4.5-6mm 
6nm
0.385ml
Tracer use for both hydrogen and carbon
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; H
^Be + H  - ► ^ B e  +'h4 1 4 I
Figure 1.2 Methods of preparing tritium atoms.
Since tritium is one of the least toxic radisotopes, 
and because it is a weak |3“ -particlfe emitter, it is often 
handled in large quantities with samples containing curies 
frequently being used. The properties of tritium make it 
difficult to detect in the laboratory and so must be handled 
in accordance with stringent safety regulations®. Therefore, 
the handling of tritium in the laboratory needs to be 
carried out using the following precautions:
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(a) Always wear rubber gloves when handling tritiated 
compounds.
/(b) Work should preferably be carried out in a fumehood.
(c) Work over a spill tray.
(d) Wear a face mask when handling fine powders.
(e) Always wash off any spills with water.
Monitoring of the laboratory should be carried out by 
using swabs and counting the activity of the samples by 
liquid scintillation counting. The routine monitoring of 
laboratory workers should also be carried out by taking 
urine samples, since the low energy of the ^--particles 
produced by tritium mean that film badges cannot be used.
1.1.3 Liquid scintillation c o u n t i n g .
The measurement of tritium is most conveniently made 
using liquid scintillation counting and the principles 
of the technique are briefly outlined here. The method can 
be used to detect a-particle, G-particle and r-ray emitters 
in a variety of sample forms. The radioactive sample is 
dissolved in a liquid scintillation cocktail, which consists 
of a solvent system and one or more scintillator compounds.
The phenomenon of fluorescence is used for the process 
of liquid scintillation counting. As the emitted a- 
particle, G-particle or r-ray passes through the scintillant 
solution it loses energy to the solvent, which is elevated 
to an excited state. Energy is transferred to the
13
scintillant solutes from the excited solvent molecules and 
is then emitted as photons due to the process of 
fluorescence, which is detected by a photomultiplier tube. 
The solvent chosen must efficiently transfer the energy to 
the scintillant molecule. Aromatic solvents such as toluene 
or xylene are most favoured though for aqueous environments 
1, 4-dioxane may be used.
The efficiency of the counting process will vary from 
sample to sample. Quenching is a phenomenon which 
interferes with the creation or transmission of light. The 
effects of quenching will mar the measurement of 
fluorescence during the counting process. There are three 
types of quenching:
(a) Colour quenching.
(b) Photon quenching.
(c) Chemical quenching.
Quench correction can be achieved by the methods of 
internal standards, channels ratio method and / or external 
standards.
1.1.4 Tritium nmr s p e c t r o s c o p y .
The development of tritium nmr spectroscopy ** ® in
the late 1960*s and early 1 9 7 0 ’s revolutionalized the use of 
tritium as a tracer for hydrogen and carbon in biological 
and chemical molecules. This was due to the fact that for
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the first time it was possible to determine the distribution 
of tritium in a co m p o u n d  by a non destructive technique. 
This meant that tritium had a distinct advantage over other 
isotopes such as c a r b o n - 14 and sulphur-35 in that its 
position of label could be determined with very little 
sample preparation and no laborious chemical degradation 
p r o c e s s e s .
The nmr properties of tritium are compared to those of 
other isotopes in Table 1.2. It will be noticed that there 
is a close similarity between and nuclei. This
implies that it is possible to relate the chemical shifts of 
the tritium spectra to the cor responding shifts in the 
proton spectra. The high resonance frequency of tritium 
coupled with the fact that it has a higher detection 
sensitivity than even hydrogen makes it a suitable isotope 
for nmr study. The chemical shifts of proton and tritium 
signals are similar and are related by the ratio of the 
Larmor frequencies of the nuclei. Hence, it is possible to 
relate the tritium nmr directly with that of the proton nmr. 
The tritium nmr spectra can be 'ghost' referenced to the 
proton nmr by multip lying the chemical shift of the proton 
reference signal of tetramethyIsilane (tms) or 2 , 2 - 
d i m e t h y I s i l a p e n t a n e - 5 - s u l p h o n ic acid (dss) by the 
magnetogyric ratio.
In addition, the tritium coupling constants are related 
to those of the proton values by the expression shown in 
Equation 1.3.
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Table 1 .2: Nuclear properties of the hydrogen isotopes
Isotope H •H 'H
Natural
abundance(%) 99.984 0.0158 < 10-1'
Nuclear
spin
Magnetic
moment
P/M n
1 /2
4.8371 1.2125
1/2
5.1594
Magnetogyric
ratio
(T/10^ radians 
T - i g - i )
28.7519 4.1004 28.5336
Resonance 
frequency 
(MHz at 
7.0463T)
300.00 48.05 320.13
Relative 
sensitivity 
for equal number 1.0 
of nuclei at 
constant field
9.65 X 10-® 1.21
Radiation Stable Stable ^--Particle
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Jx,x — Jm,x (Tx/Th) — Jh,h (tx/th)* E q n . 1.3
where :
Jx.T is the ®H-*H spin coupling constant
J h ,h  is the iH-iH spin coupling constant
J h ,x  is the iH-®H spin coupling constant
t h / t x  is the magnetogyric ratio and has the value of 
1.06663974
Also the Nuclear Overhauser Effect from concomitant 
proton irradiation is small and no tritium standard is 
required for field-frequency locked spectrometers.
1.1.5 R a d i o c h r o m a t o g r a p h y .
Radio thin layer chrom atograp hy (tic) has been used for 
this reseach to analyse radiation decomposition of tritiated 
amino acids. Inactive carrier material should be added to 
the sample of r a d i o l a b e 1 led compound to reduce the formation 
of sources of error during the elution and analysis of the 
tic plate Sources of error can be due to many causes
such as poor sample loading, decomposition of the sample 
during loading, elution, and analysis of the tic plate, and 
the existence of int er-equilibrating forces.
/
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1.1.6 Tritium l a b e lling.
There are four main ways hydrogen isotopes can be 
incorporated into a molecule :
(I) Isotope exchange reactions
(II) Direct chemical synthesis
(III) Biochemical methods 
(iv) Recoil labelling
Recoil labelling, although of interest to physical 
chemists due to mechanistic aspects, is seldom used for 
preparative purposes. The method Involves the reaction of 
recoil tritium atoms from nuclear reactors with compounds. 
The products tend to have low specific activities. 
Radiochemical and chemical yields of the compounds are often 
poor due to the formation of labelled impurities during the 
reaction. Therefore, the technique will not be discussed 
any further. The biochemical methods are discussed in 
Chapter 2.
1.1.6.1 Isotope exchange r e a c t i o n s .
These reactions involve the reversible process of 
exchange of two isotopes of the same element. The technique 
is useful for labelling complex molecules but often leads to 
a general distribution of the isotope. There are two 
procedures used to exchange label compounds with tritium:
(a) gas exposure method; (b) catalytic exchange in solution.
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The gas exposure method is often referred to as the 
Wilzbach method * ^  after the scientist who first published 
details of the method. The method involves allowing a 
c ompound to remain in contact with tritium gas for several 
days or weeks. During this time the radiation induces 
exchange reactions between the hydrogen atoms of the 
compound and the tritium gas. There are several limitations 
to the method. The radiochemical purity is low due to the 
formation of tritiated impurities, which arise either 
because of direct damage to the target material or by 
decomposition of the product and the labelling pattern of 
the product is non specific. Improvements to the method 
include: (1) activating the tritium gas with high energy
sources; (11) absorption of the substrate on a suitable 
support, such as charcoal; (ill) using a catalyst, such 
as platinum or palladium black.
Most of the proteinogenic amino acids have been 
labelled using improved Wilzbach methods The specific
activities obtained varied from 0.2-29 mCi/mmol, The 
racemization of some L-amlno acids has been reported to 
occur during Wilzbach labelling
The tritiation of peptides have been carried out by 
using modified Wilzbach methods. Peng has studied the 
tritiation of the simple peptides glycylglycyl-L-leucine and 
glycyl-L-leucine by a microwave discharge technique. 
Adrenocorticotrophlc hormone and Gonadotropin releasing 
hormone*® have also been labelled by the Wilzbach technique.
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Catalytic exchange in solution is used to label 
compounds in non-labile positions. The method is useful for 
preparing compounds of high radiochemical purity but has the 
disadvantage in that labelling patterns are often n o n ­
specific. Most of the common amino acids have been labelled 
by tritiated water in the presence of platinum catalysts *. 
The specific labelling of amino acids in the a-position has 
been achieved by refluxlng the N-acetyl derivative with 
tritiated acetic acid and anhydride*'^
The labelling of amino acid and their derivatives have 
been used to study potential models for the tritiation of 
peptides. Woodworth and Dobson*® have selectively 
deuterated aromatic amino acids at specific sites, using 
K a n e y  nickel as a catalyst and ambient temperatures, and 
Oehlke*® has investigated the conditions of deuteration of 
N-acety1-L-histidine amide.
Catalytic exchange tritiation of peptides has been 
carried out by several workers. Brundlsh and Wade*® have 
labelled (î-corticotrophin-( 1 - 2 4 )-tetracosapeptide to a level 
of 0.48Ci/mmol with 80% of the tritium incorporated into the 
histidine residue. The catalytic exchange labelling of L- 
cysteine containing peptides was reported to give the 
c orresponding tritiated L-alanine containing peptides®®*®*. 
Blenert et. al.®® tritiated histidine residues of analogues 
of luteinizing hormone-releasing agonists at high specific 
activities.
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1.1.6.2 Direct chemical s y n t h e s i s .
There are three general methods used for chemical 
synthesis of a labelled molecule: (i) reduction of an
unsaturated precursor; (ii) catalytic halogen-tritium 
replacement and (iii) reduction of compounds with tritiated 
metal hydrides.
The catalytic reduction of unsaturated compounds is one 
of the most convenient ways of introducing tritium into a 
compound. The types of reactions that can be envisaged are 
shown in Figure 1.4.
r__CH=CH-X ^  - R-CHT-CHT— X
R _ C = C - X  — ^  R-CT=CT-X
R— c =  C— X — — R— CT2— CT2 X
R— C S N  — —  R— CT3— NHj
R R 'C  =  0    ------- --  R R 'C T - O H
Figure 1.4 Catalytic reduction of unsa t u r a t e d  compounds.
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The catalytic tritiation of most of the common amino 
acids has been carried out ^. Labelled amino acids have 
also been obtained by the reduction of unsaturated compounds 
such as azlactones, acetamidoacrylic acid derivatives, a~ 
‘keto acids and h y d o x y i m i n o c a r b o x y 1ic acids. These tritiated 
intermediates are converted to the corresponding amino acid 
derivatives by a range of synthetic methods. Seduction of 
a-hydroxyiminopropionic acid and |S-phenyl-a-hydroxypropionic 
acid With tritium gave DL-C4,5-®iy-leucine
alanine and C2,3-®iy-phenylalanine 2-amino-DL-[4, 5-
3^J-adipic acid and DL-C4, 5-^H^-lysine by reduction
of unsaturated malonates.
Several workers have reported the labelling of peptides 
containing didehydroamino acid residues. A protected 
gastrin tetrapeptide amide containing a 4,5- 
didehydronorleucyl residue was tritiated to a specific 
activity of 0 . 14Ci/mmol The Callyl-glycine]-#-
c o r t i c o t r o p h i n - ( 1 - 2 4 )-tetracosapeptide gave upon labelling 
the corresponding C4,5-®iy-norvaline containing peptide 
with a specific activity of 7.42Ci/mmol . Felix 
reported the labelling of 3, 4-didehydroproline residue in a 
tripeptide analog of thyroliberin to a specific activity of 
58.4Ci/mmol. The asymmetric tritiation of N - a c e t y 1-2,3- 
didehydrophenylalanyl-S-pheny lalanine methyl ester using 
tritium gas in the presence of rhodium-(+)diop catalyst was 
reported by Levine-Pinto ® T h e  ®H nmr spectrum of N- 
a c e tyl-C2,3-®iy-K-phenylalany l-S-phenylalanine showed the 
distribution of tritium to be 46% : 54% C«: 0» respectively.
22
In the case of N-acety1-C2,3-®iy-S-phenylala nyl-S- 
p h e n y l a l a n i n e s ^ » ^ ^  distribution of tritium in the C#, and C» 
positions was observed. The difference in the distribution 
of the tritium for the former diastereomer was interpreted 
as being due to exchange with the reaction solvent, Sheppard 
et. al.®= have tritiated Locust adipokinetic hormone 
containing either a 4,5-didehydroleucine residue or 3, 4-
didehydroproline residues. In both cases over 95% of the 
tritium was found to be present in the expected residues
with specific activities of 115Ci/mmol and 12Ci/mmol being 
obtained respectively for the peptides, Oehlke et. al.®® 
studied the conditions of catalytic deuteration of N-
acetyl-3,4-didehydroproline amide as a model for the 
tritiation of peptides.
Catalytic halogen-tritium exchange is a useful 
synthetic reaction that enables labelling of compounds under 
similar conditions to those for hydrogenations. Several
reports have been made about the tritiation of amino acids
by dehalogenation
Several reports have been published concerning the 
preparation of tritiated peptides by dehalogenation. Arvis 
et. al®* have used flash photolysis in the tritiation of 
peptides containing an iodotyrosine residue. Irradiation of 
the peptide at 304nm was found to lead to the formation of a 
tyrosyl free radical, which can abstract a tritium atom from 
tritiated alcohol to give a product of high radiochemical 
purity, Tritiation by the dehalogenation technique has been
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used to label analogues of the peptides corticotrophin®®, 
somatostatin *® and calcitonin Kaspersen et. al ®®
labelled two neuropeptides, Org 2766 (an ACTH (4-9) 
analogue) and Org GK 78 (de s - T y r - r - e n d o r p h i n ) by catalytic 
deiodination of the (p-iodophenyl)alanine precursors using 
tritium gas. Exchange labelling into histidine residues has 
also been observed by several workers ®® ” Toth et. al*®
prepared ® H - D - a l a - l e u - e n k e p h a l i n - c h l o r o m e t h y 1 ketone at 
high specific activity from dehalogenation of Boc-3, 5- 
diiodotyr-D-ala-gly with tritium gas. Oehlke et. al.*® have 
studied the effects of catalyst pretreatment on the 
labelling of N-acetyIdiiodotyrosine amide for optimization 
of the conditions of tritiation of peptides.
Several other methods of preparing tritiated amino 
acids and peptides include: (i) chain elongation by the
Arndt-Eistert reaction, which was used to label the op­
position of (1-amino acids ** - *®î (ii) decarboxylation of 
acetamidomalonic acid derivatives to obtain amino acids 
specifically labelled in the «-position (iii) the
preparation of C6-®HD-Lysine and C5-®H3-ornithine by 
reduction of a - a m i n o - C ü - c y a n o c a r b o x y 1ic acids ^ and (iv) the 
reduction of didehydropyrroline carboxylic acids with sodium 
borotritide *'^ .
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1.1.7 Synthesis of didehvdroanino acids 
and d i d e h v d r o p e p t i d e s .
The lack of a wide range of commercially available 
didehydroamino acids and didehydropeptides made it necessary 
to carry out the preparation of suitable unsaturated 
precursors prior to any tritiation studies being 
undertaken. Two methods were used for the synthesis of 
didehydroamino acid and didehydropeptides : (i) synthesis via 
azlactone route and (ii) synthesis via an azide intermediate 
Previous reports of synthesis using these methods are 
d escribed briefly below.
1. 1.7.1 Synthesis via azlactone inter m e d i a t e s .
The chemistry of azlactones have been reviewed by 
Baltazzi*®. Azlactones can be categorised as being saturated 
or unsaturated. The synthesis and properties of unsaturated 
azlactones have only been described here because they are 
the group that is used as intermediates for the preparation 
of didehydroamino acids and d i d e h y d r o p e p t i d e s .
The Erlenmeyer reaction, as it is sometimes called 
after the scientist who developed the synthesis of 
azlactones, is believed to proceed via a mechanism which can 
be considered to be a special case of the Perkin 
condensation. The acylglycine is firstly converted into its 
saturated azlactone, which contains a reactive methylene 
group. Condensation then occurs between the intermediate and
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the carbonyl compound. The Erlenmeyer reaction
occurs' under milder conditions than those required for 
Perkin condensation. There are four ways in which 
unsaturated azlactones can be prepared:
(a) by the reaction of an aldehyde with an acylglycine.
(b) by the reaction of an acetic anh ydride with an a- 
haloacylamino acid in the presence of pyridine.
(c) by dehydration of acyIdehydr oamin o acids with acetic 
a n h y d r i d e .
(d) by the action of acetic anhydride, or an acid chloride, 
with an a-amino-f^-alkoxy acid.
Synthesis of the azlactones by method (a) usually 
involves refluxing an N-acyiglycine with a carbonyl compound 
and acetic anhydride in the presence of an anhydrous salt, 
typically sodium acetate (see Figure 1.5). Improvements in 
the method, which enabled the pre paration of azlactones from 
aliphatic or arylaliphatic aldehydes and ketones, can be 
made by carrying out the reaction in boiling tetrahydrofuran 
and in the presence of lead acetate. Baltazzi and Robinson 
have prepared several 4-alkylidene azlactones Finar and
Libmann used copper acetate for the azlactonization of
th i o a l d eh yd es.
H2Ç— COOH AcgO .. _ Rv  _ HgC— C
NHCOR ^  ) o  R '/
R
R: yPFigure 1.5 ^ c — C  —  Q
IR
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The preparation of un sa turated  azlactones by method
(b), which involves the reactio n of an a - (a ’- a c y l o x y a c y 1 )-or 
an a - ( a ^ - h a l o g e n o a c y l ) amino acid with acetic anhydride and 
pyridine at 0°C or room temper ature  , is useful for the 
synthesis of a-keto acids. The mechanism, which is shown in 
Figure 1.6, involves a 'pseudo a z l a c t o n e ’®^. The pseudo 
azlactone is con s i d e r e d  to be in dynamic equilibrium with 
the unsaturated azlactone. The pseudo azlactone would seem 
to be stabilized when R ' is an aryl group because of its 
greater degree of conjugation.
R C H ,-C H -C O :H  Ac^O RCHaC— /
NHCOCHXR' j b
^  L r' 
pRCH=C— C
/  \N O unsaturatedazlactone
1 ,CHgR
Figure 1.6
The preparation of u nsatura te d azlactones by reaction 
of an acid chloride, or an acid anhydride, with an a- 
acy lam ino-G-hydroxy acid, me thod (d), has been reported by 
several authors = 2 - 5 3  Figure 1.7 shows the reaction 
mechanism. The s a t u r a t e d  azlactone intermediate formed 
contains a very reactive «-hy dr ogen and this reacts with the 
n-hydroxyl group and by el im ination leads to the formation 
of the unsaturated azlactone.
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X
HN COCH “ CH r ' 
RCH*CH C O O H
X-CH-CH R
A
RI N ^ OHydrolysis '
R C H
CH = CH RI
0
HNIRCH=C-COOH
Figure 1.7
In the case of sensitive aldehydes, it is advisable to 
prepare the sat urated azlactone intermediate first, 
perhaps by the reaction of the acylglycine with ethyl 
c h 1orocarbonate and triethy lam ine in the cold. Subsequent 
condensation could then be carried out in the presence of 
diazabicyclound icene or an ion exchanger The (Z)-
azlactones formed during the reaction can be converted to 
the E-isomers by reaction with hydrogen bromide.
Unsaturat ed azla cto nes undergo aminolysis, alcoholysis 
and hydrolysis. The latter reactions are very slow and 
therefore unsatu rated azlactones can be recrys tallize d from 
alcohol. Hydrolysis can be carried out in the presence of 
acidic or alkaline con ditions (see Figure 1.8). The product 
of hydrolysis is a N-acyl-2, 3-didehydroamino acid. Sodium 
hydroxide in aqueous methanol is convenient for this 
synthesis since it proceeds via the formation of the N-
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acylamino ester, which is subsequently hydrolysed. Mild 
hydrolysis can be a c h i e v e d  by refluxing the azlactone in 
aqueous acetone solution. Prolonged hydrolysis with aqueous 
alkali can lead to formation of the a-keto acid. Ramage 
and Simonsen®®, in s t u dying  the oxidation products of 
d i d e h y d r o n o r c a r y o p h y 1 lenic acid, prepared the azlactone 2 - 
pheny1-4- iso propyli dene azlactone. This azlactone was 
converted into N-benzoyl-2, 3-didehydrovaline by re fluxing 
with potassium hydroxide  solution.
/ P
C =  C — Q +HoO R
IR Figure 1.8
Unsaturated a z l a ct on es are relatively stable in 
alcohols. However, in the presence of an acid or base ring 
opening occurs and N-acyl-2, 3-didehydroamino acid esters 
are formed*®. Higher alcohols  react readily with azlacto nes 
in the presence of an acid or base. The reaction of 
azlactones with methanol have been reported to result in the 
formation of peptides as well as the desired esters. 
The synthesis of N-acyl-2, 3-didehydropeptides can be 
obtained by a m i n oly si s of the unsaturated azlactones. 
Bergmann has r e p o r t e d  the preparation of several N- 
acyldidehydropeptides®^. The preparation of simple
dipeptides co n t a i n i n g  did ehydroamino acid residues can be 
achieved by re ac ti ng the azlactone with an amino acid or 
amino acid salts under very mild conditions, see Figure 1.9.
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R-CH-CO HI 2NH 1 M NOOH
r " ~ ch COOCH,
NHgdi e thyl ethe r
o ° c
R
R " C=C~CONH I INHCOR CH - C O H
c= C -  C O N H
r " ' 'NHCOR CH-COOCHg
R'Figure 1.9
Condensation of peptides having a C-terminal glycine 
with an aldehyde results in the formation of an azlactone. 
Ring cleavage of this azlactone with an amino acid salt 
leads to the formation of a peptide containing a central 
didehydroamino acid residue. Di-, tri-, tetra and penta- 
peptides containing one or more didehydroamino acid residues 
have been prepared
1.1.7.2 Synthesis via an azide intermedi ate.
a-Azidocarboxy 1 ic acids and aziridines are useful 
intermediates for the synthesis of didehydroamino acid 
derivatives. The pre paration of a- azid o c a r b o x y 1 ic acids has 
been reported by several authors The azido compounds
can be obtained by reaction of an inorganic azide with an 
a - b r o m o c a r b o x y 1 ic acid, usually in the presence of a phase 
transfer catalyst. It is necessary to protect the carboxyl 
group by estérificat ion so that no acyl azides are formed
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during the reaction.* Effenberger reacted sodium azide 
with a - b r o m o c a r b o x y 1 ic acid esters in an aqueous system and 
in the presence of R l i q u a t  336 (tricap^ylmethylammonium 
chloride). The azido products were obtained in quantitative 
yields. Manis and Rathke carried out the reaction by 
stirring the a- b r o m o c a r b o x y 1 ic ester with sodium azide in 
dimethylformamide at 25°C. Nakajima et. al. reported the 
azidation of a - b r o m o c a r b o x y 1 ic acids to occur qua ntitatively 
in the presence of 18-crown~6 and tetrabutylam monium bromide 
but virtually no reaction was observed in the absence of
phase transfer catalysts.
The a - a z i d o c a r b o x y 1ic acids readily undergo reduction 
to give the co rr esp ond ing amino acids by hydrogenation in 
the presence of palla diu m catalysts®*»®®. The synthesis 
of N-protected dideh ydroamino  acids from azido intermediates 
has been achieved in several ways. Manis and Rathke®® 
formed iminocarboxylates by reaction of the azide with 
lithium ethoxide in tet rahydrofuran and ethanol. The
iminocarboxylate was convert ed to the N-acyl-2, 3-
didehydroamino acid by reaction with t r i e t h y lamine and 
acetyl chloride at 0°C.
Effenberger and Beisswenger » ® ® » ®'^  have reported 
the synthesis of several N-acetyl-2, 3-d idehydroamino acid 
derivatives from their corresp ondin g a - a z i d o c a r b o x y 1 ic acid 
esters. Nitrogen elimination was achieved by reaction of 
the azido compounds with acetic anhydride/ acetic acid in
the presence of dir henium heptasulphide and sometimes
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hydrochloric acid. The diacetyl product was found to be 
formed in some circumstances. a-N-ll cetyl~a, |î-didehydro- 
a m i n o c a r b o x y 1 ic acid lactam was prepared from its 
corres pon ding azido lactam. The reaction is believed to 
proceed via a nitrene, from which an imine is formed by 
hydride shift or through an insertion reaction to give an 
aziridine and subsequent ring opening.
The reactions were carried out at high temperatures and 
often for a long period of time. The yield of the 
monoacetylated and di ace tylat ed products was dependent upon 
the reaction conditions used. Only the monoacetylated  
compound was obtained by carrying out the reaction in a 
solution of 4:1 ratio of acetic acid: acetic anhydride. The 
monoacety Ididehydr oamino acid ester was formed exclusively 
if water was added to the reaction mixture before work up. 
Since harsh reaction conditions were used, it was necessary 
to add a small amount of quinol to the reaction mixture to 
prevent polymerisation of the unsaturated product.
The preparation of N-acetyl-2, 3-dide hydro amino acid 
esters from a - a z i d o c a r b o x y 1 ic acid esters were carried out 
using the following scheme. a - B r o m o c a r b o x y 1ic acids were 
obtained from the car boxylic acids by the He 11-VoIhard- 
Zelinsky reaction. The corresponding a - a z i d o c a r b o x y 1 ic 
acids were obtained by the method of Nakajima and were
converted to the didehydroamino acids by reaction with 
acetic anhydride/ acetic acid and dirhenium heptasulphide®®. 
The overall reaction scheme is shown in Figure 1.10.
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Hel 1 — volha rd 
2eI insky
a — Bromination
E s t é r i f i c a t i o n
a — Atidation
N — ac etyl a t ion 
dehydrogenation
R
\
R'/ CH — CH'^COOH
PCI.
R\// CH - CH — COOH
Ref l uxCHpH
,/ CH — CH -COOCH3R IBf phase t r a n s f e r
R')CH
c a t a l y s t
N a
CH-COOCH
a— azido carboxyl Ic acid
R C=r C - C O O C H/ /  I 1 rR NH COCH3
N — acetyl ap—didehydroamino acid
Figure 1 . 1 0
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1.1.8 Radiation d e c o m p o s i t i o n .
The stability of com pounds labelled with radioisotopes 
must be car efully con side re d when trying to evaluate the 
suitability of tracers for biological and chemical studies. 
The decomposition of labelled molecules has been studied in 
relation to their biological stability and storage under 
various conditions ^ H e n c e ,  there is a need to 
monitor regularly the condition of the r a d i o l a b e 1 led sample.
The study of radiation decomposition previously 
undertaken has often been carried out in an empirical 
manner. The advances made in ®H nmr spe ctroscopy now mean 
that the re-evaluation of such studies can be undertaken. 
The formation of new chemical shifts in the product may give 
some idea of the type of decomposition products formed. The 
coupl ing  of the method with radio tic and liquid 
scintillation counting  makes it possible to identify a 
number of decomposition products.
There are four types of decomposition that have been 
identified by Bayly and Wiegel which constitute the
ph enomena of self-irradiation  decomposition. These are:
(a) Primary (internal) radiation decomposition
(b) Primary (external) radiation decomposition
(c) Secondary radiation decomposition
(d) Chemical effects
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Primary (internal) radiation decomposition is caused by 
the transmutation of a di sintegr ating radioisotope. In the 
case of tritium the product of the decomposition is the G"- 
particle and a helium atom. The energy that is imparted to 
the helium nuclide is very small, on average 0 - 3  ev, and 
is not sufficient to induce chemical degradation. Indeed, 
it is the change in charge of the resulting molecule that is 
likely to lead to decomposition. The transmutation effect is 
related to the half-life. In the case of radio isotopes with 
short half-lives, such as fluorine-18, the effect becomes 
very important whilst for isotopes with long half-lives, 
such as carbon-14, the effect will be virtually 
i n s i g n i f i c a n t .
Primary (external) radiation decomposition has a more 
Significant role than the transmutation effect in the 
degradation of tri tiated molecules. This mode of 
decomposition is that which results from the effect of the 
G“-particle interacting with the other molecules in the 
system. The molecule will absorb some of the energy of the 
G-farticle during the collision. The molecule will then 
become excited or form an ion by the loss or gain of a 
charged particle due to the collision. Hence, it immediately 
becomes apparent that there is & large number of resulting 
possibilities that can occur due to primary (external) 
radiation decomposition. Some of these will be discussed 
below with specific reference to amino acids and results 
reported in the literature.
Secondary radiation decomposition occurs due the 
interaction of excited molecules, which are caused mainly by 
the primary (external) effects, with other molecules or 
radicals. The products of the primary effects may undergo 
fragmentation, rearrangement, chain reaction or even 
interact with other molecules or ions in the system. 
Consequently, this type of decomposition can be the most 
damaging since it leads to a greater number of possible 
reactions occurring within the system.
Chemical and enviromental effects should also be taken 
into account when trying to understand radiation 
decomposition. The way in which a radioiso topic ally 
labelled molecule is stored will affect its stability. 
Hence, labelled compounds have been stored in various polar 
or non-polar solutions or solid form, either on a support or 
in a free form. The temperature at which the labelled 
molecule has been stored will also affect the rate of 
decomposition. Low temperature will make the molecules more 
crowded. This increases the direct and indirect effects 
unless the molecules are frozen. Also pH, photochemical or 
microbiological effects could lead to decomposition of 
labelled molecules.
The amount of decompos ition can be expressed in terms 
of the G (-M) value, sometimes referred to as the 
destruction coefficient^. Equation 1.11 shows the 
relat ion ship between the percentage decomposition (Pd) and 
the G(-H) value. It is obvious from simple evaluation of
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this expression that the amount of radiation decomposition
that is observed increases with an increase in the specific
activity of the compound.
Pd = (1-e s-fc.e >t lo ) 100 Eqn. 1.11
where :
F is the fraction of its own radiation energy absorbed by 
the compound. The value of F is often taken as unity for 
tritium because of the low penetrating power of the weak G~- 
part i c l es.
S is the specific activity of the compound (Ci m o l ” )^ 
t is the time in seconds
E is the average energy of the tritium radiation (5.7 Kev)
G* (-M) is the number of molecules irreversibly damaged per 
lOOev of absorbed energy.
There are several ways in which radiation decomposition
can be reduced. The primary (external) radiation effects
can be reduced by diluting the active compound with its
inactive counterpart and /or by immersing it in a solution. 
The effect may also be reduced by thinly spreading the
labelled material over a solid support, such as paper or 
clay. Secondary radiation decomposition may also be reduced 
by dilution. Radical scavengers, such as alcohols or 
thiols. Will also reduce the damage caused by secondary 
effects. The effects of chemicals and the environment can be 
best reduced by keeping samples at low temperatures.
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Although the storage of tritiated compounds in solution 
can reduce decompos ition by self-irradiation, the type of 
solvent used will have a profound effect on the stability of 
the labelled compound. Those solvents which readily produce 
free radicals due to radiolysis are not usually recommended. 
Organic hydrocarbons, such as benzene, would be the most 
suitable solvents to use since they only form radicals in 
small yields. Unfor tu na tely most biol ogica lly important 
compounds, including amino acids, are only soluble in 
aqueous or alcoholic solvent systems. The ionization of the 
solvent occurs in 'spurs* along the paths of the radiation^. 
The weaker the ^ “-ra diation the closer together are the 
'spurs' and in the case of tritiated compounds will have a 
profound effect on the stability of tritiated compounds in 
aqueous solution.
Evans has rep orted radiation decompo sit ion of
tritiated amino acids in aqueous solution and solid form at 
various temperatures. Willix and Garrison  ^ reported that 
hydrated electrons react with both zwitterionic and cationic 
forms of amino acids by a reductive deamination. The 
reaction of radicals, produced by the radiolysis of water, 
with L- Cm ethyl- ®H 3-methi on ine has been studied by Evans 
The labelled amino acid is vulnerable to dec omposition by 
the reaction with hydroxyl radicals. The reaction of 
aromatic amino acids with hydroxyl radicals has been 
reported to occur at a faster rate than with aliphatic amino 
acids, with the exception of methionine ’^ ®. The radiation 
decomposition of triti ated amino acids in aqueous solution
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would seem to be rela ted to the reactivity of hydroxyl 
radicals with amino acids. The effects of radiolysis on 
amino acids and peptides using external radiation sources 
have been studied by several authors. These studies can be 
c on sid ere d to be comp le mentary  to the study of s elf­
irradiation of labelled compounds.
In the case of tr iti ate d compounds labelled at high 
specific activity the amount of substrate that is studied is 
often in such a small quantity that full interpretation of 
decomposition is not possible. However experiments using 
external radiation sources to study the radiolysis of non­
labelled compounds may reveal some possible decomposition 
processes that could also possibly occur with s el f­
irradiation of tritiated compounds. Garrison^® has reviewed 
the effects of T-radiation on amino acids and their N- 
acylated derivatives. The decomposition of amino acids has 
been shown to occur mainly by secondary effects. Deamination 
of simple amino acids has been proposed to occur by reaction 
of hydrated electrons and hydroxyl radicals to yield keto- 
and alkanoic acids. Increasing the length of the aliphatic 
side chain has been reported to lead to a decrease in 
deamination In the case of N-acylated amino acids no
deamination is reported to occur in oxygen free systems. 
Also Panim^® has used ^H nmr spe ctroscopy to follow the 
build up of dec omp osition products of simple amino acids and 
peptides due to r-radiolysis.
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The racemization of tritiated optically  active amino 
acids has been reported by Evans et. al. The exact
mechanism of the racemiza tion is not knowb, though it is 
consi der ed to be caused by chemical effects rather than due 
to the G-radiation because similar results were not observed 
for carbo n-1 4 labelled amino acids. The use of neutral 
radical scavengers, such as ethanol, would seem to minimize 
the racemization. The use of basic salts, such as sodium 
formate, although reducing the amount of radiation 
decomposition was found to increase racemization^®. In the 
case of L~[3, 5-®H3-tyrosine 8 8 % of the tritium was found to 
be present in the DL-form of the amino acid after storage 
for 4.5 months at +2®C. A solution of the amino acid 
contain ing  0 , 1 % sodium formate was found to contain 1 0 0 % of 
the tritium in the DL-f orm but a solution contain ing 1% 
ethanol showed no signs of racemization.
Host studies of radiation dec omposition have been 
carried out using labelled compounds with specific 
activities of less than 12Ci/mmol. However, Hempel '^ ® 
reported the radiation decomposition of some amino acids 
with specific activities of 12 Ci/mmol or higher for ten 
different storage conditions. It was found that tritiated 
lysine stored as a solid adsorbed on paper or sand was 
relatively stable but rapidly dec omposed when adsorbed on 
NaCl. The storage of tritiated lysine in various solutions 
at -15°C and +20®C were also observed. The tritiated lysine 
was found to be most stable in 80% ethanol at -15®C.
4-0
Similar studies were carried out for tri tiated samples 
of phenylalanine, dopa, leucine and a-aminoadipic acid. In 
all cases the labelled amino acids were found to be^ more 
stable stored in solution than in solid form. The 
impurities formed upon storage of the tritiated amino acids 
were identified by high voltage electrophoresis. The 
formation of ethyl esters were found to be the predominant 
labelled impurities formed during storage in 80% ethanol 
solutions. . Il’b e n y  Ipyruvic acid,
p h e n y l e t h y lamine and an electric ally neutral compound were 
found to be present after storage of tritiated phenylalanine 
as a solid adsorbed on sodium chloride.
Evansi recommende d that the following storage 
conditions be used for amino acids:
(a) For low specific activities they should be stored as 
freeze dried solids at +2*C.
(b) For high specific activities they should be stored at 
+2=C in aqueous solution, ideally containing to 2% ethanol 
as a radical scavenger. with a maximum sample concentration 
of ImCi/ml.
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1.2 E x p e r i m e n t a l .
1.2.1 G e n e r a l .
1.2. 1.1 Nuclear Magnetic Resonance S p e c t r o s c o p y .
and nmr spectra were recorded at 2 5 “C on a Bruker 
AC 300 E ( 3 0 0 . 13 MHz) Fourier Transform nuclear magnetic
resonance spectrometer using deuterated solvents as
indicated below and refer enced to either tetramethyIsi lane 
(tms) or 2, 2 - d i m e t h y l s i lapentane-5-sulphonic acid (DSS). 
Some ^H nmr were rec or ded using a Varian EM360 (60 MHZ)
continuous wave nuclear magnetic resonance spectrometer.
Tritium nmr samples were prepared as follows: A known
quantity of the tri tiated compound was dis solved in lOOPl of 
deuterated solvent or aqueous buffer solution. The
radioactivity of the sample was checked by liquid
scintillation counting. Then the sample was placed in a
Wilmad 3mm wide necked nmr tube. The solution was frozen in 
liquid nitrogen and evacuated. The nmr tube was then 
narrowed and sealed in a bunsen flame. In general the nmr 
samples were stored at -20°C prior to analysis.
1.2.1.2 Infrared S p e c t r o s c o p y .
IR spectra were recorded using a Perkin Elmer grating 
infrared spe ctrophoto meter model 577 instrument. The 
spectra were compared, where possible, with those reported
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in the Sadtler index.
1.2.1.3 Thin Layer C h r o m a t o g r a p h y .
Thin layer chr oma to graphy (tic) was run using 
conditions as outlined under particular exp eriments where it 
was required. In all cases fluorescent silica gel plates
were used.
1.2.1.4 Rad ioactive Thin Layer C h r o m a t o g r a p h y .
Radio tic analyses were carried out using a Berthold
LB2842 automatic tic linear analyser fitted with an LB2821 
detector. Samples were run on 20cm x 20cm fluorescent
backed silica gel plates.
1.2. 1.5 Gas C h r o m a t o g r a p h y .
Gas chrom atogr aphy (G C ) was carried out using a Sigma 
3B gas ch romat ography instrument fitted either with a 
Carbowax 20M or O V 1 column.
1.2. 1.6 High Performance Liquid C h r o m a t o g r a p h y .
High performance liquid chrom ato graphy (HPLC) was
carried out using a Kontron instrument model Uvikon 735LC 
fitted With a Ubondapak 10C18 30cm x 3.9mm column.
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1.2. 1.7 Elemental M i c r o a n a 1 v s i s ♦
CHN elemental analysis was carried out by Mrs N. 
Walker using a Carlo Erba elemental analyzer model 1106.
1.2. 1.8 Melting P o i n t s .
Melting points and decomposition temperatures were 
recorded using a Gal len ka mp apparatus.
1.2. 1.9 Liquid Scintillation C o u n t i n g .
The radioactivity of tritiated samples were counted 
using a Beckman LS 1800 liquid sci ntillation counter. 
Samples were prepared using a solution of 2,5- 
d i p h e n y l o x a z o le (PPO) in toluene as the scintillant 
(3.4gl“ ^), unless otherwise stated.
1.2.1.10 R e a g e n t s .
The reagents used throughout this work were all 
analytical grade, unless stated otherwise, and were either 
used directly or pur if ied as described for each experiment.
1.2.1.11 So 1 v e n t s .
Pure tetrahydr ofuran was prepared for use by leaving 
HPLC grade solvent over lithium alumi nium hydride and 
distilling over the dry fraction at 6 5 - 6 6 “C. The purified
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t e t r ahydr of uran was used immediately or stored over calcium 
h y d r i d e .
1.2.1.12 Buffer S o l u t i o n s .
Buffer solutions were prepared as described  below, in 
accordance with the methods outlined by Perrin and 
Dempsey^^.
(a) Acetate buffer (pH 4.0): 0.21M acetic acid (80cm®), 
0.19M sodium hydroxide (22cm®).
(b) Phosphate buffer (pH 6 .8 ): 0.025M anhydrous potassium 
di hyd rogenph osphate (3.4 2 5 g / 1“ ^), 0.025H anhydrous 
dipotassium hy drogenphospha te (4.4g/l“ ^).
(c) Borate buffer (pH 9.0): 0.5M anhydrous tet rasodium 
borate ( 1 1 .3 g / 1 0 0 c m ® ) .
1.2.2 Synthesis of didehydroamino acids via azide
interm e d i a t e s .
1.2.2.1 2-Bromopr opionic  a c i d .
Pure propionic acid was prepared by distilling a sample 
of the general purpose reagent at 140-141=0, after p re ­
drying by standing over 4A molecular sieve. Dry bromine was 
prepared, in accordance with the instructions of Vogel by 
shaking bromine with an equal volume of sulphuric acid and 
separat ing  off the halogen layer.
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Freshly dis tilled dry propionic acid (30mls, 0.40
moles) and dry bromine (ISmls, 0.29 moles) were placed in a 
three necked flask, fitted with a thermometer and condenser, 
to which a sodium hydroxi de trap was attached. Phosphorus 
trichloride (l.Smls) was slowly added to the mixture and the 
reaction heated at 50°C for two hours. 2-Bromopropionic 
acid was collected by distillation at 162=C / 30mmHg, Yield 
67% (84g, 0.55 moles). A yield of 45% (53.9g, 0.37 moles)
was obtained using un purified reagents. nmr (solvent
CDCls) S ppm: 11.7 ( IH, broad s, of carboxylic acid group
proton); 4.4 (IH, q, CH group); 1.8 (3H, d, CHs group). IE 
(Nujol mull, NaCl plates) cm ” ^: 3100-3000 broad sh (carboxyl 
OH stretch), 298 0-2700 v. sh, 1720 sh (0=0 stretch), 1420 sh 
(0-0 and OH coupled vibrations). OHN (for 03, H5, 02, B r ): 
calculated 0 23.70%, H 3.30%; found 0 23.58%, H 3.27%.
1.2.2.2 2-Brom o- 4-methv Ip entanoi c a c i d .
4-MethyIpentanoic acid (25g, 0.21 moles) was mixed with 
dry bromine (15mls, 0.29 moles) and phosphorus trichloride
(4mls) was added slowly. The reaction mixture was heated at 
75=0 for four hours. 2- Br omo~4 -methyipe ntoic acid was 
collected by distilla tion at 64=0. Yield 57% (25.7g, 0.122 
moles). ^H nmr (solvent ODOls) S ppm: 4.1 (IH, m, a-OH
group); 1.7 ( IH, m, OH group); 1.4 (2H, m, OHz group); 1.0 
(6H, d, d-OHs groups). IE (Wujol mull, NaOl plates) cm""^: 
3100 broad m (carboxyl OH stretch), 300 0-2900 sh, 1750 m 
(Oarboxyl 0=0 stretch). OHN (for 06, Hll, 02, Br): 
calculate d 0 36.92%, H 5.64%; found 0 37.17%, H 5.76%.
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1.2.2.3 2-BrQmopropiQnic acid methyl ester.
2- Bro mopropionic acid (20mls, O.lSmoles), 2, 2-
dimethoxypropane ( lOmls, O.lmoles), methanol (5mls, 
0.13moles) and toluene-p-su lphonic acid (O.lg) were added 
together. The mixture was refluxed for two hours at 60=C. 
The mixture was washed with sodium bicarbonate (20mls) to 
neutralise any unreacted 2-bromopropionic acid. The organic 
layer was extracted with dichloromethane ( 3  x 2 0 mls). 2 -
Bromopropionic acid methyl ester was collected by 
distillation at 143-5=0. Yield 75% (16mls, 0.096 moles). 
nmr (solvent ODCI 3 ) S ppm: 4.3 ( IH, q, OH group); 3.7 (3H,
s, OH 3  of methyl ester group); 1.8 (3H, d, O H 3  group). IE 
(Nujol mull, NaOl plates) c m ~ M  3000-2800 sh, 1750 sh (0=0 
stretch), 1180 m (0-0 stretch). OHN (for 04, H7, 02, Br): 
calculated 0 28.74%, H 4.19%; found 0 30.58%, H 4.42%.
1.2.2.4 2-Bromo- 3-methylb utanoic acid methyl e s t e r .
2-Bromo -3 -methyIbutano ic acid ( lOg, 0.055moles), 
methanol (3mls, 0.075moles), 2, 2-dimethox ypr opane (12mls,
012moles) and tolue ne- p-sulphon ic acid (O.lg) were refluxed 
together for three hours at 70=0. The reaction mixture was 
washed with sodium bic arbonate (lOmls). The organic layer 
was extracted with dichloromethane (3 x 20mls). The 
dichloromethane was evaporated off and 2 - b r o m o - 3 - 
methylbutanoic acid methyl ester collected at 80=0 / 20mmHg. 
Yield 54%. (5ml, 0.025 moles). ^H nmr (solvent CDCls) S
ppm: 4.0 ( IH, d, a-OH group); 3.7 (3H, s, OHa of methyl
ester group); 2.1 (IH, m, G-OH group); 1.1 (6 H, dd, t-CHs
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groups). IE (NujO-1 mull, NaCl plates) cm~^: 3000-2900 sh, 
1740m and 1620m (0=0 stretch), 1160m (0-0 stretch). OHN 
(for 06, Hll, 02, Br); calcula ted  C 36.92%, H 5.64%; found C 
36.85%, H 5.93%.
1.2. 2 .5 2-B ro mo-4-met hvlpentan oic acid methyl e s t e r .
Methanol (5mls, 0.13moles), toluene -p-sulpho nic acid 
(O.lg), 2-b ro mo-4-me th yIpenta no ic acid methyl ester (8g, 
0.044moles) and 2, 2-dimet hoxypropa ne (lOmls, O.lmoles), 
methanol (5mls) and toluene-p-su lphonic acid (O.lg) were 
refluxed for three hours at 70=0. The reaction mixture was 
washed with sodium bicarbonate (lOmls) and then the organic 
layer extracted with dichloromethane (3 x 20mls). The 
volume of the solvent was reduced by rotary evaporation. 2 - 
B r o m o - 4 - m e t h y Ipenatanoic acid methyl ester was collected at 
94=0 / 25mmHg. Yield 58% (5ml, 0.025 moles). ^H nmr
(solvent CDCls) d ppm; 4.1 ( IH, m, CH group); 3.7 (3H, s, 
CHs of methyl ester group); 1.5 ( IH, ra, CH group); 1.3 (2 H, 
m, CHs group); 1.0 (6 H, d, d-CHs groups). IE (Nujol mull, 
NaCl plates) cm~^t 3000- 290 0 sh, 1740 m (0=0 ester 
carbonyl), 1170 (00 stretch). OHN (for 07, HIS, 02, Br): 
ca lcu lated 0 40.19%, H 6.22%; found C 40.67%, H 6.08%.
1.2.2.6 2-AzidoprQpionic acid methyl ester.
Three experiments were carried out to optimise the 
reaction conditions. These are described below.
(a) Small scale p r e p a r a t i o n : 2-Bromopropionic acid methyl
ester (2mls, 0.012moles), water (4rals), sodium azide (0.96g)
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and tet rab ut ylammon iu m bromide (150mg) were stirred for five 
hours. The product was then extracted with dichloromethane 
C3 x lOmls). The solution was dried over sodium sulphate 
and then the solvent removed by rotary evaporation. Yield 
89% (1.4g, O.Ollmoles). 93% pure by G C .
(b) Twelve hour p r e p a r a t i o n : 2-B romopropionic acid methyl 
ester (9mls, 0.054moles), water (20mls), sodium azide (4g) 
and tetr ab utylammonium  bromide (0.5g) were stirred for 
twelve hours at room temperature. The reaction mixture was 
worked up as above. Yield 92% (6.5g, O.OSmoles). 96% pure 
by GC.
(c) Short reaction t i m e s : The above reaction was repeated
but the time was reduced to one and a half hours. In the 
second experiment the weight of the phase transfer catalyst 
was halved. The samples were worked up as previously 
described. The yields were 82% C5.7g, 0.044moles) and 70%
(4.9g, O.OSBmoles) respectively. 94% pure by G C ,
nmr (solvent CDCI3) S ppm: 3.9 (IH, m, CH group);
3.7 (3H, s, CHs of methyl ester group); 1.4 (3H, d, CHs 
group). IE (Nujol mull, NaCL plates) cm~^: 3000-2900 sh,
2100 sh (C-N stretch azido group), 1750 m (C=0 ester 
carbonyl), 1625 m (N=N stretch), 1360 m (C-N stretch), 1160 
w (C-0 stretch propionate). CHN (for C4, H7, 02, N3):
calculated C 37.20%, H 5,43%, N 32.56%; found C 37.46%, H 
5.54%, N 32.78%.
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1.2.2.7 2-Azi do -S-methylbu tanoic acid methyl e s t e r .
2 - Brom O“ 3-meth yIbutanoi c acid (8 g, 0.4moles), sodium 
azide (4g), water (20mls) and tet rabutylammoniun bromide
(0.4g) were stirred for six hours. 2- Azido-3-m ethyIbuta noic 
acid methyl ester was colle cted by vacuum distillation at
76=C / 20mmHg. Yield was 67% (4mls, 0.026moles). 96% pure by 
GC. nmr (solvent CDCls) d ppm: 4.0 (IH, d, CH group); 3.7 
(3H, s, CHs of methyl ester group); 2.2 ( IH, m, CH group);
1.2 (3H, d, t -CH s group); 1.1 (3H, d, t - C H s group). IE
(Nujol mull, NaCl plates) cm~^: 3000-2900 sh, 2100 sh (C-N
stretch azido group), 1740 m (C=0 stretch ester carbonyl), 
1620 m (N=N stretch), 1160 w (C-0 stretch). CHN (for C 6 , 
Hll, N3, 02): calcula ted C 45.86%, H 7.00%, N 26.75%; found 
C 45.65%, H 6 .8 6 %, N 26.34%.
1.2.2.8 2-A zi do-4-met hyIpentan oic acid methyl e s t e r .
2- Bromo -4 ~methyIpentan oic acid methyl ester (4 g, 
0 .0 2 2 moles), sodium azide (2 g), distilled water (8 mls) and
tetrabutyl ammonium bromide (0.4g) were stirred for six 
hours. The product was purifed as above. Yield 78% (3ml, 
0.017moles). 97% pure by G C . ^H nmr (solvent CDCls) d ppm:
4.0 (IH, m, CH group); 3.7 (3H, s, CHs of methyl ester
group); 1.7 ( IH, m, r-CH group); 1.3 (2H, m, #-CHz group);
1.0 (6 H, d, d-CHs groups). IE (Nujol mull, NaCl plates) cm~
^: 3000-2900 sh, 2080 sh (C-N stretch azido group), 1740 m
(C=Q stretch ester carbonyl), 1630 (N=N stretch), 1160 (C-0 
stretch). CHN (for C7, H13, 02, N3): calc ula ted C 49.12%, H
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7.80%, N 24.56%; found C 49.45%, H 7.34%, N 24.25%.
1.2.2.9 Chr omatograp hic analysis of 
2 -azidopropio nic acid methyl e s t e r .
(a) Tic analysis of the 2 - a z idocar prop ionic acid methyl 
ester was carried out using the following solvent systems: 
chloroform, 1 : 1  (v/v) hexane: chloroform, 1 : 1  (v/v) hexane: 
ethanol. Samples were referen ced  to 2~bromopr opionic acid 
methyl ester and propionic acid. Tic plates were air dried 
and Visualized by exposure to iodine and by spraying with 
sulphuric acid. Similar analysis was carried out for 2- 
a z i d o - 3 - m e t h y Ibutanoic acid methyl ester and 2-azido-4- 
met hyIpentanoic acid methyl ester.
(b) Gas chrom atography  analysis of 2-azi dopropionic 
acid methyl ester was carried out using the following 
procedure. 0.5M1 of 2-azi dop ropoinic a d d  methyl ester 
(50pl/ml d i c h l o r o m e t h a n e ) was injected onto the column 
(O V 1 ), which was set at 100=C. Reference samples of 
propionic acid and 2-brom opropioni c acid were prepared. The 
purity of 2 -a zid opropionic acid methyl ester was determined 
by measuring the amount of 2 -bromopropionic acid methyl 
ester and propionic acid present in the sample compared to 
the reference samples. Both Carbowax 20H and O V 1 columns 
were used. In the case of carbowax 20M insufficient 
resolution of the product was obtained. Attempts were made 
to carry out analysis at higher column temperatures but it 
was found that the azide decomposed. Similar analysis was
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carried out for samples of 2 - a z ido-3-raethyIbutanoic acid 
methyl ester and 2-azido~4~inethylpentanoic acid methyl 
e s t e r .
1.2.2.10 2- Ac etamidopro p-2-enoic  acid methyl e s t e r .
(N-acetyl-2, 3-didehydro alanine methyl ester)
2-Azidopropionic acid methyl ester (4g, 0.03moles),
acetic anhydride (50mls) and glacial acetic acid (24mls) 
were refluxed for sixteen hours at 80°C in the presence of 
quinol (O.lg) and rhenium heptasulphide (O.lg). Acetic acid 
and acetic anhydride were removed by distillation at 
30=C/20mmHg. The residue was taken up in 1:1 (v/v)
petroleum ether: diethyl ether (lOOmls). The solvents were
removed by rotary evaporation. The crude product was 
recrystallised from a minimum volume of 1 : 1  (v/v) petroleum 
ether: diethyl ether after the insoluble matter had been
removed by filtration. Yields 10% (.48g, 0.003moles) and
35% (1.68g, 0,012moles). M.pt 51-52=0 found, 52-54=0
literature nmr (solvent de-DHSO) S ppm: 9.3 (IH, s,
NH group); 8.1 ( IH, s, #-OHz group); 5.6 (IH, s, #-OHz 
group); 3.7 (3H, s, CHs of methyl ester group); 2.0 (3H, s, 
CHs of acetyl group). IE (Nujol mull, NaCl plates) cm~^: 
3400-3200 broad m (amide I), 3000-2900 sh, 1780-1760 m (C=0
stretch of methyl ester group), 1650 m (0=0, amide II/ C=C 
stretch). CHN (for C5, H7, 03, N ): calcula ted  C 50.35%, H
6.29%, N 9.80%; found 0 50.04%, H 10.01%, N 6.42%.
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1.2.2.11 Att empted preparation of 2-acetaBiido-3- 
m e t h y lbut- 2 - e n o ic acid methyl ester 
(N-acetyl-2, 3-didehydrov aline methyl e s t e r ) .
2- Azi do-3-m et hylbuta no ic acid methyl ester (Ig, 
O.OOSmoles) was reac ted  with acetic anhydride (5mls) in the 
presence of quinol (lOmg) and rhenium heptasulphide (4 2 m g ) 
for thirty five hours at 90=C. Water (3mls) was added to the 
mixture. The reaction mixture was heated for a further 
thirty hours at 90°C. The product was extract ed using 1:1 
(v/v) petroleum ether : diethyl ether (lOOmIs). A black
residue was obtained after evaporating off the solvents. 
Attempts to isolate a crystalline product from the crude 
mixture was unsuccessful.
1.2.2.12 First attempted preparation of 2-ace tamido-4-  
m e t h y lpent- 2 - e n o ic acid methyl ester 
(N-acetyl-2, 3-didehydr oleucin e methyl e s t e r ) .
2-Azido-4 ~methyl pe ntanoic  acid methyl ester (4g, 
0.023moles), acetic anhydride (56mls) and acetic acid 
(24mls) were refluxed in the presence of rhenium 
heptasulphide ( 0.Ig) and quinol ( 0. Ig) at 90=C. The 
reaction was mon itored by following the disappearance of the 
azido stretching frequency at 2 1 0 0 c m ”  ^ in the infrared 
spectrum. After thirty hours the reaction was stopped. 
Excess acetic acid and acetic anhydride were removed by 
vacuum distillation at 30=C/20mmHg. The residue was taken 
up in 1:1 (v/v) petroleum ether: diethyl ether (SOmls). The
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solvents were removed by rotary evaporation. Attempts to 
recrystal lise the product from a minimum volume of 1:1 (v/v) 
petr ole um ether: diethyl ether was unsuccessful. The
product of the reaction was a black tarry solid.
1.2.2.13 Second at tempted preparation of 2-acetamido-4- 
m e t h y l p e n t - 2 - e n o ic acid methyl e s t e r .
2 - A z i d o - 4-m et hyIpentanoic acid methyl ester (Ig, 
O.OOSmoles) and acetic anhydride (5mls) was refluxed in the 
presence of quinol (40mg) and rhenium heptasulphide (40mg) 
for thrty five hours at 90=C. Mater (4mls) was added to the 
system and the reaction mixture refluxed for a further 
thirty hours at 90=C. The product was extra cted with 1:1 
(v/v) petroleum ether: diethyl ether (lOOmls). The solvents
were removed by evaporation and the crude residue 
recrystallised from a minimum volume of 1:1 (v/v) petroleum 
ether: diethyl ether. A dirty white powder was obtained.
Subsequent analysis showed that the reaction had been 
u n s u c c e s s f u l .
1.2.3 Synthesis of didehydroamino acids 
via azlactone intermediates.
1.2.3.1 Preparation of 4-is opropyl idene-  
2-phenyloxazo1-5-one 
(M - b e n z o y 1-2, 3-d ide hydrovaline a z l a c t o n e ) .
The following synthesis was based on the method of 
Ramage and Simonsen Powdered benzoyIglycine (4 0 g ),
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acetic anhydride (90g), acetone (120g) and sodium acetate 
(24g), which had been pre-dried at 100=C, were placed in a 
dry 500ml round bottomed flask. The reaction mixture was 
then refluxed at 90=C for six hours. The solution was 
allowed to cool and then poured into distilled water 
(300mls). The resulting crystalline solid was collected by 
vacuum filtration. The crude product was washed with a 
dilute solution of sodium bicarbonate (3 x 30 mis). 
Recrystallization from ethanol gave a pink needle 
crystalline product. M.pt. 103-4=0 found, 100-102=0 
literature Yield 40% (17.4g). nmr (solvent ODCla) S
ppm: 8.0 (2H, dd, ortho protons of 2-phenyl group); 7.3
(3H, complex, meta and para protons of 2-phenyl group); 3.4 
(SH, d, OHa groups).
1.2.3.2 Attempted preparation of 4-iSQpropvlidene- 
2-methyloxazo1-5-one 
(N-acetvl-2. 3-didehvdrovaline azlactone).
N-Acetylglycine (40g); acetic anhydride (90g); acetone 
(120g) and sodium acetate, pre-dried at 100=0, were added to 
a dry 500ml round bottomed flask. The reaction mixture was 
refluxed at 85=0 for six hours. Initially a pasty solid 
formed and this eventually dissolved to give a green 
solution. The solution turned orange on prolonged heating. 
After cooling, the solution was poured into distilled water 
(400mls). Attempts to isolate a product were unsuccessful.
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1.2.3,3 Preparation of 4 - b e n z y 1idene- 
2-methvloxazo1-5-one  
(N-acetyl-2. 3 - d i d e h y d r ophenylalanine a z l a c t o n e ) .
N-Acetylglycine (5g), benzaldehyde (8mls), anhydrous 
sodium acetate (3g) and acetic anhydride (lOmls) were 
liquified. The solution was boiled for two hours. After 
cooling, it was kept in a refrigerator overnight. The 
crystalline product was stirred with water (30mls) and 
filtered under suction. The product was washed with cold 
water (2 x 25mls) and ether (lOmls). The product was dried 
at 100=C. The pale yellow crystalline product had a yield 
of 83% (4.88g). M.pt 148-9=0 found, 150=0 literature 
nmr (solvent ODCl») S ppm: 8.0 (2H, dd, ortho protons of 2-
phenyl group); 7.4 (3H, m, meta and para protons of 2-phenyl 
group); 4.4 (2H, s, OH® group).
1.2.3.4 Preparation of 4 - b e n z y 1idene- 
2 r P h e n y l o x a z o 1-5-one 
(N - b e n z o y 1-2, 3-didehydrophenylalanine a z l a c t o n e ) .
N-Benzoylglycine (5g), freshly distilled benzaldehyde 
(12mls), acetic anhydride (lOmls) and anhydrous sodium 
acetate (5g) were added to a conical flask and liquified on 
a hot plate. The solution was boiled at 110=C for one hour. 
Absolute ethanol (50ml) was added slowly to the solution. 
Cooling the solution in ice resulted in the formation of a 
pale green crystalline product. The product was collected 
by filtration under suction and washed with cold ethanol (2
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X lOmIs), and then with boiling water. The product was 
recrystallised from benzene. Yield 89% (6.33g). M.pt 188- 
187=C found, 167-168=0 literature ’^ ®. ‘H nmr (solvent 
CDC I3 ) S ppm: 8.1 (4M, overlapping dd, ortho protons of both 
the 2-phenyl and 4-phenyl groups); 7.4 (8H, complex,
overlapping meta and para protons of both the 2-phenyl and 
4-phenyl groups); 7.2 ( IH, s, CH group).
1.2.3.5 2 - a c e t a m ido-3-phenvlprop-2-en oic acid 
(N-acetvl-2. 3 - d i d e h v d r o p h e n v l a l a n i n e ) .
4-Benzylidene-2-methyloxazol- 5-one (4g), water (18mls) 
and acetone (45mls) were refluxed for four hours at 98=C.
The acetone was evaporated off and water (40mls) added to
the solution. The solution was boiled for ten minutes and 
then filtered through a hot funnel. Decolourising charcoal 
was added to the filtrate and the mixture boiled for ten
minutes. The mixture was filtered through a hot funnel and
the filtrate stood in a refrigerator overnight. The 
resulting crystalline product was collected by vacuum 
filtration and washed with water (2 x lOmls). The product 
was dried at 100=C. Yield 79% (3.78g). M.pt. 191-192=C
found, 192=C literature ^H nmr (solvent de-DMSQ) S  ppm:
9.5 (IH, s, NH group); 7,8 (2H, d, ortho protons of
phenylalanine aromatic ring); 7.4 (3H, m, meta and para
protons of phenylalanine aromatic ring); 7.2 ( IH, s, G-CH
group); 1.9 (3H, s, CH» of acetyl group). CHN (for
C11,H11,N, 03): c a l c ulated C 84.39%, H 5.36%, N 8.82%; found 
C 84.03%, H 5.28%, N 6.82%.
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1,2,3.6 2 - b e n 2 a m i d o - 3 - p h e n y Iprop-2-enolc acid 
(N-benzoyl-2, 3 - d i d e h v d r o p h e n y l a l a n i n e ).
4-B e n z y l i d e n e - 2 “ p h e n y l o x a z o l “5-one (Ig) and potassium 
hydroxide (0.5g/ lOmls water) were refluxed at 100=C for\two 
hours. Excess c o n c e ntrated hydrochloric acid was added to 
the solution. The white needle crystalline product was 
collected by vacuum filtration. Yield 93% (0.94g). M.pt
198-199=0 found, 199-200=0 literature (®'^ . nmr (solvent
da-DMSO) S ppm: 9.9 ( IH, s, NH group); 8.0 (2H, d, ortho
protons of phenylalanine aromatic ring); 7.8 (5H, complex,
o verlapping meta and para protons of phenylalanine aromatic 
ring and ortho protons of benzoyl group aromatic ring); 7.3 
(4H, m, overlapping meta and para protons of benzoyl group 
aromatic ring and (Î-CH group). CHN (for C16, H15, N, 03):
calculated C 71.91%, H 4.86%, N 5.24%; found C 70.45%, H
4.87%, N 5.53%.
1.2.3.7 N -benzoyl-3-methylbut-2-enoic acid 
(N-benzoyl-2. 3 - d i d e h y d r o v a l i n e ).
2 - P h e n y l - 4 - i s o p r o p y l ideneoxazol-5-one (1.21g) and
potassium hydroxide (0.5g/ lOmls distilled water) were
heated on a water bath for two hours. Excess concentrated 
hydrochloric acid was added and the reaction solution stood 
over ice for four hours. The resulting crystalline product 
was collected by vacuum filtration and washed with cold 
water (3 x 30mls). Yield 98% (1.45g). M.pt 215=C
(decomposition). ^H nmr (solvent da-DMSO) S ppm: 9.5 ( IH, s,
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NH group); 7.9 (2H, d, ortho protons of benzoyl group
aromatic ring); 7.5 (3H, m, meta and para protons of benzoyl 
group aromatic ring); 2.1 (3H, s, t -CH» group); 1.8 (3H, s, 
T-CHa group). CHN (for C7, H13, N, 03): calculated C
52.83%, H 8.17.%, N 8.80.%; found C 53.28%, H 8.37%, N 
8.58%.
1.2.3.8 N-acetyl-4, 5 - d i d e h v d r o l e u c i n e .
N-acetyl-4, 5-didehydroleucine was supplied by Dr. Wade 
of Ciba-Geigy pharmaceuticals. M. pt. 158-159=0 found, 158- 
159=C literature . ^H nmr (solvent de-DHSO) S ppm: 8.0
( IH, d, NH group); 4.8 ( IH, s, d-CHz group); 4.8 ( IH, s, d- 
CHz); 4.3 ( IH, m, a-CH group); 2.4 (IH, m, G-CHz group); 2.2 
(IH, m, G-CHz group); 1.8 (3H, s, CH» of acetyl group); 1.6 
(3H, s, d-CHa).
1.2.4 Synthesis of didehydropeptides via 
azlactone inter m e d i a t e s .
1.2.4.1 Synthesis of N-acetyl-2. 3 - d i d e h y d r o p h e n y l a l a n y 1-
L - a l a n i n e .
L-Alanine (0.9g), acetone (lOmls), IM sodium hydroxide 
(lOmls) and 4 - b e n z y 1 idene-2-methyloxazol-5-one (2.0g) were 
stirred for several hours until a clear solution was formed. 
IH hydrochloric acid (11 mis) was added to the solution. The 
solvents were e v a p orated off to leave a creamy white 
residue. Recrystallization from 80% methanol by the addition
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of water gave a creamy crystalline product. The 
recrystallization of the product was carried out three 
times. Yield 54% (1.6g). M.pt 193-184=0 (decomposition) 
found; 195-196°C (decomposition, corrected) literature
nmr (solvent d*-DMSO) S ppm: 9.4 (IH, s, NH of acetyl
group); 8.1 (IH, d, NH of peptide bond group); 7.5 (2H, d, 
ortho protons of phenylalanine aromatic ring); 7.4 (3H, m, 
meta and para protons of phenylalanine aromatic ring); 7.0 
(IH, s, (1-CH group); 4.3 (IH, m, a-CH group of alanine); 1.9 
(3H, s, CHs of acetyl group); 1.3 (3H, d, (l-CHs group). CHN 
(for C14, H16, N2, 04): calculated C 80.87%, H 5.79%, N
10.14%; found C 81.28%, H 5.58%, N 10.13%.
1.2.4.2 Attempted synthesis of N-benzoyl-2. 3- 
didehvdrophenylalanvl-L-jglutamic a c i d .
L-Glutamic acid (3g) was stirred in a solution of IM 
sodium hydroxide (lOmls) and acetone (5mls) for ten minutes 
and then 4 - b e n z y 1idene-2-phenyloxazol-5-one (5g) was added. 
The mixture was stirred for several hours until a clear 
solution formed. Then IH hydrochloric acid (lOmls) was added 
and the resulting precipitate collected by vacuum 
filtration. Recrystallization from 80% methanol by 
subsequent addition of water gave a white crystalline 
product. Analysis of the product by nmr showed that 
several compounds were present. Attempts to isolate the 
desired compound by repeated recrystallization and 
preparative tic using a 5:2:3 (v/v) butan-l-ol: acetic acid: 
water system were unsuccessful.
60
1.2.4.3 Attempted preparation of N-acetyl-2, 3- 
p h e n y l a l a n y l - L - t v r o s i n e .
L-Tyrosine (3g), 4 - b e n z y 1idene-2-phenyloxazol-5-one 
(5.5g), acetone (38mls) and IM sodium hydroxide (17mls) were 
stirred for five hours. The mixture was filtered and washed 
with water (3 x lOmls). The combined filtrate and washings 
were collected and acidified with IM hydrochloric acid 
(18mls). The solution was stood in ice and a thick white 
precipitate formed. The product was collected and 
recrystallised from methanol. Analysis of the product 
showed it to contain predominantly N - b e nzoyl-2,3-
phenylalanine. The reaction was repeated but at temperature 
of 0=C, 30®C and 50 “ C. In all cases the reaction was
unsucessful. The reaction was then carried out with the IM 
sodium hydroxide replaced by 2M sodium hydroxide (17mls) and 
2H potassium hydroxide (17mls) respectively. In both cases 
no coupling of the azlactone and L-tyrosine was observed.
1.2.4.4 Preparation of N -acetyl-2,3- 
d i d e h y d r o p h e n y l a l a n y I g l y c i n e .
Glycine (3g) was suspended in acetone (40mls) and IM
sodium hydroxide (40mls) was added slowly. After stirring 
the mixture for several minutes, 4 - b e n z y l idene-2-methyl
oxazol-5-one (7.5g) was added. The mixture was stirred
until a clear solution formed and then IM hydrochloric acid 
(40mls) was added. The solution was stood in a refrigerator 
for two days. The resulting crystalline product were
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filtered under suction. The crude product was dissolved in 
10% aqueous potassium bicarbonate (20mls) and reprecipitated 
by the addition of IM hydrochloric acid. The product was 
washed and dried at 60=C. Yield 91% (9.6g). M.pt 193-194=0 
found; 194-195=0 literature nmr (d«-DMSO) S ppm: 9.4
(IH, 8, NH of acetyl group); 8.2 (2H, d, NH of peptide bond 
group); 7.5 (2H, d, ortho protons of phenylalanine aromatic 
ring); 7.4 (3H, m, meta and para protons of phenylalanine 
aromatic ring); 7.1 ( IH, s, (Î-CH group); 3.8 (2H, s, OHz 
group); 1.9 (3H, s, OHs of acetyl group). OHN (for 013, 
H14, N2, 04): calculated 0 59.54%, H 5.34%, N 10.68%; found
0 59.67%%, H 5.63%%, N 10.59%.
1.2.4.5 Attempted synthesis of N-benzoyl-2, 3- 
didehydrovalinvlglycine ethyl e s t e r .
4 - I s o p r o p y l idene-2-phenyloxazol-5-one (Ig) was stirred 
at 0=0 in diethyl ether (ISmls) until a clear solution 
formed. After one hour freshly prepared glycine ethyl 
ester, dissolved in diethyl ether (0.5mls, 0.5g/ml diethyl
ether. The mixture was stirred overnight but no product 
precipitated out. The ether was evaporated off and the 
residue recrystallized from ethyl acetate. Analysis of the 
residue by ^H nmr showed a mixture of compounds to be 
present. Attempts to isolate the desired compound by 
repeated recrystallization and preparative tic using a 
12:3:4 butan-l-ol: acetic acid: water system and a 9:1
chloroform: methanol system were unsuccessful. The reaction
was repeated using glycine methyl ester instead of glycine
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ethyl ester but the reaction was also unsuccessful.
1.2.4.6 Attempted synthesis of N-benzoyl-2, 3- 
didehydrovaliny1-L-alan in e .
4 - I s o p r o p y 1idene-2-phenyloxazol-5-one (4g) and L- 
alanine (2.5g) were stirred in IM sodium hydroxide (ISmls) 
for ten minutes and then acetone (8mls) was added. The
mixture was stirred for several hours until a clear solution 
formed. IM hydrochloric acid (18mls) was added and the 
resulting precipitate collected by filtration under vacuum. 
The product was recrystallized twice from 60% methanol by
addition of water. The product was dried at 60=C. Analysis 
of the product by nmr spectroscopy showed the major 
component to be N-benzoyl-2, 3 - d i d e h y d r o v a l i n e .
1.2.4.7 Synthesis of N-benzoyl-2, 3- 
didehydrophenylalanylglycine ethyl e s t e r .
4 - B e n z y l i d e n e - 2 - p h e n y loxazo1-5-one (Ig) was dissolved 
in diethyl ether (20mls) and stirred for half an hour at 
0=C. Freshly prepared glycine ethyl ester, dissolved in 
diethyl ether (O.Smls) was added. The mixture was stirred at 
0 “C and after one hour a white crystalline product was
formed. The product was filtered and dried at 60=C. Yield
76% (1.07g). M.pt 138-9=C found, 135-136=0 literature®®. 
nmr (solvent de-DMSO) S ppm: 9.9 (IH, s, NH of benzoyl
group); 8.3 (2H, d, NH of peptide bond group); 8.0 (2H, d, 
ortho protons of phenylalanine aromatic ring); 7.6 (5, m.
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o verlapping meta and para protons of phenylalanine aromatic 
ring and ortho protons of benzoyl group aromatic ring); 7.3 
(4H, m, overlapping meta and para protons of benzoyl group 
aromatic ring and G-CH group); 3.8 (2H, d, CHa group of 
glycine). CHN (for 020, H20, N2, 04): calculated 0 68.18%, H 
5.88%, N 7.95%; found 0 88.28%, H 5.73%, N 8.17%.
1.2.4.8 Synthesis of N-benzovl-2, 3- 
didehydrophenylalanvlglycine (first m e t h o d ) .
N-Benzoyl-2, 3-didehydrophenylalanyIglycin e ethyl ester 
(Ig) was suspended in IM sodium hydroxide (lOmls) and 
stirred. After half an hour a clear solution formed. The 
solution was neutralized by the addition of IM hydrochloric 
acid. The solvent was removed by freeze drying. The 
residue was taken up in hot 60% methanol (10ml) and filtered 
through a hot funnel to remove the insoluble matter. 
Decolourising charcoal was added to the solution and the 
mixture was boiled for five minutes. The charcoal was 
removed by filtration through a hot funnel. The methanol 
was removed by rotary evaporation. Recrystallization from 
acetone by the addition of water gave a white needle 
crystalline product. Yield 98% (1.07g). M.pt 203-204=0
found; 208-209=0 literature®^. ^H nmr (solvent d®-DMSO) S
ppm: 9.9 (IH, s, NH of benzoyl group aromatic ring); 8.3
(IH, s, NH of peptide bond group); 7.9 (2H, d, ortho protons 
of benzoyl group aromatic ring); 7.6 (5H, m, overlapping
meta and para protons of benzoyl group aromatic ring and
ortho protons of phenylalanine aromatic ring); 7.2 (4H,
G4
complex, overlapping meta and para protons of phenylalanine 
aromatic ring and G-CH group); 3.7 (2H, d, GHz of glycine). 
CHN (for 018, H16, N2, 04): calculated 0 66.87%, H 4.94%, N
8.64%; found 0 66.45%, H 5.02%, N 8.44%.
1.2.4.9 Synthesis of N-benzovl-2, 3- 
d i d e hvdrophenylalanyIglvcine (second m e t h o d ) .
Glycine (3g) was dissolved in acetone (40mls) and IM 
sodium hydroxide (40mlsJ and stirred for twenty minutes. 4- 
B e n z y l idene-2-phenyloxazol-5-one (8g) was added to the 
solution. The mixture was stirred for several hours until a 
clear solution formed. IM hydrochloric acid (40mls) was 
added to the solution and a precipitate formed immediately. 
The product was collected by vacuum filtration an'd 
recrystallized from 60% methanol by the addition of water. 
The white crystalline product was dried at 60=0. Yield 81% 
(8.41g). M.pt 208-209=0 found; 208-209=0 literature ‘H
nmr (solvent de-DMSO) S ppm: 9.8 ( IH, s, NH of benzoyl
group); 8.3 ( IH, s, NH of peptide bond group); 8.0 (2H, d, 
ortho protons of benzoyl group aromatic group); 7.6 (5H,
complex, overlapping meta and para protons of benzoyl group 
and ortho protons of phenylalanine aromatic ring), 7.2 (4H, 
complex, overlapping protons of meta and para protons of 
phenylalanine aromatic ring and #-CH group); 3.8 (2H,
complex d, OHz of glycine). OHN (for 018, H16, N2, 04):
calculated 0 66.67%, H 4.94%, N 8.64%; found 0 66.76%, H 
5.23%, N 8.88%.
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1.2.4.10 Synthesis of N-acetvl-2, 3- 
d i d e h v d r o p h e n v l a l a n y 1 - L - p h e n v l a I a n i n e .
L-Phenylalanine (0.9g), acetone (lOmls), IM sodium 
hydroxide (5mls) and 4-benzylidene-2-methyloxazol- 5-one  
(0.9g) were stirred together until they formed a clear 
solution. IM hydrochloric acid (5mls) was added and a 
crystalline product formed immediately. The product was 
recrystallized three times from methanol by the subsequent 
addition of water. Yield 62% (1.05g). M.pt 213-214=0
(decomposition) found; 213-215=0 (decomposition) literature 
nmr (solvent d©-DMSO) S ppm: 9.4 ( IH, s, NH of acetyl 
group); 8.1 (IH, d, NH of peptide bond group); 7.6 (2H, 
ortho protons of didehydrophenylalanine aromatic ring); 7.3 
(8H, complex, meta and para protons of
didehydrophenylalanine aromatic ring and phenylalanine 
aromatic ring); 7.0 (IH, s, G-OH group); 4.5 (IH, m, a-OH 
group of phenylalanine); 3.0 (2H, complex, G-OHz of
phenylalanine); 1.9 (3H, s, CHs of acetyl group). OHN (for 
020, H20, N2, 04): calculated 0 68.18%, H 5.68%, N 7.95%;
found 0 67.96%, H 5.34%, N 7.76%.
1.2.4.11 Attempted synthesis of N-benzoyl-2, 3- 
di d e h y d r o p h e n y l a l a n y 1 - L - p r o l i n e .
L-Proline (4g) was dissolved in acetone (25ml) and IM 
sodium hydroxide (27ml). 4-Benzylidene-2-phenyloxazol- 5-one  
(8.6g) was added to the solution and the mixture was stirred 
until a clear solution formed. After stirring the solution
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for two hours, IM sodium hydroxide (26mls) was added and 
the resulting precipitate was collected. Recrystallization 
of the product from carbon tetrachloride gave a white
powder. Analysis of the product showed it to be a mixture
of compounds, of which N-benzoyl-2, 3-didehydrophenylalanine
was the major component.
1.2.4.12 Attempted synthesis of N-acetvl-2, 3- 
d i d e h v d r o p h e n y 1a I a n v l - L - l y s i n e .
L-Lysine (5g) was dissolved in IM sodium hydroxide 
(18mls) and acetone (8mls) was added. The solution was 
stirred for ten minutes and then 4 - b e n z y 1idene-2-methyl 
oxazol-5-one (6g) was added slowly. The mixture was stirred 
overnight and the residual azlactone removed by filtration. 
IM Hydrochloric acid (25mls) was added and the resulting
precipitate collected. The product was recrystallized from 
methanol. Analysis of the product by ^H nmr showed it 
contained mainly N-acetyl-2, 3-didehydrophenylalanine and 
that coupling of the azlactone and amino acid had not 
occured.
1.2.5 Miscellaneous s y n t h e s i s .
1.2.5.1 Preparation of N - a c e t y l g l y c i n e .
Glycine (50g, 0.87mol) was dissolved in distilled water 
(100ml) and acetic anhydride (130ml, 140g, 1.4mol) was added 
in three equal portions. The solution was cooled and the
67
resulting crystalline product collected by vacuum 
filtration. Thé product was recrystallised from boiling 
water. Yield of acetylglycine was 96% (75g). M.pt 206- 
207=C found, 207-208=0 literature ’^ ®.
1.2.5.2 Preparation of N - b e n z o v l g l v c i n e .
Glycine (50g, 0.67mol) was dissolved in IM sodium
hydroxide solution (550mls) and benzoyIchloride (90mls, 
lOBg, 0.77mol) was added in five portions with shaking. 
After cooling, the solution was acidified with concentrated 
hydrochloric acid. The resulting precipitate was collected 
under vacuum. The product was boiled in carbon 
tetrachloride. Recrystallisation from boiling water 
(600mls) gave a white crystalline product. Yield was 88g 
(75%). M.pt 186-7=0 found, 187=0 literature
1.2.5.3 Preparation of glycine methyl e s t e r .
Glycine methyl ester was prepared by dissolving glycine 
methyl ester hydrochloride in 0. IM NaOH. The free ester was 
e xtracted with diethyl ether (3 x 20ml). The solvent was 
removed by rotary evaporation. The product was used 
directly to prevent the formation of diketopiperazone.
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1.2.5.4 Preparation of alanine methyl e s t e r .
Alanine methyl ester was prepared from alanine methyl 
ester hydrochloride by using the same procedure as outlined 
above for obtaining glycine methyl ester.
1.2.5.5 Preparation of glycine ethyl e s t e r .
Glycine ethyl ester was obtained from glycine ethyl 
ester hydrochloride by using the procedure outlined for 
glycine methyl ester.
1.2.5.6 Preparation of leucine ethyl e s t e r .
Leucine ethyl ester was prepared from leucine ethyl 
ester hydrochloride by using the same method as outlined for 
glycine
1.2.5.7 Preparation of C4, 5 - ® H ] - l e u c i n e .
N - A c e ty1-C4,5“®H3-leucine (specific activity = 
943mCi/mmol) was refluxed with 3M hydrochloric acid for six 
hours. The product was lyophilized by freeze drying and 
washed with ether (3 x 5ml). The product was dissolved in 
water (1ml) and lyophilized by freeze drying. The sample 
was weighed and its radioactivity determined. The product 
of [4, 5-®H3-leucine was found to have a specific activity 
of 897mCi/mmol. Analysis of the product was by and ®H 
nmr spectroscopy. nmr (solvent DzO) S ppm: 4.1 ( IH, m.
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a-CH group); 1.7 (IH, m, t-CH); 1.5 (2H, m, G-CH=); 0.9 (6H, 
dd, . d-CH® groups). ®H nmr (solvent DzO) S ppm: 1.5 (t-CH
group, 15.1% T); 0.9 (d-CH© groups, 84.9% T)
1.2.5.8 Preparation of N-acetyl-2. 3 - d i d e h y d r o a l a n i n e .
N-acetyl-2,3-didehydroalanine methyl ester (0.5g) was 
stirred with hot IH sodium hydroxide (lOmls) for half an 
hour. The solution was acidified with IH hydrochloric acid. 
The solvent was evaporated off and the residue taken up in 
ethyl acetate (20mls). The insoluble matter was filtered 
off and the solvent removed by rotary evaporation. *-H nmr
(solvent de-DHSO) S ppm: 9.3 ( IH, s, NH group); 8.1 (IH, s,
(î-CHz group); 5.6 ( IH, s, #-CHz group); 1.9 (3H, s, CH© of 
acetyl group).
1.2.6 Hydrogenation of didehydroamino a c i d s .
1.2.6.1 General hydrogenation m e t h o d .
N-acyldidehydroamino acid or peptide (6-12mg) and 5% 
Pd/C catalyst (3-6mg) were suspended in tetrahydrofuran 
(1ml). The reaction flask was attached to the hydrogenation 
line and its contents frozen in liquid nitrogen. The 
hydrogenation line was evacuated and helium swept through it 
(3 times) to remove any air. Hydrogen (10ml) was 
transferred to the mercury burette, which had been p re­
evacuated. The hydrogen gas was then transferred to the
reaction flask. The reaction mixture was thawed out and
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stirred for two hours. The catalyst was removed by 
filtration. The product was lyophilized by freeze drying. 
The product was analysed by ‘H nmr. The nmr spectroscopy 
data of the hydrogenation products of N-acyldidehydroamino 
acids is given below and the corresponding information for 
the hydrogenation of didehydropeptides is found in section 
1.2.7.
1.2.6.2 Hydrogenation of N-acetyl-2. 3-didehydroalanine
methyl e s t e r .
nmr (solvent de-DMSO) S ppm: 8.2 (IH, d, NH group);
4.2 ( IH, m, a-CH group); 3.7 (3H, s, CHs of methyl ester
group); 1.8 (3H, s, CHa of acetyl group); 1.2 (3H, .d, (1-CHa
g r o u p ) .
1.2.6.3 Hydrogenation of N-benzovl-2. 3 ~ d i d e h v d r o v a l i n e .
nmr (solvent ds-DMSO) S ppm: 8.4 (IH, d, NH group);
7.9 (2H, d, ortho protons of benzoyl group aromatic ring);
7.5 (3H, m, meta and para protons of benzoyl group aromatic
ring); 4.3 (IH, m, a-CH group); 2,2 (IH, m, fl-CH group); 1.0 
(6H, dd, T-CHa groups).
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1.2« 6.4 -Hydrogénation of N-acetvl-2. 3- 
d l d e h v d r o p h e n v l a l a n i n e .
*H nmr (solvent d#-DM30) S ppm: 8.1 (IH, d, NH group);
7.2 (5H, m. Phenylalanine aromatic ring); 4.4 ( IH, m, a-CH 
group); 3.0 (IH, m, G-CHz group); 2.8 (IH, m, fî-CHat group);
1.8 (3H, s, CHa of acetyl group).
1.2.6.5 Hydrogenation of N-acetyl-4. 5 - d i d e h y d r o l e u c i n e .
*H nmr (solvent da-DMSO) â  ppm: 8.1 ( IH, d, NH group);
4.2 (IH, m, a-CH group); 1.8 (3H, s, CHa of acetyl group);
1.8 ( IH, m, t-CH group); 1.4 (2H, m, G-CHz group); 0.9 (6H, 
dd, d-CHa groups).
1.2.6.6 Hydrogenation of N-benzovl-2. 3- 
d i d e h y d r o p h e n v l a l a n i n e .
^H nmr (solvent de-DHSO) S ppm: 8.6 (IH, d, NH group);
7.8 (2H, d, ortho protons of phenylalanine aromatic ring);
7.5 (3H, m, meta and para protons of phenylalanine aromatic 
ring); 7.3 (5H, m, benzoyl group aromatic ring); 4,6 ( IH, m, 
a-CH group); 3.1 (2H, m, # - CHz group).
1.2.6.7 Hydrogenation of N-acetyl-2. 3 - d i d e h y d r o a l a n i n e .
*^ H (solvent DaO) S  ppm: 8.1 ( IH, d, NH group); 4.3 ( IH, 
m, a-CH group); 1.9 (3H, m, CHa of acetyl group); 1.2 (3H, 
d, G-CHa groups).
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1,2.7 Hydrogenation of d i d e h y d r o p e p t I d e s .
1.2.7.1 Hydrogenation of N-acetyl-2. 3- 
d i d e h y d r o p h e n y l a l a n v l - L - a l a n i n e .
^H nmr (solvent da-DMSO) fppm: 8.2 (2H, cd, NH of
acetyl and peptide bond groups); 7.3 (5H, complex,
phenylalanine aromatic ring); 4.6 (IH, m, a-CH group of 
phenylalanine); 4.2 ( IH, m, a-CH group of alanine); 3.0 ( IH, 
m; (1-CHa group of phenylalanine); 2.8 (IH, m, (3-CHz group of 
phenylalanine); 1.8 (3H, s, CHa of acetyl group); 1.2 (3H, 
d, (1-CHa group of alanine).
1.2.7.2 Hydrogenation of N-benzoyl-2. 3- 
d i d e h y d r o p h e n v l a l a n y l g l y c i n e .
^H (solvent da-DMSO) S ppm: 8.6 ( IH, d, NH of benzoyl
group); 8.4 ( IH, d, NH of peptide bond group); 7.8 (2H, d, 
ortho protons of benzoyl group aromatic ring); 7.5 (5H,
complex, overlapping meta and para protons of benzoyl group 
and ortho protons of phenylalanine aromatic rings); 7.2 (3H, 
meta and para protons of phenylalanine aromatic ring); 4.7 
( IH, m, a-CH group); 3.8 (2H, m, CHa of glycine); 3.2 (IH, 
m, G-CH group); 3.0 ( IH, m, G-CH group).
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1.2.7.3 Hydrogenation of N-benzoyl-2. 3- 
d ldehydrophenylalanylglycine ethyl e s t e r .
(solvent d*-DMSO) f ppm: 8. G (IH, d, NH of benzoyl
group); 8.4 (IH, d, NH of peptide bond group); 7.8 (2H, d, 
ortho protons of benzoyl group aromatic ring); 7.5 (5H,
complex, overlapping meta and para protons of benzoyl group 
and ortho protons of phenylalanine aromatic rings); 7.2 (3H, 
meta and para protons of phenylalanine aromatic ring); 4.7
(IH, m, a-CH group); 3.8 (2H, m, CHa of glycine); 3.2 (IH,
m, G-CH group); 3,0 (IH, m, G-CH group); 2.0 (2H, m, CHa of 
ethyl ester group); 1.3 (3H, t, CHa of ethyl ester group).
1.2.7.4 Hydrogenation of N-acetyl-2, 3- 
di d e h y d r o p h e n y l a l a n y l - L - p h e n y l a l a n i n e .
*^ H nmr (solvent de-DMSO) 8.3 (IH, d, NH of acetyl 
group); 8.1 ( IH, d, NH of peptide bond group); 7.7 (2H, d, 
ortho protons of N-acetyIphenylalanine aromatic ring); 7.5 
(3H, m, meta and para protons of N-acetyIphenylalanine
aromatic ring); 7.2 (5H, m, phenylalanine aromatic ring);
4.6 ( IH, m, a-CH of N-acetylphenylalanine group); 4.3 (IH, 
m, a-CH of phenylalanine); 3.0 (4H, cm, o verlapping G-CHa of 
N -acetyIphenylalanine and phenylalanine); 2.0 (3H, s, CHa of 
acetyl group).
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1.2.8 Tritiation of didehydroamino a c i d s .
1.2.8.1 General tritiation m e t h o d .
N-Acyldidehydroamino acid or peptide (6-12mg) and 5% 
Pd/C catalyst (6-12mg) were suspended in redistilled 
tetrahydrofuran (1ml) and reacted with a hydrogen-tritium 
mixture (20ml Ha, 1Ci Ta) and stirred for two hours. Then 
the catalyst was removed by filtration. The solvent was 
r emoved by evaporation. Labile tritium was removed from the 
product by repeatedly dissolving the product in methanol 
(1ml) and e vaporating off the solvent until the 
radioactivity of the product was a constant value. The 
product was analysed by ^H and ®H nmr s p e c t r o s c o p y . The 
specific activities and ®H nmr spectroscopy data for the 
tritiated amino acids is given below while the corresponding 
data for tritiated peptides is found in section 1.2.9.
1.2.8.2 N - A cety1— C2. 3-”H3-alanine methyl e s t e r .
specific activity = 835mCi/mmol.
*H nmr (solvent de-DMSO) f ppm: 4.2 (a-CHT, 4.6% T);
1.2 (G-CHzT, 95.4% T).
1.2.8.3 N-Acetyl-C4. 5 - * H ] - l e u c i n e .
specific activity = 943mCi/mmol.
®H nmr (solvent de-DHSO) <5“ ppm: 1.6 (t-CT, 13% T); 0.9
(f-CHzT, 87% T).
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1.2.8.4 N-Acetvl-C2. 3- ” H 3 - p h e n v l a l a n i n e .
specific activity = 827mCi/mmol.
*H nmr (solvent de-DHSO) S  ppm: 4.4 (a-CT, 87.2% T);
3.0 (G-CHT, 32.8% T).
1.2.8.5 N-Benzovl-C2. 3- ” H 3 - v a l i n e .
specific activity = 612mCi/mmol.
®H nmr (solvent de-DHSO) S  ppm: 4.3 (a-CT, 50% T); 2.2
(G-CT, 50% T).
1.2.8.6 H-Benzoyl-C2. 3 - ”H 3 - p h e n v l a l a n i n e .
specific activity = 733mCi/mmol. 
nmr (solvent de-DHSO) S  ppm: 4.6 (a-CT, 58.8% T)5
3.1 (G-CHT, 41.4% T ) .
1.2.9 Tritiation of d i d e h y d r o p e p t i d e s .
1.2.9.1 N-Acetyl-[2. 3- ”H 3 - p h e n v l a l a n v l - L - a l a n i n e .
specific activity = 2.7 Ci/mmol.
®H nmr (solvent de-DHSO) S ppm: 4.5 (a-CH
phenylalanine, 80.4% T ) ; 3.0 (G-CHa phenylalanine, 18.8% T);
2.7 (G-CH= phenylalanine, 14.7% T ) ; 1.2 (G-CHe alanine,
8.3% T).
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1.2.9.2 N-Acetvl-[2. 3 - * H 3 - P h e n v l a l a n v l - L - p h e n v l a l a n i n e .
specific activity = 2.1 Ci/mmol.
*H nmr (solvent d#-DM90) S ppm: 4.5 (a-CH first isomer, 
34.3% T)î 4.4 (a-CH second isomer, 30.9% T); 3.0 (G-CHa
second isomer, 15.2% T); 2.9 (G-CHa first isomer, 19.5% T).
®H nmr (considering first isomer only) â  ppm: 4.5 (a- 
CH, e i . l %T) ;  2.9 (G-CHa, 39.9%T).
®H nmr (considering second isomer only) S  ppm: 4.4 (a- 
CH, 62.8% T); 3.0 (G-CHa, 37.2% T).
Diastereoisomer ratio first: second = 52.6: 47.3
1.2.9.3 N-Benzoyl-[2, 3 - " H 3 - p h e n v l a l a n v l g l v c i n e .
specific activity = 1.8 Ci/mmol.
®H nmr (solvent de-DMSO) S ppm: 4.7 (a-CH
phenylalanine, 50.8% T); 3.2 (49.4%T).
1.2.10 Optimisation of the labelling of N-acetyl- 
C4t 5 - ” H 3 - l e u c i n e .
1.2.10.1 Variation of catalyst: substrate r a t i o .
N-Acetyl-4, 5-didehydroleucine (7.5mg) a nd a known 
quantity of 5% Pd/C catalyst (0.2 to 5 x weight of the 
substrate) were suspended in glacial acetic acid (1ml). The
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mixture was reacted with hydrogen (30ml) and tritium (ICi) 
for two hours. The product was worked up and analysed as 
de s c ribed under the general tritiation procedure (see part 
1.2.8.1). The catalyst: substrate (w/w) ratio was varied in 
the following proportions 1:5, 1:4, 1:3, 1:2,1:1, 2:1, 3:1,
4:1, 5:1. Investigations were carried out for both 5% Pd/C
type B and C catalysts (Johnson Hatthey). Analysis of the 
products was by and *H nmr. Results for the catalyst: 
substrate ratio of 5:1, which resulted in a partially 
hydrogenated product are given below.
5:1 (w/w) catalyst: substrate r a t i o .
*H nmr, result for both 5% Pd/C types B and C (solvent
da-DMSO) S ppm: 8.0 (broad s, NH group); 4.8 (d, «S-CHa group
of N-acetyl-4, 5-didehydroleucine); 4.3 (m, a-CH group); 2.4 
(m, G-CHa group of N-acetyl-4, 5-didehydroleucine); 2.3 (m, 
t-CH group of N-acetyl-4, 5-didehydroleucine); 1.8 (s, CHa 
of acetyl group); 1.6 (&-CHa group of N-acetyl-4, 5- 
d i d e h y d r o l e u c i n e ); 1.5 (m, t-CH group); 0.9 (dd, a-CHa
group)
®H nmr, result for 5% Pd/C type B (solvent de-DHSO) S
ppm: 4.8 (&-CHa group, 65.0% T); 1.6 (d-CH® group, 10.7%T);
1.5 (T-CH, 2.3% T ) ; 0.9 (&-CH® groups, 21.8% T).
*H nmr, result for 5% Pd/C type C (solvent de-DMSO) S
ppm: 4.8 (f-CHa group, 68.4% T): 1.6 (d-CH® group, 8.4% T ) ;
1.5 (t-CH, 2.5% T ) ; 0.9 (d-CH® groups, 20.7% T).
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1.2.10.2 Variation of s o l v e n t .
N-Acetyl-4, 5-didehydroleucine (7.Sag) and 5% Pd/C type 
B or C (7.5mg) were suspended in solvent (1ml) and reacted 
with a mixture of hydrogen (lOmls) and tritium (ICi) for two 
hours. The samples were worked up as described above under 
the general tritiation procedure. The solvents studied were 
tetrahydrofuran, ethyl acetate and glacial acetic acid. 
Analysis was by and ®H nmr spectroscopy.
1.2.11 Radiation decomposition studies of 
t ritiated amino a c i d s .
1.2.11.1 General method of sample p r e p a r a t i o n .
®H Nmr samples were prepared for the tritiated N- 
acylamino acids in the usual manner with the compounds 
dissolved in acetate, phosphate and borate buffer solutions 
( l O O P l ) respectively. The ®H nmr samples were stored at 
room temperature and analysed by nmr spectroscopy at known 
time intervals. Subsequent analyses of the samples by radio 
tic analyses and by liquid scintillation counting was 
carried out at a known time interval after the decomposition 
studies were concluded. These latter analyses were carried 
ou after the ®H nmr studies were completed. The methods of 
analysis are described in detail below. The following 
compounds were studied:
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(a) N-acetyl-C4, 5-*H3-leucine (specific activity 3,78 
Ci/mmol) With a ®H nmr sample concentration of 150 mCi/ml.
(b) N-acetyl-[2, 3-®H3-phenylalanine (specific activity 18.2 
Ci/mmol) with a ®H nmr sample concentration of 400 mCi/ml.
(c) N-benzoyl-[2, 3-®H3-phenylalanine (specific activity
12.0 Ci/mmol with a ®H nmr sample concentration of 400 
m C i / m l .
1.2.11.2 ®H nar s t u d i e s .
®H nmr spectra were obtained at known time intervals 
for the labelled samples in buffer solutions. In all cases 
deuterated water was used as an external lock solvent. 
Buffer solutions were r e f e renced to the same tritiated 
c ompound in de-DMSO. In all cases ®H nmr spectra were run 
for 1000 scans (acquisition time of 1.6s per scan) with 
proton decoupling. Some proton coupled ®H nmr spectra were 
also run. The formation of new chemical shifts in the ®H 
nmr spectra were measured as a function of time.
1.2.11.3 nmr studies
Since the decomposition of tritiated compounds in 
buffer solutions was being investigated, the presence of a 
large water signal meant that direct nmr spectra gave 
little information about the decomposition products being 
formed. Some presaturation experiments were carried out but 
these did not reveal much information due to the close 
proximity of the chemical shift of the water signal and some
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of the chemical shifts of the amino acids. However, some 
detail was obtained by simple expansion of the nmr
spectra.
1.2.11.4 Analysis of decomposition products 
by radio t i c .
The tritium nmr sample of the decomposition product 
(80P1) was added to methanol (5ml). Portions (lOpl) of the 
solution were spotted onto tic plates. Reference samples of 
N-acylated and amino acids and free amino acids were spotted 
over the tritiated samples and, after drying the spots in 
air, the plates were run in a variety of solvent systems. 
Radio tic were run for all buffer solutions of tritiated 
compounds. The solvent systems used were 5: 2s 3 butan-1-
o l : acetic acids water, 1s 1 ethyl acetates diethyl ether,
9:1 chloroform: methanol, 12:4:5 butan-l-ol: acetic acid:
water, 1:1:1 pyridine: butan-l-ol: water and 8:1 hexane:
ethyl acetate.
A variety of compounds have been run in the solvent 
systems to elucidate potential decomposition products by 
comparison of Rr values to those obtained by radio tic. Some 
classes of compounds c onsidered were N-acylamino acids, 
amino acids, pyruvic acids and carboxylic acids.
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1.2.11.5 Analysis of labile t r i t i u m .
An aliquot (0.5mls) of the tritiated sample (BOPl 
buffer solution d i s s olved in 5mls of methanol) was freeze 
dried. lOMl of the distillate was counted in Unisolve 
liquid scintillation solvent. This was assumed to represent 
the total tritium present in a labile form plus any volatile 
material formed on storage. nmr spectra were obtained
for the residue and showed a disappearance of the chemical 
shift at 64.8 ppm. These observations were in agreement with 
the analysis of labile and volatile tritium by liquid 
scintillation counting.
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1.3 R e s u l t s .
1.3.1 G e n e r a l .
The results for the work described in this chapter are 
shown below. and ®H nmr spectra of tritiated amino acids
and peptides are illustrated in sections 1.3.3 and 1,3.4.
®H Nmr spectra for the radiation decomposition of 
tritiated N-acylamino acids have been Illustrated here so as 
to show the formation of new chemical shifts with time (see 
section 1,3.6). Several possible radiation decomposition 
products have been identified by radio-tlc. These results 
are shown in sections 1.3.7 and 1.3.8. A comprehensive list 
of all the reference compounds used for radio-tlc analysis 
has not been given, although those compounds which had Rf 
values that were similar to those of radiation decomposition 
products are shown in Table 1.28
Several conclusions can be drawn from the synthesis of 
N-acyl-2,3-didehydroamino acids and peptides. The synthesis 
of N-acetyl-2,3-didehydroamino acid esters via azido 
intermediates was generally unsuccessful. The a-bromo- and 
a - a z i d o c a r b o x y 1ic acid precursors were prepared in 
reasonable yields. N-acetyl-2,3-didehydroalanine methyl 
ester was successfully prepared from 2-azidopropanoic acid 
methyl ester using the method of Effenberger®*. The low 
yields obtained were probably due to the vigorous reaction 
conditions, which may have caused some polymerisation of the
83
product. Attempts to prepare N-acetyl-2,3-didehydrovaline 
methyl ester and N-acetyl-2,3-didehydroleucine methyl ester 
from their corre s p o n d i n g  2-azidocarboxylic acids were 
unsuccessful. Black tarry residues were formed instead of 
the desired products.
N-acyl-2,3-didehydroamino acids were prepared in good 
yields from azlactone intermediates. The preparation of N- 
acyl-2,^*”didehydrophenylalanyl dipeptides containing L- 
alanine, L-phenylalanine and glycine residues were 
successfully carried out. Attempts to prepare N-acyl-2,3- 
didehydrophenylalanine dipeptides containing L-tyrosine, L- 
proline, L-glutamic acid and L-lysine residues were 
unsuccessful. The major product, in these latter cases, was 
N-acetyl-2,3-didehydrophenyla laninine and no peptides were 
observed to have been formed. In the case of reactions 
involving L-glutamic acid and L-lysine, two other products 
were found to be present but could not be properly 
identified. Attempts to synthesis N-benzoyl-2,3- 
didehydrovaline dipeptides were also unsuccessful and the 
major product was N-benzoyl-2,3-didehydrovaline.
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1.3.2 Optimisation of the catalytic tritiation of 
N-acetyl-4. 5-didehydroleucine
Table 1 .3: Variation of the c a t a l y s t : substrate ratio
Catalyst : Substrate Specific Activity for
Ratio (w/w)
type B type C
(mC i / m m o l ) (mCi/mmo:
5: 1 23 14
4: 1 118 97
3: 1 421 448
2: 1 854 908
1:1 1246 1171
1:2 1156 1080
1:3 980 1000
1:4 780 831
1:5 580 497
Table 1,4: Variation of the solvent
Solvent Radioactivity (mCi)
sample A sample B
Glacial acetic acid 29 35
Ethyl acetate 43 54
Tetrahydrofuran 66 59
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1.3.3 Mar.spectra of tritiated amino acids.
The following pages contain nmr spectra of N- 
acyIdidehydroamino acids and the and *H nmr spectra of 
the corresponding tritiated amino acids.
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Figure 1.12 Nmr spectrum of N-acetyl-2, 3-didehydroalanine methyl ester.
1 o SPPM 4
Figure 1.13 Nmr spectrum of N-acetyl-[2, 3 - ® H 3 - a l a n inè
methyl ester.
I j i L
1 0 5 PPM 4
Figure 1.14 ®H Nmr spectrum of N-acetyl-C2, 3-®H3-alanine
methyl ester.
10 g 8 6 5PP M 4 1 0
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Figure i.15 Nmr spectrum of N-benzoyl-2, 3-didehydrovaline.
10 89 67
Figure 1.16 ’■H Nmr s p e ctrum of - N-benzoy 1-C2, 3-®H3-valine
3 012S PPM 46&10 79
Figure 1.17 Nmr s p e ctrum of N-benzoyI-C2, 3-®H3-valiné
10 9 8 7 6 SPPM 4 3 2 1 0
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Figure 1.18 Nmr spectrum of N-acetyl-4, 5-
didehydroleucine.
  la
10 5PPM 4
Figure 1.19 Nmr spectrum of N-acetyl-C4, 5 - ® H 3 - l e u c i m
10 9 8 7 3 05P PM 4 2b 1
Figure 1.20 ®H Nmr spectrum of N-acetyl-C4, 5-®H3-leucine
A
10 6 5PPM 4
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Figure 1.21 Nmr spectrum of N-acetyl-2, 3-didehydrophenylalan ine.
10 9 6 r 6 3 2 1 0
Figure 1.22 ■‘H Nmr "spectrum of N-acety 1-C2, 3-®H3-
p h e n y l a l a n i n e .
j \
10 SpPM. 4
L
Figure 1.23 Nmr spectrum of N-acetyl-C2, 3-=H3-phenylalan i ne.
10 9 5 PPM 4
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Figure 1.24^H Nmr spectrum of N-benzoyl-2, 3-didehydrophenylalanine.
iO 9
J'J.. I J ' ' L_
5PPM 4
Figure 1.25 Nmr spectrum of N - b e n z o y 1 - C 2 , 3-®H3phenylalanine.
710 9 8 SPPM 4 016 3 2
Figure 1.26 ®H Nmr s p e ctrum of N-benzoy 1-112, 3-®H3-
p h e n y 1alan i n e .
10 9 8 6 SPPM 4 . 2
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1.3.4 Nmr' spectra of tritiated peptides.
and nmr spectra associated with the tritiation of 
N-acyl-2, 3-didehydrophenylalanine peptides are shown on the 
following pages.
92
Figure 1*27 Nmr spectrum of N-benzoyl-2, 3- 
d i d e h y d r o p h e n y l a l a n y l g l y c i n e .
u u
1Ô 5PPM 4
Figure 1.28 Nmr sp e c t r u m  of N-benzoyI-C2, 3-^H3 p h e n y l a l a n y l g l y c i n e .
5PPM 47 18 3 26 O91 0
Figure 1.29 Nmr s p e ctrum of N-benzoyl-[2, 3-^H3p h e n y l a l a n y l g l y c i n e .
10 9 a 6 SPPM 4
&3
Figure 1.30 Nmr spectrum of N-acetyl-2, 3- 
didehydrophenylalanylalanine.
68 7910
Figure 1.31 Nmr spectrum of N - a c e t y 1 - C 2 , 3-®H 3 -
phenylalanylalan ine.
SPPM 4 3 17 2 068910
Figure 1.32 Nmr spectrum of N-acetyl-t2, 3-=H3
phenylalanylalanine.
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Figure 1.33 Nmr s p e ctrum of N-acetyl-2, 3- 
d i d e h y d r o p h e n y l a l a n y I p h e n y l a l a n  ine .
o3 15PPM 461 0
Figure 1.34 Tmr s p e c t r u m  of N-acetyl-T-, 3-®H3' 
pher. y lal any ipheny lalan i ne.
10 SPPM 4
Figure 1.35 Nmr s p e ctrum of N-acetyl-[2, 3-®H]- 
p h e n y l a l a n y IphenylaIan ine .
10 S P P M  4
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1.3.5 Radiation decomposition analysis by nmr
The following tables contain information about the 
radiation decomposition of tritiated N-acylamino acids, 
which were stored in buffer solutions. The formation of new 
chemical shifts in the tritium spectra of the tritiated 
N-acylamino acids were monitored. Changes in the integrals 
of the new ®H chemical shifts with time have been measured 
and expressed as a percentage of the total tritium in the 
system.
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Table 1.5: N-Acetyl-C4. 5-*HD-leucine (3. 75 Ci/mmol)
in acetate buffer (pH 4)
No. of % decomposition % decomposition total %
days at S 2.2 ppm at S 4.8 ppm decompos it
30 1. 1 1. 1
36 1.7 1.7
43 1.5 0.9 2.4
50 1.6 1.4 3.0
73 2.7 2.5 5.2
112 4. 1 4.9 9.0
Table 1.6: N-Acetyl-[4. 5-”H3-leucme (3.75 Ci/mmol) 
in phosphate buffer (pH 7)
No. of % decomposition
days at S 2.2 ppm
% decomposition 
at S 4.8 ppm
total % 
decomposition
19 0.8 0.8
30 1.8 1.8
36 0.7 1.4 2. 1
43 2.0 0.6 2.6
50 1.8 1.4 3.2
73 2.9 1.9 4.8
112 5.5 nd
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Table 1.7: N-Acetvl-C4. 5-”H3-leucine (3.75 Ci/mmol)
in borate buffer (pH 9)
No.of % decomposition % decomposition total %
days at S 2.2 ppm at S 4.8 ppm decomposition
43 2.7 2.7
50 2.6 0.6 3.2
73 4.8 0.4 5.2
112 4.4 • 3.4 7.8
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Table 1 ,8: N-Acetyl-C2« 3~*H]-phenvlaIanine (18 Ci/mmol)
in acetate buffer (p H 4)
No. of % decomposition
days at S 2.9 ppm
38 1.5
41 1.3
72 1.9
100 2. 1
136 3.7
% decomposition total %
at S 4.8 ppm decomposition
1.2 
1.8
3.3
3.6
4.0
2.7 
3. 1 
5.2
5.7
7.7
Table 1 . 9 : N-Acetyl~C2. 3-^H3-phenvlalanine (18 Ci/mmol)
in phosphate buffer (pH 7)
No. of % decomposition
days at S 2.9 ppm
25 1.7
38 1.7
41 1.5
72 2.3
100 2.4
136 3.5
% decomposition 
at Ô 4.8 ppm
0.4
0.6
1.2
1.6
2.4
total % 
decomposition
1.7 
2 . 1 
2 . 1
3.7
4.0 
5.9
100
Table 1. 10: N-Acetyl-C2. 3-^H3-phenvlalanine (18 Ci/mmol)
N o . of % decomposition % decomposition total %
days at «y 2.9 ppm at S 4.8 ppm decompos it :
25 1. 1 0.5 1.6
38 1.4 0.6 2.0
41 1.5 1. 1 2.6
72 2.3 1.4 3.7
100 2.7 2.3 5.0
136 3.2 3.4 6.6
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1.11: N-Benzovl-[2. 3-®H3-Phenvlalanine (12Ci/ramol)
in acetate buffer (p H 4).
N o . of % decomposition for chemical shifts total %
days at 3 . Ippm at 3.2ppm at 3.7ppm at 4.8ppm decomposition
88 1.1 0.9 1.2 2.3 5.5
95 0.9 1.3 1.4 2.2 5.8
110 0.5 0.9 1.9 2.8 6. 1
123 1.0 0.7 1.7 3.2 6.6
140 1.3 0.8 1.5 3.4 6.8
Table 1.12: N-Benzoyl-[2, 3-®Hl-phenYlalanine ( 12C i / m m o 1)
in phosphate buffer (pH 7).
N o . of % decomposition for chemical shifts total %
days at 3 . Ippm at 3.2ppm at 3.7ppm at 4.8ppm decomposition
88 0.4 1.1 1.3 2. 1 4.9
95 0.7 0.9 1.8 1.8 5.2
110 1.0 1.2 1.6 1.7 5.5
123 1.1 1.4 1.6 1.8 5.9
140 1.3 1.3 1.8 1.9 6.3
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Table 1.1 3 : N-Benzovl~C2. 3~^H3~Phenvlalanine (12Ci/imol)
in borate buffer (p H 9 ) .
No. of % decomposition for chemical shifts total %
days at 3 . Ippm at 3.2ppm at 3.7ppm at 4.8ppm decomposition
88
95
110
123
140
1.2 
1. 1 
1.2 
1.4 
1. 1
0.7
1.2
1.4
1.4
1.5
1.5
1.4
1.4
1.5 
1.7
0.7
0.9
0.7
1.0
1.4
4. 1 
4.4
4.7 
5.3
5.7
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1.3.6 Hnr spectra of radiation decomposition studies
Some of the ®H nmr spectra for the radiation 
decomposition of t r i t iated N-acylamino acids are shown on 
the following pages. The spectra have been selected to 
illustrate the different stages of radiation decomposition 
for the tritiated N - a c ylamino acids.
106
*H Nmr spectrum after 30 days
10 9 8 7 6 5PPM 4 3 2 1 0
Nmr spectrum after 50 days
t l  II" T * r - T n j ~t ~ t l‘ 1 . *  —  ■ I I - '  *  n V p A * * * ^
10 9 e 7 6 5PPM 4 3 2 1 0
Nmr spectrum after 112 days
_____
10 9 8 7 6 5PPM 4 3 2 1 0
107
Figure 1.37 ®H Nmr spectra of N-acetyl-[2, 3-=H]-
phenylalan i n e .
(Radiation d e c o m position of acetate buffer sample)
*H Nmr spectrum after 25 days
10 9 8 7 6 5PPM 4 3 2 1 0
Nmr spectrum after 41 days
1 0 89 67 05 PPM 4 3 2 1
*H Nmr spectrum after 72 days
10 9 8 6 S P P M  4 3 2 1 0
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Figure 1.38 Nmr spectra of N-benzoy1-C2, 3-=H]phenyialan ine.(Radiation decomposition of borate buffer sample)
H Nmr spectrum after3
1 day
810 9 6pp M 4 17 06 3 2
®H Nmr spectrum after
88 days
o2 110 SPPM 4 369 78
Nmr spectrum after
110 days
10 a9 SPPM 467 3 2 1 O
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1.3.7 Radiation decomposition analysis by radio tic
The following solvent systems were used for radio-tlc 
analysis of the radiation decomposition of tritiated amino 
acids:
A) 5:2:3 Butan-l-ol: acetic acid: water
B) 1:1 Ethyl acetate: diethyl ether
C) 1:1:1 Pyridine: butan-l-ol: water
D ) 12:4:5 Butan-l-ol: acetic acid: water
E) 9:1 Chloroform: methanol
F) 8:1 Hexane: ethyl acetate
Tritiated samples were prepared and analysed as 
described in section 1.2.11.4. A variety of methods were 
used to analyse the tic plates including: (i) Ninhydrin
spray; (ii) UV/ fluorescence and (iii) sulphuric acid spray.
Some reference samples which had Rr values that 
corresponded to those of radiation decomposition products 
are shown in Table 1.28.
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Table 1 . 1 4 : N-Acetyl-C4, 5-*H3-Ieucine (3.75 Ci/mmol) 
acetate buffer sample (solvent system A)
Peak Rr value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0.36 0.47 negative
2 0.37 5.69 8.06 positive
3 0.47 19.32 21.73 positive
4 0.54 12.40 9.21 negative
5 0.62 62.16 60.54 negative
Table 1.1 5 : N-Acetyl-C4. 5-=H]-leucine (3.75 Ci/mmol) 
phosphate buffer sample (solvent system A)
Peak Rf value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0,06 0.57 negative
2 0.37 5.24 7.61 positive
3 0.47 18.42 22.31 positive
4 0.54 13.56 6.75 negative
5 0.62 61.73 62.76 negative
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Table 1.16: N-Acetvl-[4. 5-*H3-leucine (3.75 C i / m m o l )
borate buffer sample (solvent system A)
>eak E r value Sample A Sample B Ninhydrin% Tritium % Tritium test
1 0 0.22 0.02 negative
2 0.37 9.38 6.61 positive
3 0.47 23.83 20.03 positive
4 0.54 11.84 11.70 negative
5 0.62 54.73 61.64 negative
Table 1.17: N-acetyl-[4, 5-®H3-leuc ine buffer samples
(other solvent systems)
Solvent E r value Ninhydrin Inference
test
B 0 positive Single peak at baseline
C 0.60 positive Broad single peak with
some forward tailing.
D 0 positive Single peak at baseline
E 0 positive Major peak at baselineWith very minor peaks.
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Table 1. 1 8 : N-Acety1-C2. 3-^H3-Phenvlalanine (18 Ci/mmol)
Peak Rr value Sample A % Tritium
Sample B 
% Tritium
Ninhydrin
test
1 0 0.23 0.27 negative
2 0.38 30.29 33.87 pos itive
3 0.62 55. 15 54.38 negative
4 0.70 11.80 11.48 negative
Table 1.19: N-Acetyl-[2. 3-=H] -phenylalanine (18 Ci/mmol)
phosphate buffer sample (solvent system A)
Peak Rf value Sample A 
% Tritium
Sample B 
% Tritium
Ninhydrin
test
1 0 0.45 0.65 negative
2 0.38 33. 16 32.67 positive
3 0.61 55.53 54.89 negative
4 0,68 10.86 11.79 negative
Table 1.20: N-Acetyl-[2, 3-=H] -phenylalanine (18 Ci/mmol)
borate buffer sample (solvent system A)
Peak Rf value Sample A 
% Tritium
Sample B 
% Tritium
Ninhydrin
test
1 0 0.63 0.30 negative
2 0.39 33. 19 36.75 positive
3 0.61 55.97 55.96 negative
4 0.70 10.22 6.98 negative
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Table 1.21: N-Acety1-C2. 3-^Hl-phenvlalanine (18 Ci/mmol) 
acetate buffer sample (solvent E)
Peak Er value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0.03 0.51 negative
2 0.25 11.83 11.76 negative
3 0.32 42.18 41.96 negative
4 0.43 8.34 6.31 negative
5 0.49 39.61 39.41 positive
Table 1.2 2 : N-Acetyl-C2. 3-^H3-phenvlalanine (18 Ci/mmol) 
phosphate buffer sample (solvent E)
Peak Er value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0,26 0.15 negative
2 0.25 11.94 11.80 negative
3 0.32 42.36 42.13 negative
4 0.43 8.26 6.35 negative
5 0.49 37.18 39.57 positive
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Table 1 . 2 3 : N-Acetyl-C2, 3-^H3-phenvlalanine (18 Ci/mmol) 
borate buffer sample (solvent E)
Peak Ef value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0.24 0.15 negative
2 0.25 11.14 11.78 negative
3 0.32 42.58 42.15 negative
4 0.43 9.21 . 8.31 negative
5 0.50 38.83 39.61 positive
Table 1 . 2 4 : N-acety1-L2. 3-®H3-phenylalanine buffer samples
(other solvent systems)
Solvent Rf value Ninhydrin Inference
test
B 0 positive Single peak at baseline
C 0.60 positive Single peak with tailing
D 0 positive Single peak at baseline
Table 1 .25: N-Benzoy1-C2. 3-^H3-phenvlalanine (12 Ci/mmol) 
acetate buffer sample (solvent system A)
Peak Rf value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0.27 0.10 negative
2 0.69 48.45 50.82 negative
3 0.72 51.28 49.08 negative
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Table 1.26: N-Benzovl-[2, 3~”H]-phenvlaIanine (12 Ci/mmol)
phosphate buffer sample (solvent A)
Peak Ef value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0.24 0.33 negative
2 0.69 49.86 50.58 negative
3 0.72 50.14 49.42 negative
Table 1.2 7 : N-Benzovl-C2. 3-“^H3-phenylalanine (12 Ci/mmol)
borate buffer sample (solvent A)
Peak Er value Sample A Sample B Ninhydrin
% Tritium % Tritium test
1 0 0.40 0.31 negative
2 0.69 50.09 43.98 negative
3 0.72 49.51 55.71 negative
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Table 1.28: Tic analysis of some reference compounds
Compound Solvent Rr value
system
Leucine A 0.47
C 0.60
Phenylalanine A 0.45C 0.60
E 0. 19
Tyrosine A 0.37E 0.46
3, 4-dihydroxy A 0.38
phenylalanine E 0.48
Norvaline A 0.31
C 0.59
N-acetyInorvaline A 0.56
C 0.57
N - a c e t y 1 leucine A 0.62
C 0.61
N-acetyIphenylalanine A 0.62
C 0.60
E 0.32
N -acetyItyrosine A 0.66
C 0.60
E 0.40
N - b e n zoylphenylalanine A 0.70
117
1.3.8 Examples of radio-tlc of radiation 
d e c o m position s a m p l e s .
Examples of the radio-tlc for the radiation 
decomposition studies are shown over. Chromatograms for 
some of the different solvent systems are illustrated.
t18
Figure 1.39 Radio tic analyses of N-acetyl-[4, 5-=H]-leuc.ne
TITLE PPA.PPi LIN
C  IQ.00 0 I5B2D
/ V
"TO.DD
?P i- 0 - 5 - I-
1023,
(a) Tic plate ran in 5:2:3(v/v) butanol: acetic acid: water
TITLE L0P.PL2 LIN 
C 10.00 0litID
I V
0.00
?p i-0-3"
ID23.I
(b) Tic plate ran in l:l:l(v/v) pyridine: aceti c acid: water
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Figure 1.40 Radio tic analyses of N-acetyl-[2, 3-®H3phenylalan ine.
C  121.OD S3 SUED
A' u
L
D.QQ 4----- 1-----r—---rrI S 3 U
1 -
■I ' 1IDS3.I
(a) Tic plate ran in 5:2:3(v/v) butanol: acetic acid: water
TITLE PLOTS.PL6 LIN
C  kDS.DO IE .3 5 5 0
V*”  "ki 'Joi
?p i-0-3-
I * IDS3.I
(b) Tic plate ran in 9:l(v/v) chloroform: methanol
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Figure 1.41 Radio tic analyses of N-benzoy1-C2, 3-=H]
phenylalanine.
TITLE PHE.EiP LIN
C  G59.00 29 I05DD
?P i-Q-k-t"
D.QD
(a) Tic plate ran in 5:2:3(v/v) butanol: acetic acid: water
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1.3,9 Analysis of labile and volatile components of 
radiation decomposition s a m p l e s .
Table 1.29 Labile tritium and tritiated water
by radiation decomposition of
1-C4,5-»H3 -leucine (240 days)
Activity of sample (mCi) % THO
A
0.57.
B average 
0.84 0.61
average
4
0.73 0.65 0.69 5
0.55 0.53 0.54 4
Buffer solution
acetate
phosphate
borate
Table 1 . 3 Q : N - a c e t y l - C 2 .3-^H3-phenvlalani ne (240 days)
Buffer solution Activity of sample (mCi) % THO
A B average average
acetate 0.97 0.90 0.94 2
phosphate 1.10 1.20 1.15 3
borate 0.60 0.70 0.65 2
Table 1.3 1 : N-benzoy1-C2.3 - ^ H 3 - p h e n y l a l a n i n e  (240 days)
Buffer solution A c t ivity of sample (mCi) % THO
A B average average
acetate 0.72 0.80 0.76 2
phosphate 1.27 1.21 1.24 3
borate 0.98 1.00 0.99 3
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1.4 Discussion.
In order to prepare N-acetyl-2, 3-didehydroamino acid 
esters a reaction scheme involving azido intermediates and 
based upon the work of Effenberger et. al** h&d been 
proposed. It was hoped to prepare methyl esters of N- 
acetyl-2, 3-didehydroalanine, N-acetyl-2, 3-didehydrovaline 
and N-acetyl-2, 3 - d i dehydroleucine by this route.
The first stage of the synthesis involved the 
conversion of carboxylic acids into their c o rresponding 2- 
b r o m o c a r b o x y 1 ic acids. The H e l 1 - V o l h a r d t - Z e 1 insky reaction 
was used to carry out the synthesis. The 2-bromocarboxylic 
acids were then co n v e r t e d  into the corresponding methyl 
esters by refluxing in a mixture of 2, 2-dimethoxypropane  
and methanol and catalytic amounts of toluene-p-sulphonic 
acid. The reaction involves the regeneration of methanol by 
degradation of 2, 2-dimethoxypropane into acetone and 
methanol. 2 - B romopropionic acid methyl ester was prepared 
in a reasonable yield of 75%. The yields of 2-bromo-3- 
methyIbutanoic acid methylester and 2-bromo-4-
methylpentanoic acid methyl ester were much lower at 54% and 
58% respectively. One reason for this could be that the 
reflux temperature of the latter compounds were higher than 
that for the case of the estérification of 2-bromopropionic 
acid. This may have led to a more rapid degradation of 2,
2-dimethoxypropane than the reaction required.
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The preparation of 2 - a z i d o c a r b o x y 1ic acid methyl ester 
from the 2-bromo derivatives was carried out using the 
method of Nakajima The reaction involves stirring the
bromo compound with sodium azide in water and in the 
presence of tetrabut y l a m m o n i u m  bromide. The product was 
r ecovered from the reaction mixture by solvent extraction 
with d i c h l o r o m e t h a n e . The reaction proceeds efficiently at 
room temperature and good yields, in excess of 80%, were 
obtained. The purity of the azides were determined by GC 
analysis and were found to be greater than 87%.
The reaction for converting the 2 - a z i d o c a r b o x y 1 ic acid 
esters into N - a c e t y l-2,3-didehydroamino acid esters involves 
refluxing the azide in acetic acid/ glacial acetic acid in 
the presence of rhenium heptasulphide as a catalyst. A long 
time and high temperatures are required for the reaction to 
be successful. Since such harsh conditions are used, it is 
necessary to protect the alkene group of the didehydroamino 
acid product from polymerisation by the addition of quinol. 
The reaction can lead to the formation of a mixture of both 
mono- and d i a c e tylated products. The latter can be 
prevented from forming by adding water to the reaction 
medium. Effenberger and Beisswenger have reported the 
synthesis of several N-acetyl-2,3-didehydroamino acid methyl 
esters using various conditions. The reported yields varied 
from about 20% to 98% and were found to be dependent upon 
the reaction conditions used.
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N - a c e t y l - 2 , 3-didehydroalanine methyl ester was 
successfully prepared in a yield of 30%. N-ac e t y l - 2 , 3- 
didehydroalanine was prepared by stirring the ester in a hot 
solution of potassium hydroxide. However, the preparations 
of N - a c e t y l - 2 , 3 -didehydrovaline methyl ester and N-acetyl-
2 , 3-didehydroleucine methyl ester were unsuccessful. Tarry 
residues were formed when the attempted synthesis of the 
latter compounds were carried out. In these . cases 
polymerisation seems to have occured.
The attempted synthesis of several N-acyl-2,3- 
didehydroamino acids and peptides have been carried out 
using azlactones as intermediates. The azlactones of N- 
a c e t y 1-2,3 - d idehydrophenylalanine and N - b e n z o y 1-2,3-
phenylalanine were prepared in good yields by condensation 
of the corresponding acylglycine with benzaldehyde. The 
preparation of N - b e n z o y 1-2,3-didehydrovaline azlactone was 
carried out using the method of Ramage and Simonsen
The azlactones were converted into the N-acyl-2,3- 
didehydroamino acids in good yields either by refluxing in 
an acetone-water mixture or with aqueous potassium 
hydroxide. N - A c y 1-2,3 -didehydropeptides have been prepared 
by coupling the azlactones with amino acids or amino acid 
esters. The syntheses of simple N-acyl-2,3-
di dehydrophenylalanine peptides containing glycine, glycine 
ethyl ester, L-alanine and L-phenylalanine have been carried 
out using the methods of Bergmann et. al However,
attempts to couple L-glutamic acid, L-tyrosine, L-proline
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and L-lysine with the azlactones were unsuccessful. In 
these cases the reactions may not have proceeded due to 
improper neutralisation of the amino acids with sodiumm 
h y d r o x i d e .
The optimum conditions for the labelling of N-acetyl- 
4 , 5-didehydroleucine using tritium-hydrogen mixtures were 
studied. The highest incorporation of tritium occurred when 
the tritiation reaction was carried out in THF. Glacial 
acetic acid as the reaction solvent was found to give the 
lowest levels of tritium incorporation. In the latter case, 
there are 1.75 x 10~* moles (1.053 x 10*® molecules) of 
glacial acetic acid and 4.38 x 10”® moles (2.84 x 10^® 
molecules) of N - a c e t y l -4,5-didehydroleucine in the reaction 
system. Hence, there is a total of 1.056 x 10** carboxyl 
group protons which can undergo labile isotope exchange 
With tritium atoms. However, there are only 1.724 x 10” ® 
moles (2.07 x 10^® atoms) of tritium in the reaction system. 
Hence, there are a p p r o ximately 500 times more carboxyl group 
protons as there are tritium atoms in the reaction system. 
It can be concluded that there may be a reduction in the 
effective amount of tritium available for reduction of the 
didehydroamino acid substrate because of the large excess of 
carboxyl group protons, which can can take part in labile 
isotope exchange reactions.
The variation of catalyst: substrate ratio has been
studied for two 5% Pd/C catalysts (see Table 1.3). 
Incomplete tritiation , of N-acetyl-4,5-didehydroleucine
126
o ccurred with the 5:1 catalyst: substrate ratio. Analysis
by and ®H nmr s p e c t roscopy showed a mixture of products
had been formed. The majority of the tritium was present at 
a chemical shift of 4.6ppm, which corresponded to the S -  
methylene chemical shift of the unsaturated precursor. This 
would seem to imply that the labelling occured mainly via an 
isotope exchange process at a 5:1 catalyst: substrate ratio
since tritium was not present at a chemical shift of 0.9ppm. 
Similar results have been reported by Tang ®^ for the 
partial tritiation of N -acetyl-4,5-didehydroleucine with a 
small volume of a hydrogen-tritiurn mixture.
Complete hydrogenation occured at all other catalyst: 
substrate ratios. In all cases nmr spectra of the
products showed that the majority of the tritium was found 
in the terminal methyl groups and the remainder was present 
in the T-methine group.
As can be seen from Table 1.3 the optimum tritium 
incorporation was found to occur with a 1:1 catalyst: 
substrate ratio. There was no significant difference 
between the amount of tritium incorporated when carrying out 
the labelling reactions in the presence of 5% Pd/C type B 
and C catalysts.
The tritiation of N-acyIdidehydroamino acids were 
carried out using a mixture of hydrogen (20mls) and tritium 
(ICi). The labelling of didehydroamino acids containing 
terminal vinylic methylene groups, such as N -acetyl-2,3-
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didehydroalanine methyl ester and N - a c etyl-4,5-
d i d e h y d r o l e u c i n e , lead to products where the majority of the 
tritium was incorporated in the terminal methyl groups. This 
implied that isotopic exchange with the vinylic methylene 
protons occurred as well as the reduction of the alkene 
bond. This observation was in agreement with work reported 
by Sheppard et. al.®*.
In the case of N - a c yl-C2,3-®H3-phenylalanine compounds 
about 60% of the tritium was found in the 2-position with 
the remainder in the 3-position of the aliphatic side chain. 
No tritiation of the aromatic ring occurred;ith 5% Pd/C as 
the catalyst. In the case of N - b e n z o y 1-2,3-didehydrovaline 
even distribution of tritium across the alkene bond occured.
The tritiation of N - a c e t y l - 2,3-didehydrophenyla lanine  
peptides was carried out using a mixture of hydrogen (2mls) 
and tritium (ICi). The tritiation of N - b e n z o y 1-2,3- 
di d e h y d r o p h enylalanyIglycine resulted in a product with a 
labelling pattern that was in accordance with that found for 
N - b e n z o y 1-C2,3-®H3-phenylalan ine and no tritium was found to 
be present in the methylene protons of the glycine residue.
The tritiation of N - a c e t y l - 2 , 3 - d i d e h y d r o p h e n y l a l a n y 1- 
L-alanine resulted in a tritiated product with a
specific activity of 2.7 Ci/mmol. Analysis by ®H Nmr 
spectroscopy showed that tritium was also incorporated into 
the G-CHa group, #1.2ppm, of the alanine residue as well as 
the a- and G-positions of phenylalanine side chain. The
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additional presence of tritium in the alanine residue at a 
level of 8% implied that an isotope exchange process had 
occurred in addition to the reduction of the 
d idehydrophenylalanine residue. The observation is
supported by result o b t ained for the tritiation of N-acetyl-
2 , 3-didehydroalanine methyl ester. In the case of N-acetyl- 
[2,3-®H]-alanine methyl ester 95% of the tritium was found 
in the G-position while the remainder was in the a-position. 
This result indicates that isotope exchange labelling is 
occurring in addition to the reduction of the vinylic 
methylene group.
Diasteroisomers were formed when N-ac e t y l - 2 , 3- 
didehy d r o p h e n y l a l a n y 1 - L - p h e n y l a  Ianine was tritiated. Tritium 
was found in the side chain of the N-acetyIphenylalanine but 
not in the L-phenylalanine residue. The methine group was 
found to contain 81% of the tritium while the remainder was 
found in the methylene group. The ratio of the 
diastereoisomers was d etermined from the ®H nmr spectrum by
measuring the ratio of the two methine chemical shifts and
was found to be 53:47.
Although several authors have studied the radiation 
decomposition of tritiated amino acids no similar
investigations have been reported for labelled amino acid
derivatives. N-Acylated amino acids are important 
biological molecules in their own right and understanding of 
the radiation decomposition of the radio label led compounds 
is desirable. The studies described herein are possibly the
Ifirst systematic investigation of radiation decomposition of 
such compounds.
The pH of the solvent in which tritiated N-acylamino 
acids were stored would seem to affect their stability. The 
radiation decomposition of all compounds studied were found 
to be greatest in acidic and basic solvent systems (see 
Tables 1.5-1.13).
There would seem to be. an induction period before new 
®H chemical shifts were observed. N-acety1-C4,5-®H3-leucine 
(3.75 Ci/mmol), stored in phosphate buffer solution, was 
found to have the shortest induction period (19 days) while 
N-benzoy1-C2, 3-®H3-phenylalanine (18.2 Ci/mmol) had the 
longest period (88 days). Evans^ has reported induction 
periods for the radiation decomposition of samples of 
t ritiated compounds, including C G - ® H 3 - p h e n y l a l a n i n e . The 
reasons for this apparent period of stability are not fully 
understood. The induction period could be due to the build 
up of reactive radical species or ions being necessary 
before any radiation decomposition of the r a d i o l a b e 1 led 
compounds can occur. This hypothesis may be applicable to 
the observations for the tritiated amino acid derivatives in 
buffer solutions.
Eadio-tlc analysis of N-acety1-C4,5-®H3-leucine (3.75 
Ci/mmol) samples showed that decomposition had occured. The 
major tic component was found to be N-acety1-C4,5-®H3- 
leucine. Comparison of the decomposition products with
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suitable reference samples indicated that tritiated leucine 
and N-acetyInorvaline may be present. Tic analysis of the 
tritiated compounds run in 5:2:3 BuOH : AcOH : HssO gave a 
component at a Rf value of 0.47 (Ninhydrin + v e ), which 
corresponded to that for a reference sample of leucine. A 
second component at a Rr value of 0.54 (Ninhydrin - v e ) was 
found to match with the reference sample of N- 
a c e t y I n o r v a l i n e . The third radiation decomposition product 
was not clearly identified. No significant difference was 
observed for the tic analysis of the radiation decomposition 
products of the three buffer samples of N-acety1-C4,5-®H3- 
leuc i n e .
Radio-tlc analysis of buffer solutions of N-acetyl-C2, 
3-®H3-phenylalanine (18.2 Ci/mmol) indicated the presence of 
at least three decomposition products. Tritiated hydroxy 
substituted phenylalanine derivatives have been shown to 
possibly occur by running the radiation decomposition 
samples against reference compounds. Tritiated
phenylalanine was shown not to be present. Tic analysis of 
samples run in 5:2:3 B u O H :A c O H :HzO gave three components at : 
(i) a Rf value of 0.38 (Ninhydrin + v e ), which corresponded 
to reference samples of 3 , 4 - dihydroxyphenylalanine and 
tyrosine; (ii) a Rr Value of 0.61 (Ninhydrin -ve), which 
corresponded to a reference sample of N-acetylphenylalanine 
and (iii) a Rf value of 0.68 (Ninhydrin ve), that matched 
with a reference sample of N - a c e t y I t y r o s i n e . Tic analysis 
of samples run in 9:1 C H C l a:MeOH gave four components at :
(i) a Rf value of 0.25 (Ninhydrin -ve), which was
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unidentified; (ii) a Er value of 0.32 (Ninhydrin + v e ), which 
matched with phenylalanine; (iii) a Rf value of 0.43 
(Ninhydrin -ve), which c o r r e sponded to a reference sample of 
N-acetyItyrosine and (iv) a Rf value of 0.49 (Ninhydrin 
+ve), which matched with a reference sample of tyrosine.
The radio-tlc analysis of the samples of N-benzoy1-C2,
3-®H3-phenylalanine (12 Ci/mmol) produced a double peak when 
the tic plate was run in 5:2:3 B u O H :A c O H :HzO. This 
phenomenon was observed with and without the addition of 
carrier material. The presence of a double peak should be 
considered as an undesirable effect of the tic system used. 
The validity of the results obtained using the above solvent 
system should be treated with sceptism. All other solvent 
systems indicated that only the starting material was 
p r e s e n t .
Tables 1,32, 1.33 and 1.34 show the total tritium
present in a labile form and any volatile components formed 
in storage. Buffer solutions of N-acety1-C4,5-®H3-leucine 
(3.75 Ci/mmol) were found to contain the highest percentage 
of tritium in a labile form and/ or as volatile compounds. 
The lowest values were found for buffer solutions of N- 
benzoylC2,3-®H D - p h e n y l a l a n i n e  (12 Ci/mmol).
Several points have emerged in carrying out the 
radiation decomposition studies. ®H Nmr spectroscopy can be 
used to successfully follow the fate of the labelled 
positions of tritiated N-acylamino acid. The labelled
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positions in the tritiated N-acylamino acids would seem to 
be fairly stable. This observation is in agreement with the 
reports of several authors
Radio-tlc analysis showed that several radiation 
decomposition products were formed upon storage of tritiated 
N-acylamino acids in buffer solutions. The method of 
analysis will only allow the determination of non-volatile 
compounds and, to obtain a better picture of the radiation 
decomposition processes, it is also necessary to determine 
the total tritium present in a labile form or as volatile 
materials.
Secondary effects, due to the interaction of reactive 
species in the solvent system and the labelled compoumd, 
would thus seem to be the predominant cause of radiation 
decomposition. The actual site of labelling is not directly 
involved in the radiation decomposition of the compound. The 
products formed in storage would probably support this 
h y p o t h e s i s .
Hydroxyl radicals have been reported to exchange with 
tritium in the aromatic rings of labelled phenylalanine and 
tyrosine compounds. Indeed evidence for the presence of 
labelled hydroxyl substituted phenylalanine derivatives has 
been shown by radio tic. Both mono- and
d i h y d roxyphenylalanine derivatives are formed. Radio-tlc 
analysis of buffer solutions of N-acety1-C2,3-®H3- 
phenylalanine upon storage showed components that matched
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With reference samples of tyrosine (Er 0.38 solvent 5:2;3 
B u O H : AcOH:H2Ü Er 0.49 solvent 9:1 CHCl«:MeOH), N-
acety Ityros ine (R<- 0.68 solvent 5:2;3 BuOH : AcOH : HaO ) and
3 , 4-dihydroxypheny lalan ine (E*- 0.38 Solvent 5:2;3
B u O H :A c O H :H z O ) to be present as radiation decomposition 
p r o d u c t s .
Tritiated leucine has been shown to be formed during 
storage of N - a c e t y 1 - C 4 , 5 - ® H 3 ~ l e u c i n e . Radio-tlc analysis of 
samples of N-acety1-C4,5-®H3-leucine run in 5:2;3 
B u O H :A c O H :HaO showed a component to be present at a Rf value 
of 0.47 (Ninhydrin + v e ) whiched matched with the reference 
sample of leucine. There is no indication that further 
reaction by deamination of either the trititiated acylated 
or free amino acid had occured. Supportive evidence for this 
observation comes from the work of Garrison , who found 
that deamination did not occur during the radiolysisof N- 
a c e t y 1 leucine with an external ®*P source. The formation of 
any tritiated 2-keto-4-methyIpentanoic acid during the 
storage period would thus seem to be at the most a minor 
p r o d u c t .
Similar deacetylation of tritiated N-acyIphenylalanine 
compounds may not occur, since no tritiated phenylalanine or 
phenyIpyruvic acid was found to be present by radio-tlc 
analysis. Radio-tlc analysis of tritiated N-
a cetyIphenyalanine samples which had been stored in buffer 
solutions showed components that matched with reference 
samples of tyrosine (Rf 0.38 solvent 5:2:3 B u O H :A c O H :HasO),
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N-actyItyrosine (Rr 0.68 solvent 5:2:3 BuOH:AcOH:HzQ) and
3 , 4 - dihydroxyphenylalanine (Rf 0.38 solvent 5:2:3
BuOH:AcOH:HzO) were present.
The radio-tlc analysis indicated the possible formation 
of tritiated N-acetyInorvaline occured during storage of N- 
a c e t y 1 - C 4 , 5 - ® H 3 - l e u c i n e . This observation implies loss of 
one of the terminal methyl groups would have happened. The 
process would most likely result from a secondary mode of 
radiation decomposition. It can be envisaged that in an 
aqueous environment this may lead to the formation of an 
alcohol or carbonyl compound as a by-product. It is likely 
that the process may not involve the simple interaction of 
N-acetyl-C4,5-®H3-leucine with reactive solvent species but 
could be brought about by fragmentation of the starting 
material into radicals or ions.
The identification of the third radiation decomposition 
product of N - acety1-C4,5-®H3-leucine by radio-tlc analysis 
was not possible. The Rf value of the decomposition product 
was 0.37 (solvent 5:2:3 BuOH:AcOH:HzO) and it gave a
positive ninhydrin test. The product was unidentified due to 
the fact that none of the reference compounds selected had
Rf values that exactly correlated with the radiation
decomposition product. The reference compounds that had 
similar Rf values to the tritiated unknown were found to be 
those without an acetyl group. This observation would imply 
that the unknown may be an amino acid derivative.
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The formation of a chemical shift at S 4.8ppm was 
observed to occur in the ®H nmr spectra of all buffer 
solutions of the tritiated N-acylamino acids. ®H Nmr spectra 
of the samples after l y o p h i p h i 1isation showed that the 
chemical shift had disappeared. Therefore, the chemical 
shift at S 4.8ppm may indicate the presence of tritiated 
water. Tritiated water may be produced by loss of tritium 
from the labelled site in the molecule. Interaction of a 
reactive solvent species with the tritiated compound at a 
labelled site could bring about this situation. The amount 
of tritium associated with the chemical shift was found to 
be less than 10% for all tritiated N-acylamino acids.
Evidence for the formation of a volatile radiation 
decomposition products comes from the ®H nmr studies of the 
storage of N - a c e t y 1 - C 4 , 5 - ® H 3 - l e u c i n e . The formation of a 
chemical shift at «5^ 2.2ppm was observed for samples of N- 
a cetyl - C 4 , 5 - ® H 3 “ leucine in buffer solutions. The new ®H 
chemical shift could be associated with the change in 
enviroment of the tritiated methine group due to the 
cleavage of the Cz-Ca bond. The change in chemical shift of 
the tritiated methine group is therefore a result of 
molecular fragmentation and not due to the effect of the 
instassing the radiation decomposition of tritiated N- 
acylamino acids no attempt has been made to propose any 
reaction mechanisms. This is because several reactive 
species may be produced by the radiolysis of water. Hence 
the environment in which radiation decomposition of the 
labelled amino acid derivatives occurs is a complex system
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in which several competing reaction processes could possibly 
be envisaged. It is considered that in carrying out these 
studies the identification of the radiation products was of 
primary importance. However, in explaining the formation of 
the products the most likely mode of r a d i a t i o n ,decomposition 
and type of reaction have been suggested.
There are several conclusions that can be drawn from 
the study of tritiated N-acylamino acids and peptides. The 
reduction of compounds that contain terminal vinyl groups, 
such as N-acetyl-4,5-didehydroleucine and N - a c e t y 1-2,3- 
didehydroalanine methyl ester, with hydrogen-tritium 
mixtures yield products where the majority of tritium is 
found in the methyl group. The tritiation of other N- 
acyIdidehydroamino acids led to products where the addition 
of tritium to the alkene group was more evenly distributed.
The labelling of N - a c e t y 1-2,3-didehydrophenylalanine 
peptides has been investigated. In the case of N-acetyl- 
C2,3-®H3-phenylalany1-L-alanine (2.7Ci/mmol) about 8% of the 
tritium was found to be present in the G-methyl group of the 
alanine residue. This implied that a hydrogen isotope 
exchange reaction was competing with the reduction of the 
alkene group. The tritiation of N - a c etyl-2,3-
di d ehydrophenylalany1-L-pheny lalanine gave the corresponding 
d i a s t e r e o m e r s . The tritiation of N - b e n z o y 1-2,3-
didehydrophenylalanylglycine gave a product that had a 
similar pattern to that of N - b e n z o y 1 - C 2 , 3 - ® H 3 - p h e n y l a l a n i n e .
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The radiation "decomposition of tritiated N-acylamino 
acids in aqueous buffer solutions would seem to occur by 
secondary effects rather than by the direct radioactive 
disintegration of the tritium label. Evidence for 
decomposition by secondary modes comes from the discovery of 
tritiated hydroxyphenylalanine derivatives in samples of N- 
acetyl-C2,3-®H]-phenylalanine s after a period of storage. 
Deacetylation of the tritiated amino acid derivatives has 
been shown to occur by radio tic analyses of buffer 
s o l u t i o n s .
The radiation decomposition of tritiated N-acylamino 
acids have been successfully followed by nmr
spectroscopy. In all cases there is an induction period
before any radiation decomposition is observed. This period 
may be due to a build up of solvent radicals. The greatest 
decomposition were observed for buffer solutions of N-
acety1-C4,5-®H3-leucine while much slower rates were 
observed with samples of N-acyl-t2,3-®H3~phenylalanines.
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CHAPTER TWO
The Development of a Biological Method for 
Labelling Amino Acids with Deuterium.
148
2.1 Introduction.
2.1.1 General.
The synthesis of compounds by chemical methods may 
sometimes result in a mixture of stereochemical products. 
Stereochemical mixtures are a major problem to the 
pharmaceutical industry, where current practice often 
demands that a drug should not only be chemically pure but 
also present only in one stereochemical form. In an attempt 
to overcome these problems chemists have used biochemical 
methods to synthesize desired products
The use of isotope exchange labelling to introduce 
deuterium or tritium into a molecule by chemical methods can 
lead to a mixture of generally labelled products. This can 
be a nuisance if the labelled molecule is to be used as a 
tracer or for studying reaction mechanisms. For these cases 
the desired compound would be of more value if it was 
labelled specifically and in one stereochemical form. 
Several attempts have been made to use biochemical methods 
to prepare specifically labelled compounds
The work described in this chapter is concerned with 
the development of a biochemical method for labelling amino 
acids. The transaminase methionine-r-lyase and bacteria 
Pseudomonas put Ida have been used as catalysts for the 
hydrogen isotope exchange of the a- and depositions of amino 
acids.
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2.1.2 The transamination process.
The transamination reaction was discovered by 
Braunstein in 1937® when L-glutamic acid and pyruvic acid 
were incubated with minced pigeon breast muscle to generate 
alanine and a-ketoglutaric acid. The reaction involves
transfer of an amine group from an amino acid or an amine to 
a keto acid. The reaction is catalysed by enzymic or
non-enzymic processes Indeed the transamination
reaction has been shown to be important in the synthesis of 
amino acids in plants, animals and microorganisms with
keto acids often being prepared as precursors.
The presence of pyridoxal phosphate as a coenzyme would 
seem to be essential to the transamination reaction. A non- 
enzymic model with copper, iron or zinc ions replacing the 
apoenzyme showed this certainly to be the case The
study of vitamin Be deficient rats revealed that the 
catalytic activity of the heart and kidney transaminases was 
increased by the addition of pyridoxal phosphate
The mechanism of enzymatic transamination for a-amino 
acids was proposed by Braunstein et, al. and Snell et.
ai. The reaction is shown in equation 2.1 and involves
the formation of a Schiff's base between the pyridoxal
coenzyme and the amino acid. This results in the
labilisation of the «-hydrogen of the amino acid. The
pyridoxal coenzyme is converted into pyridoxamine by
transfer of the nitrogen of the amino acid and results in
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the formation of a keto acid. In the case of diamines or w - 
amino acids the corresponding aldehydes are formed
In order to try to understand and utilise the 
transamination reaction, several substitutes for the 
pyridoxal coenzymes have been used. The stereochemistry of 
the reaction was studied by Dunathan et. al *'*» who prepared 
both enantiomers of pyridoxamine in a monodeuterated form at 
the 4-methylene group. Kuzuhara studied the
transamination reaction using pyridoxamine analogs with 
planar chirality that were capable of enantio-face 
differentiation. Murakami et. al. studied the effects of 
a pyridoxamine analog in vesicular and micellar phases. They 
found that the transamination of L-phenylalanine proceeded 
slowly in these phases but was greatly increased by the 
presence of metal ions, especially copper.
2.1.3 Classification of transaminases.
Transaminase enzymes are conveniently classified into 
three groups as shown in equations 2.2, 2.3 and 2.4,
according to the type of amino acid and/ or amine that they 
react with. However, it is important to appreciate that 
often the transaminases cannot be classified so clearly. The 
transaminases may promote more than one type of 
transamination process as well as other reactions Also
they Will often act as catalysts for a wide range of amino 
acids, amines and carbonyl compounds
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Type 1 •transaminases which convert a— amino acids into their
c o r r e s p o n d i n g  keto acids
a~.keCo acid a— amino acid
R — CH— COOH-*---- — ---iTransaminasej----------- RCOGOOH Eqn. 2.2I (pyruvate) t. JNH t J
examples are m e t h i o n i n e - r - 1yase and serine glyoxalate 
transaminase
Type 2 transaminases which c o n v e r t Ctô-amino acids and amines 
into their corresponding aldehydes.
\ acid r I a— amino acid Eqn. 2.3NH2(CH,)COOH77r ^  Tranaminase  »-CHO(CH2)COOHn ^ P y r u v a t e j  _ Jj n i— i
examples are (î-aminovalerate, GABAT, diamine aminotransferase
Type 3 transam inases which are a miscellaneous group o'f 
enzymes that promote transamination for one substrate.
C H ^O C H gO ®  jjransaminasej^^ Ilfrj'l?^*^ > CHgCH^NH ^ C H ^ O  ®
Eqn. 2.4
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Transamination using whole cells has not been fully 
investigated^®. It is considered that several transaminases 
may be present in cells. The enzymes may be multispecific 
and their roles could o v e rlap several biochemical pathways. 
Two groups of aromatic transaminases which showed an overlap 
of different biochemical pathways were found to occur in
Esch e r i c h i a  coli and in Pseudomonas aeruginosa
respectively. In the latter case the biosynthesis of L-
phenylalaine and L-tyrosine was shown to occur by catalysis 
of phenyIpyruvate with five transaminases.
2.1.4 Pvridoxine c o e n z v m e s .
Pyridoxine, or vitamin B© as it is more commonly known, 
is one of the most important biochemicals The
derivatives of pyridoxine, pyridoxal and pyridoxamine, 
parti c u l a r l y  in the form of phosphate esters, as discussed 
above are important coenzymes in the biological process. The 
structures of pyridoxine, pyridoxal and pyridoxamine are 
shown in figure 2.1.
CH OH
C H g O HHO. , .CH,OH HO -
c h ;^  n 
pyridoxine
Figure 2.1
The pyridoxine derivatives also act as coenzymes for 
several other enzymatic reactions Some of these
pyridoxal pyr i doxam ine
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reactions are summarised in equations 2.5-2.10. The 
pyridoxine derivatives act as "electron sinks" as electrons 
are delocalised away from the substrate into the aromatic 
ring of the S c h i f f ’s base. It is the direction of 
de localisation that dictates the type of reaction that will 
occur (see figure 2.2).
• J  °R —cVjl^a process a: leads to decarboxylation
J, P process b : leads to transamination 
process c : leads to aldol-type 
Q<-' condensation and
retrocondensation
Figure 2.2
The labilisation of the a-hydrogen of the substrate in 
the S c h i f f ’s base complex during transamination makes it 
possible to use the enzymes as catalysts for the labelling 
of amino acids with hydrogen isotopes. The study of
hydrogen isotope exchange reactions of transaminases is 
briefly reviewed below.
2.1.5 Hydrogen isotope exchange by transaminase e n z y m e s .
The ability of some pyridoxal dependent enzymes to 
catalyse hydrogen isotope exchange with amino acids is the 
key feature to work described in this chapter. Grisolia 
and Hilton et. al. were among the first workers to
demonstrate this phenomenon when they showed that glutamic- 
oxalacetic transaminase will catalyse the a-hydrogen
exchange of glutamate. Evidence for G-hydrogen exchange was 
reported by Oshima and Tamiya when they labelled L-
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HOC2 CH, CHz— CH— COf-~^HO..C —  CHgCHg CHg— NHg+ CO^ Eqn. 2.b
NH
decarboxylation
H
R —  C^COt
H CO0
NH
R  C ^ C O ®  +  R — C - H  Eqn. 2 -b/ 2
®NH ©  ^ NH 3
racemization
HOCH,— CH— CO®
©NH
^C =  O + CH2— CO2®
/  I©NH.
Eqn. 2.7
reverse condensation
CH — CO©
©NH
CH\ ©  ' 
NH,
0
Eqn. 2 . S
tryptophan synthesis
HO MD —  CHj CHg—  CH— CO2 —► CH3—  CH^ CH —  CO2 '
© NH, © NH
Eqn. 2.9
phosphate elimination-hydration
0HOCH,—  CH —  CO, —► CH, — C —  CO © Eqn. 2.10
© NH:
elimination-hydration
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phenylalanine.
Esaki et. al ® showed that aethionine-T-lyase was able 
to catalyse both the a-hydrogen and ^-hydrogen exchange of 
L-aethionine and L-S-aethylcysteine. They also found that 
the L-isoaers of linear aliphatic a-amino acids underwent 
isotope exchange at the a- and (î-positions but no reaction 
was observed for branched chain a-amino acids. In the case 
of glycine, L-phenylalanine and L-tryptophan slow a-hydrogen 
exchange was observed.
The mechanism proposed by Esaki et. al ® for the
hydrogen isotope exchange labelling of a- and ^-positions of 
a-amino acids by transaminases is shown in equation 2.11. 
The first stage of the reaction involves the 
transaldimination of the coenzyme-enzyme Schiff’s base (I) 
to the coenzyme-substrate Schiff’s base (II). This is 
followed by the abstraction of the a-hydrogen by another 
enzyme-coenzyme Schiff’s base to give an a-carbanion 
(iminium ion) intermediate (III). The protonated enzyme- 
coenzyme Schiff’s base undergoes rapid isotope exchange in 
the presence of deuterated (or tritiated) solvent. Reversal
of the reaction at this stage leads to the formation of an
a-amino acid labelled in the a-position with deuterium (or 
tritium).
The labelling of the G-position occurs via the
tautomerism of the ketimine (IV) to enamine (V), after the 
(î-hydrogen is abstracted by an enzyme-coenzyme Schiff’s
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Enz
LHB.
T ronsa ld im ina t i o n
R— CHz— CH — COO
■^Ah 3
Enz
Enz
DB.1 .
BH
R -C H -C :\C O O
R— CH,“ C - C O O t
>11fjiH
CH,
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Cijn
CH,
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R—C H = C —COO 
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K e t i m i n e ^ I
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CHg E nam ine
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D , 0 Enz
+DB
Eqn. 2.11
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alanine at the a- and (3-positions using semi-purified 
glutamate-alanine transaminase. Nmr spectroscopy has been 
used by several authors to study the latter reaction.
Evidence from this work s u g gested that (3-hydrogen exchange
occurred via t a u t o merism of a pyridoxamine-keto acid 
S c h i f f ’s base rather than by énolisation of the keto acid. 
Indeed kinetic studies by Cooper showed that the rate 
limiting step of the reaction was the abstraction of the a- 
hydrogen from the amino acid. This implied that one of the 
protons of the amino acid could be exchanged from the amino 
acid onto the active site of the enzyme and back to the
substrate while the other position undergoes isotopic
exchange at the active site.
Several other reports about the enzymatic exchange 
labelling of amino acids have been made. Babu and
Johnston®® found that ^lutamic-oxalacetic transaminase also
catalysed the a- and (3-positions of L-alanine. The same
authors also found that glutamate-alanine transaminase 
exchanges one hydrogen of glycine. Both enzymes were found 
to label the a-positions of glutamate and aspartate with
deuterium.
There is considerable confusion as to whether the (3- 
hydrogens of glutamate and aspartate are exchanged in the 
presence of a-keto acids by these enzymes Also a
study by Gout et. al. showed that aspartate transaminase, 
isolated from Escherichia c o l l . was able to catalyse the a- 
hydrogen but not the (3-hydrogen exchange of aspartate and
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base. The protonated enzyme-coenzyme S c h i f f ’s base undergoes 
isotope exchange with the solvent deuterium (or tritium). 
Reversal of the reaction at this stage results in deuterium 
(or tritium) being added to the (3-position.
The above reports show that transaminases are useful 
catalysts for labelling amino acids by the hydrogen isotope 
exchange reaction. The enzymes are usually able to catalyse 
the labelling of more than one amino acid.
2.1.6 Pseudomonas p u t i d a .
Pseudomonas putida has been used for this
research to obtain the enzyme m e t h i o n i n e - r - l y a s e . The 
bacteriiU-nis found naturally in soil and water. The taxonomy 
of Pseudomonas putida is summarised in T a b l e  2,1. The 
bacteria is fairly versatile and can be grown on a wide 
range of substrates, including most of the proteinogenic 
amino acids.
Pseudomonas putida whole cells have been used for 
several biochemical processes. The preparation of cis-diols 
from benzene and other aromatic compounds by catalytic 
action of Pseudomonas putida is carried out on an industrial 
scale This is a reaction that has yet to be
successfully carried out using conventional chemistry 
methods. The cis-diol can be used to prepare inositol and 
polyphenylene.
16 0
Recent studies have been carried out on the adhesion of 
t?seudomonas bacteria to soil particles Evidence
suggested that Pseudomonas fluorescens and Pseudomonas 
putida strains adhere strongly to sand and may involve the 
flagella. The results imply that Pseudomonas putida is 
suitable for whole cell immobilization.
2.1.7 Transaminases of Pseudomonas p u t i d a .
There are two important t r a n s aminase enzymes that can 
be found in Pseudomonas p u t i d a . These are methionine-r- 
lyase, which is a potential anti-tumor enzyme and a
branched-chain transaminase. The former is a type 1 
t r a n s a m i n a s e , found in the cytoplasmic region of the 
bacteria. The enzyme has been purified by several authors 
45-48 Its ability to label the a- and (3-carbon positions 
of amino acids by hydrogen isotope exchange ® has already 
been discussed. The enzyme is also capable of promoting 
several other reactions  ^ such as a, r - e 1i m i n ation, t -
replacement, a, ^-elimination and ^-replacement with sulphur 
containing amino acids and thiols, as shown in equations 
2.12-2.13. The reactions were also shown to be possible 
when selenium was used in place of sulphur
2. 12RS-CHg-CH-CH-CO2H +H2O — RSH + CHg-CH^-CO-COgH + NH3 
tllHj
a, T - e l imination
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R S - C H - Ç H - C 0 , H + R ' S H  r ' S - C H -C H -C O .H  .  RSH
The branched-chain transaminase belongs to the type 2 
category and has been studied because of its ability to 
catabolise both L-and D-lysine The potential of the
enzyme for catalysing hydrogen isotope exchanges with amino 
acids has not yet been assessed.
2.1.8 Whole cell and enzyme immobilization.
One of the major problems in carrying out reactions 
using biochemical processes is the recovery and reuseability 
of the biological catalyst Immobilization of the
biological catalyst is a technique which overcomes these 
problems. The immobilized biocatalyst is physically 
confined or localized in a defined region of space but still 
retains its catalytic activity. Several reviews have been 
written about the methods of immobilization of cells and 
enzymes
The most common method of cell immobilization is
entrapment. The whole cells are physically confined to the 
pores of a polymeric c a r rier Agar, polyacrylamides,
cellulose and epoxides have all been used as support
matrices. The method has the drawback in that often cell
loading is poor and the support material may be sensitive to
chemicals. Methods e m p l oying adsorption, flocculation,
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covalent bonding and encapsulation have also been used to 
immobilize whole cells. The preferred methods of
immobilization of enzymes involve covalent attachment or 
adsorption to a support.
The immobilization matrix should, in addition to being 
economically priced, meet the following criteria:
1. Loss in catalytic activity on immobilization should be 
kept low.
2. High cell or enzyme loading should be obtained.
3. Substrates and products should be able to diffuse freely 
through the biosupport.
4. The biosupport should have high mechanical strength and 
show negligible abrasion.
5. The biosupport should be thermally and chemically stable.
6. Regeneration of the biocatalyst should be possible.
7. The biosupport should have a high contact area with the 
surrounding medium.
2.1.9 Biofix b i o s u p p o r t s .
Biofix is the name given to a range of ceramic 
biosupports®® developed by English China Clays international 
limited ( E C O  from the mineral kaolinite (Al2O9 .2SiO2 .2H2O). 
There are two grades of biofix designed for whole cell and 
enzyme immobilization respectively. The cell supports 
consist of hollow porous microspheres of interconnecting 
ceramic needles, which resemble birdsnests in appearance.
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Table 2 . 1 : Taxonomy of Pseudomonas P u t i d a .
1. Member of the pseudomonas genus
2. A gram negative bacteria
3. Bacteria are rod shaped, non-sporulating 
and have polar flagella
4. Grows on a wide range of substrates
5. Does not hydrolyse gelatin
6 . Incapable of denitrification
7. Forms fluorescent pigments
8 . No strains grow above 41°C
9. Most strains do no not grow below 4°C
10. Maximum growth between 25-30=C
11. Subdivided into two biotypes- only 
biotype B utilizes L-tryptophan for growth
12. Dimensions: Length 2-4pm; width 0.1-0.2pm
Table 2 . 2 : Properties of biofix C2 
biosupport ( E C O .
Hollow porous microspheres
Pore diameter 
Mean pore size 
Particle size 
Surface area 
Bulk density 
pH stability 
Thermal stability
= 20Pm 
= 900Â 
= 50 —75pm 
= 9.5m®/g 
= 0.50g/cm 
= 1-14 
= 1000=C
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that allow substrate and nutrients to flow freely in and out 
of the entrapped cell. Whereas the enzyme supports consist 
of porous microspheres that allow the ingress of enzymes and 
s u b s t r a t e s .
Biofix cells supports have been used for the
immobilization of Saccharomvces cerevisiae while the enzyme 
support has been used for immobiIzation of trypsin and
urease The supports give high levels of biocatalyst
loading. In the case of the cell support uniform loading
down a column can be achieved. Hence, biofix supports would 
seem to be suitable for the immobilization of methionine-r- 
lyase and Pseudomonas p u t i d a . which as has been mentioned 
above shows good adherence properties to silicates. The
immobolization of Pseudomonas putida to biofix C2 support 
has been studied in this work. The properties of Biofix C2 
are shown in Table 2.2.
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2.2 Experimental.
2.2.1 G e n e r a l .
2.2.1.1 R e a g e n t s .
All chemicals and solvents used for growth of 
Pseudomonas putida were autoclaved at 140=C prior to use. 
The exception to this was L-methionine which was sterilized 
by filtration through a millipore filter.
2.2.1.2 A p p a r a t u s .
All glassware and plastic apparatus used for the 
growth, cultivation and storage of Pseudomonas putida and 
methionine-T-lyase were either autoclaved at 140®C prior to 
use or purchased in p r e - s t e r i 1 ized packages.
2.2.1.3 Enzyme a s s a y .
The activity of the enzyme methionine-T-lyase was 
d etermined using the method of Ito et. al*". The method 
utilizes the reaction of methanethiol with 5, 5*- dithiobis- 
(2- n i t r o b e n z o i c ) acid to form thionitrobenzoic acid. The 
formation of thionitrobenzoic acid can be followed 
conveniently by uv spectroscopy.
A fresh solution c o n t aining 5mH of L-methionine, 50PM 
of pyridoxal phosphate and 0. IH potassium pyrophosphate (pH
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8.5) was prepared and d e s i gnated the reaction solution. The 
enzyme assay reagent was prepared by dissolving 4mM of 5, 
5 ’-dithiobis-(2-nitrobenzoic) acid in 50mH potassium 
phosphate buffer (pH 7).
The reaction solution (1ml) was incubated at 30®C for 
ten minutes. The enzyme sample (1ml) was added to the 
reaction solution. The methanethiol released from the 
reaction solution was c o l lected in the enzyme assay reagent 
(1ml). After thirty minutes, 80% perchloric acid (0.1ml) 
was added to the reaction solution. The reaction solution 
was stood for a further twenty minutes at 30®C to allow 
complete absorption of all the methanethiol by the enzyme 
assay reagent.
The uv absorption of the enzyme sample was measured at 
30=C using a fixed wavelength of 412nm. The sample was 
referenced to a blank solution of the enzyme assay reagent. 
The number of moles of methanethiol released by the enzyme 
was determined using the Beer-Lambert law and a 
molar extinction coefficient of 120001mol‘"*^cm“ *^ for 
thionitrobenzoic acid. One unit of enzyme activity for 
m ethionine-T-lyase was defined as being equivalent to one 
/-» mole of methanethiol *®.
2.2.1.4 Protein a s s a y .
The bicinchoninic acid (BCA) protein assay kit was
used to determine protein concentration during the
1 67
purification of methionine-T-lyase. The protein assay kit 
consists of two ready made reagents; Reagent A contains 
sodium carbonate, sodium bicarbonate, BCA detection reagent 
and sodium tartrate in 0.2M sodium hydroxide; Reagent B 
contains a 4% copper sulphate solution.
A working reagent was prepared by adding 50 parts of 
reagent A to 1 part of reagent B. Protein standards were 
prepared using albumin standard (BSA, 2mg/ml) at 
concentrations of 200-1200pg/ml inclusively. The working 
reagent (2mls) was added to each of the protein standards 
(1ml). The assay sample was prepared by taking a known 
volume of the extract of methionine-T-lyase (25-lOOOMl) and 
making up to 1ml with doubly distilled water. Working 
reagent (2mls) was added to the assay sample. The solutions 
of the protein standards and assay sample were left for a 
minimum period of two hours and then their uv absorptions 
were measured at 562nm. The protein concentration of 
m ethionine-T-lyase was d etermined from a plot of the uv 
absorption against concentration for the protein standards.
2 .2.1.5 Plate c o u n t i n g .
The number of colonies of Pseudomonas putida were 
determined using a plate counting method ®*. The suspension 
of Pseudomonas putida in 50mM of potassium phosphate buffer 
(1ml) was added to a 10% peptone solution O m i s ) .  A portion 
(1ml) of this solution was diluted by adding it to 10% 
peptone O m i s ) .  Further samples were prepared in a likewise
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manner until a final solution containing a 10“ fold dilution 
of the original b a c teria cell concentration had been made. 
Six spots of the sample (20M1) were plated out onto a dry 
nutrient agar plate using a 50 dropper pipette. Four plates 
were used per sample. The process was repeated for all 
solutions of Pseudomonas p u t i d a .
The plates of Pseudomonas putida were stored at 30°C 
for one day. The colonies of bacteria per spot were counted 
for each sample. Only plates that contained spots with 
between 30 and 100 colonies were deemed accurate enough for 
counting. The concentation of Pseudomonas putida was 
d etermined as the number of bacteria colonies/ ml.
2.2.1.6 C e n t r i f u g e .
Bacteria cells and enzyme extracts were centrifuged at 
4®C using a HSE HS18 high speed centrifuge.
2.2.1.7 Nmr s p e c t r o s c o p y .
and Nmr s p e ctra were run on a Bruker AC300E
spectrometer. In some cases, particularly the kinetic 
studies, a water suppression method was used to improve the 
FID of spectra of the labelled amino acids. In the case 
of glycine and alanine the change in the integrals of the 
chemical shifts for the a- and/ or (3-positions were measured 
relative to an external standard of sodium acetate (6mg), 
which was added to the sample prior to analysis.
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2.2.2 Growth and cultivation of Pseudomonas p u t i d a .
Pseudomonas putida bacteria were grown using the method 
of Ito et. al *®. Pseudomonas putida cells (ATCC 2032) 
s uspended in a 10% peptone solution were streaked onto horse 
blood enriched agar (Oxoid) plates. The plates were 
incubated at 3 0 “C overnight. The Pseudomonas putida cells 
were scraped off the agar plates and grown in a culture 
medium of the following composition (w/v): 2.0% glycerol,
0.015% L-methionine, 0.001% F e C U . 6 H = 0 ,  0.17% MgCl = .6H=0, 
0.01% CaClg.2H20, 0.35% NaNH ^ H P O ^ . 4H e O ; in potassium 
phosphate buffer (pH7.0, 50mM). The bacteria cells were
grown in 600 mis of the medium (GxlOOmls portions) on a 
platform shaker at 30®C for a period of 24 hours. The 
bacteria cells were c entrifuged down at SOOOrpm and the 
culture medium decanted off. The bacteria cells were then 
washed with buffered saline solution (pH7, 3x20mls) and then 
either used directly or stored at - 2 0 “C.
2.2.3 Cell disruption and enzyme e x t r a c t i o n .
A suspension of Pseudomonas putida cells in potassium 
phosphate buffer solution (pH7, 50mM) were stood over ice
and disrupted using a polytron shearing instrument (4x30s 
bursts). The cell debris was centrifuged down at 5000rpm. 
The crude extract of the enzyme was collected by decanting 
off the supernatant. The crude enzyme was either sem i ­
purified or used directly in labelling studies.
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2.2.4 Semi purification of * e t h i o n i n e - T - l y a s e .
2.2.4.1 Enzyme precipitation with ammonium s u l p h a t e .
20Mls of the crude extract of methlonine-r-lyase was 
s tirred at 0®C for ten minutes. 4Mls of 20% streptomycin
sulphate solution, adjus t e d  to pH 7 with NaOH, was added
dropwise. The precipitate that formed was removed by
centrifugation. Solid (NH^lzSO* was added slowly to the 
supernatant. The solution was stirred for thirty minutes. 
The resulting precipitate was collected.
2.2.4.2 Enzyme purification by DEAE cellulose c h r o m a t o g r a p h y .
A DE32 cellulose ion exchange column was prepared as 
follows. The dry cellulose (30g) was pretreated by stirring 
With 0.5H HCl (450mls) and leaving for one hour. The
supernatant was filtered off and the filtrate was washed 
with doubly distilled water until an intermediate pH 4 was 
obtained. The cellulose was stirred with 0.5M NaOH (450mls) 
and left for thirty minutes. The supernatant was removed 
and the cellulose was s t irred with a second amount of 0.5M 
NaOH (450mls) and left for thirty minutes. The mixture was 
filtered and the filtrate washed with doubly distilled water 
until neutral pH was obtained.
The cellulose was stirred with Ô.2H potassium phosphate 
for three minutes. The slurry was allowed to settle and the 
supernatant decanted off. The ion exchange material was
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redispersed in buffer solution (lOOOmls) and allowed to 
settle for eighteen hours. The slurry was packed into the 
column and was washed with 0.2M potassium phosphate buffer 
at a flow rate of 4 5mls/hour until the column bed height was 
constant. The column was then washed with a 0.5M KCl buffer 
until the pH of the solution at the top and bottom of the 
column was equal.
The ammonium sulphate precipitate of the enzyme was 
d i s s olved in 0.2M p o t a ssium phosphate buffer and applied to 
the DE32 column without predialysis. The enzyme was eluted 
with 50ml of KCl buffer gradient from 0 to 0.5H, in steps of 
10ml of 0 . IH, at a flow rate of 40mls/hour. The eluent was 
collected in 10ml fractions. The fractions were combined 
and reduced in volume by evaporation to 5mls. The total 
protein content and enzyme activity were determined for the 
se mi-purified methionine-r-lyase.
2.2.5 Labelling studies using m e t h i o n i n e - r - l v a s e .
2.2.5.1 Attempted deuteration of amino acids using 
crude extracts of m e t h i o n i n e - T - l v a s e .
Amino acid (30mg), pyridoxal phosphate (Img), 
methionine-T-lyase (enzyme activity of 87units/mg) in 2mls 
of potassium phosphate buffer solution (pH7, 50mH) and
O.Smls of DzO were left at 37®C for seven days. The product 
was freeze dried. The residue was repeatedly dissolved in 
water and freeze dried to remove the labile deuterium. The
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product «as then analysed by and ®H nmr spectroscopy. 
Attempts were made to label glycine, L-alanine and L- 
methionine by this method. In all cases no incorporation of 
deuterium was observed.
2.2.5.2 Attempted deuteration of amino acids using 
semi-purified extracts of m e t h i o n i n e - r - l v a s e .
The method de s c r i b e d  above for the attempted 
deuteration of amino acids using a crude extract of the 
enzyme was repeated, with the exception that a post 
cellulose column extract of methionine-T-lyase (enzyme 
activity of 1 4 4 3 u n i t s / m g ) was used. The samples were worked 
up as above. Analysis by nmr spectroscopy showed the 
reactions were unsuccessful.
2.2.6 Labelling studies using Pseudomonas p u t i d a .
2.2.6.1 Deuteration of amino acids using DaO.
Initial deuteration studies using Pseudomonas putida 
were carried out in the absence of a cofactor. However, it 
was found that insufficient incorporation of deuterium 
occured in these cases. The method below was used for 
further studies.
A mixture of amino acid (30mg), pyridoxal phosphate 
(5mg), Pseudomonas putida (approx. 3x10* ± 0 . 5 x10* bacteria 
colonies) and 50mM potassium phosphate in D2O (O.Smls, pH 7)
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were stored at 37®C for seven days. The bacteria cells were 
removed by filtration and the sample freeze dried. The 
sample was successively dissolved in water and freeze dried 
until all the labile deuterium had been removed. and
nmr spectra of the sample was obtained.
2.2.6 .2 Deuteration of amino acids usina DaO-HgQ m i x t u r e s .
After establishing that the deuteration of amino acids 
could be carried out in the presence of Pseudomonas putida 
and a pyridoxine coenzyme, it was decided to investigate the 
effect of using a DzO-HzO mixture as the solvent medium 
rather than DzO.
Amino acid (SOmg), pyridoxal phosphate (5mg), 
Pseudomonas putida (approx. 3x10* ± 0.5x10* bacteria cells) 
and , 50mH potassium phosphate (pH 7.0) in a mixture of H=0 
(0.4mls)- DzO (O.lmls) were stood at 37®C for seven days.
The sample was worked up and analysed as described in 
sect ion 2.2.6.1.
2.2.6.3 Labelling studies using different batches 
of Pseudomonas p u t i d a .
In order to verify the reproducibility of the labelling 
studies, it was decided to compare the deuteration of amino 
acids using different batches of Pseudomonas putida. Three 
batches of newly grown Pseudomonas putida were used to 
deuterate L-methionine using a HgO-DzO mixture as described
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above in section 2.2.6.2.
2.2.7 Immobilization of Pseudomonas putida c e l l s .
A biofix C2 column (5x1.5cm) was prepared by suspending 
the biosupport material (5g) in potassium phosphate buffer 
solution (pH7, 50mM, 20mls). The biofix C2 column was
washed with potassium phosphate buffer solution (pH 7, 50mM, 
2 0 0 m I s ).
Pseudomonas putida cells were suspended in potassium 
phosphate buffer solution (pH7, 50mM, lOOmls) and loaded
onto the biofix C2 column at a flow rate of 5mls/min. The 
column was then washed with potassium phosphate buffer 
solution (2x200mls). The biocatalyst was stored at -20®C 
until required.
The efficiency of cell loading was m e a sured by plate 
counting by taking colony counts for: (i ) the initial and
final cell concentrations for the loading solution; (ii) the 
eluted solution d u ring loading at known time intervals and 
(iii) the eluent from washing the biofix column with buffer 
s o l u t i o n .
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2.2.8 Labelling studies usin* immobilized 
Pseudomonas putida cells.
Since the deuteration of amino acids using whole cells 
had been shown to be clearly possible, then the next stage 
of the studies involved trying to recover and reuse the 
biocatalyst. Successful immobilization of Pseudomonas 
putida enabled labelling studies using bound cells to be 
undertaken. The following method was used.
Amino acid (SOmg), pyridoxal phosphate (5mg), 
immobilized Pseudomonas putida (0.2g) and 50mM potassium 
phosphate in a mixture of HzO (0.4mls)-Da0 (O.lmls) were 
stored at 37®C for seven days. The biocatalyst was removed 
by filtration. Labile deuterium was removed by several 
cycles of dissolving the sample in water followed by freeze 
drying. The product was analysed by and nmr
spectroscopy.
2.2.9 Biocatalyst regeneration.
Biocatalyst, which had been previously used for 
labelling studies, was collected on a sterilized sintered 
funnel by gravity filtration. The biocatalyst (Ig) was 
suspended in 10% peptone solution (lOmls) and stood at 30=C 
overnight. The peptone solution was removed by gravity 
filtration. The biocatalyst was washed with potassium 
phosphate buffer (pH7, SOmM, SOmls).
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In order to assess the viability of the regeneration 
process, the deuteration of L-methionine was carried out 
respectively in the presence of freshly prepared 
biocatalyst, regenerated biocatalyst and previously used 
biocatalyst. The standard labelling method, as described 
above, for immobilized Pseudomonas putida was followed.
2.2.10 Labelling studies using different coenzymes.
The effects of different coenzymes on the efficiency 
and labelling pattern of deuteration have been studied, 
Pyridoxine, pyridoxal phosphate and pyridoxal hydrochloride 
were used as coenzymes. The same labelling studies for 
amino acids deuterated with Pseudomonas putida. both as a 
free and immobilized cell, and pyridoxal phosphate were 
repeated but using the other two coenzymes instead.
2.2.11 Labelling studies using sugar solutions.
Sugar solutions were used to investigate the effect of 
cell dehydration on the ability of the bacteria to deuterate 
amino acids. A change in the osmotic pressure, due to 
dehydration of the bacteria, may result in disruption of the 
cell wall and could even inhibit some of the reactions 
catalysed by the bacteria's enzymes. Hence, these 
experiments were used to determine the suitability of
Pseudomonas putida as a catalyst for isotope exchange
studies in semi- and non-aqueous solvent systems. The
deuteration of amino acids in 40% (w/v) sugar solutions were
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studied by the following method. Solutions of sucrose,
fructose and glucose were used for the study.
A mixture of amino acid (30mg), pyridoxal phosphate 
(5mg), immobilized Pseudomonas putida (O.lg), sugar solution 
(0.4mls) and D*0 (0.1ml) were stood at 37°C for seven days. 
The sample was worked up and analysed as described under 
section 2.2.8.
A ^owex 50^^ column (15cm) was prepared by washing 
through with citric acid buffer (pH 3.4; 40mls of 0.IM 
citric acid and lOmls of 0. IH sodium citrate diluted to 
lOOmIs). The crude sample of deuterated amino acid was 
dissolved in formic acid-acetic acid buffer (pH 1.88, 5mls). 
The buffer solution was applied to the column. The column 
was washed with further portions of the formic acid-acetic 
acid buffer (3xl0mls). The amino acid was eluted with 
pyridine-acetic acid buffer (pH6.5). The buffer solution 
was freeze dried and the sample analysed by *^H and ®H nmr 
spectroscopy.
2.2.12 Labelling studies using semi- and 
non-aqueous solvent systems.
The following semi- and non-aqueous solvent systems 
have been investigated as potential media for the 
deuteration of amino acids and their derivatives? 10% DMSO, 
40% glycerol, 10% DMF , 10% ethanol, 50% ethanol, ethanol,
chloroform, tetrahydrofuran, DMSO and DMF .
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A mixture of amino acid (30mg), pyridoxal phosphate 
(5mg), immobilized Pseudomonas putida (O.lg), solvent 
(O.Smls) and DaO (50M1) were stood at 37°C for seven days. 
The sample was worked up and analysed as described under 
section 2.2.8.
2.2.13 Qualitative assessment of the effects of
inorganic salts on the deuteration of amino acids.
The effect of metal ions on the amino acid-enzyme and 
amino acid-coenzyme Schiff's bases has been assessed in 
terms of the labelling pattern and efficiency of deuteration 
of amino acids. The following inorganic salts were used for 
the study: iron (III) chloride, calcium chloride, magnesium
chloride, copper (II) chloride and zinc acetate.
Amino acid (30mg), pyridoxal phosphate (5mg), D*0
(0.1ml), 10% (w/v) inorganic salt solution (0.4ml) and
biocatalyst (0.Ig) were stood at 37=C for seven days. The 
sample was worked up and analysed as described in section 
2.2.8.
2.2.14 Kinetic studies.
The deuteration of glycine esters by Pseudomonas putida 
has been studied by ‘H nmr spectroscopy. The loss in the 
chemical shifts of the «-positions of the amino acids were 
followed at 37=C as a function of time. Glycine methyl ester 
and glycine ethyl ester have been studied. The method below
1 fy
was used.
Amino esters (20mg), pyridoxal phosphate (5mg), 50mH 
potassium phosphate in d«-dmso (O.Smls), DaO (SOPl) and 
Pseudomonas putida (approx. 3x10* ± 0.5x10* bacteria
colonies) were placed in a 5mm nmr tube. The nmr spectra 
were obtained at 37=C using an automated solvent suppression 
technique. nmr spectra were recorded at ten minute
intervals for 3 hours. Subsequent nmr spectra were
obtained for samples that were seven days old and had been 
stored at 37®C.
The integrals of the chemical shifts for the a- 
positions of the amino acids were measured. The change in 
the integrals were plotted as a function of time and the 
first order rate constants have been determined for the amino 
acids.
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2.3 Results.
2.3.1 General.
The results obtained for protein and enzyme assays of 
the crude and semi-purified extracts of methionine-T-lyase 
are summarised in sections 2.3.2. The results of plate 
counting experiments for determining the number of bacteria 
colonies are summarised in section 2.3.3.
The deuteration of amino acids by using free and
immobilized whole cells of Pseudomoas putida are summarised 
in sections 2.3.4-2.3.9. The results of the labelling
studies have been tabulated in terms of the percentage 
distribution of deuterium in the amino acids and the degree
of incorporation at the sites of isotope exchange. The
former results were obtained directly from the integration 
of the nmr spectra of the deuterated amino acids. The 
amount of deuterium incorporated was determined from the 
integrals of the nmr spectra of the deuterated amino 
acids and has been expressed as a percentage of the total 
hydrogen atoms at a particular position.
The following amino acids and amino acid derivatives 
were found not to undergo isotope exchange labelling with 
deuterium using the methods described in section 2.2.
(i) L-a-amino acids: valine, isoleucine, tyrosine, serine,
threonine, tryptophan, proline, hydroxyproline, aspartic
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acid, glutamic acid, (3-hydroxygIutamic acid, ornithine, 
histidine, arginine and lysine.
(ii)U)-amino acids* (l-alanine, T-aminobutyric acid and 6- 
aminohexanoic acid.
(iii) Sulphurcontaining L-a-amino acids* cysteine and 
cystine.
(iv) D-a-amino acids* alanine, leucine and methionine.
(V ) DL-amino acids* alaninine, leucine, norleucine,
phenylalanine and methionine.
(Vi) N-substituted amino acids* N-acetylalanine, N-
acetylvaline, N~acetylleucine, N-acetylphenylalanine, N-
benzoylvaline, N-benzoylphenylalanine, N-methylalanine and
N-methylmethionine.
(vii) Dipeptides* glycyIglycine and glycylalanine.
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2.3.2 Enzyme specific assay results for crude and
semi-purified extracts of methionine-T-lyase
Table 2.3: Enzyme specific assay results
Sample no. 1 2  3 4 5 6
Crude enzyme
Absorbance 1.12 1.18 1.23 1.20 1.31 1.20(562nm)
Protein conc. 410 460 500 410 550 410
(mgl~i)
Absorbance 1.41 1.35 1.39 1.41 1.37 1.43(412nm)
Total enzymeactivity /batch 117 112 115 117 114 119of Ps. putida (units X 10~®)
Enzyme specificactivity (units 285 243 230 285 207 29110“®/mg Protein)
Semi-purif ied enzyme
Absorbance 0.58 0.57 0.59 0.57 0.58 0.61(582nm)
Protein conc. 207 206 208 206 207 215
(mgl-i)
Absorbance 0.41 0.42 0.57 0.47 0.51 0.40(412nm)
Total enzyme
a ctivity /batch 138 140 188 156 171 133
of Ps. putida 
(units X 10-*)
Enzyme specificactivity (units 667 680 904 761 830 61910-*/mg Protein)
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2.3.3 Plate counting results for samples of
Pseudomonas putida.
Table 2.4; Bacterial colonies of P. putida cultures
BatchNo.
ABC
Average Colony count / ml of peptone solution
32 ± 8 X 10»46 ± 15 X 10» 36 ± 6 X 10®
Number of bacterial colonies /600ml of culture media
19.2 ± 4.8 X 10»27.6 ± 9.0 X 10»21.6 ± 3.6 X 10»
Table 2.5; Efficiency of bacteria cell immobilization
Sample Colonycount/ml Sample volume / m l Total number of bacteria colonies
Initial loadsolution 44 X 10*concentrât ion
1st eluent 32 x 10*sample
2nd eluent 36 x 10*sample
1st wash 78 x 10»sample
2nd wash 2 x 10»sample
Immobi1ized bacteria concentration / 4.5g biofix
Immobi1ized bacteria concentration / g biofix
Efficiency of bacteria cell immobilization
100
50
50
100
100
44 X 10® 
16 X 10» 
18 X 10» 
78 X 10» 
2 X 10»
2.2 X 10® 
5 X 10®
5%
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2.3.4 Deuteration of amino acids using 
Pseudomonas putida and pyridoxal phosphate
Table 2.6; Studies using sulphur-containing L-a-amino acids 
(Labelling pattern of amino acids from *H nmr spectra)
Amino Chemical Distribution ofacid position shift deuterium
6 ppm (%)
Methionine a 3.9 64
a 2.2 36
Ethionine a 3.9 64
(1 2.2 36
S-MethyIcysteine a 3.9 64
a 3. 1 36
Table 2. 7; Studies using sulphur-containing
L-a-amino acids
(Degree of »H incorporation)
% of incorporatedAmino into stable positionsacid position P. putida in the form i
free cells bound cel
Methionine a 26 767 21
Ethionine a 18 67
G 5 19
S-Methyleysteine a 13 43
a 12
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Table 2 .8% Studies using other L-a-amino acids
(Labelling pattern of amino acids from nmr spectra)
Amino Chemical Distribution ofacid position shift 
S ppm deuterium(X)
Glycine a 3.5 100
Alanine a 3.8 83
G 1.4 17
Norvaline a 4.0 87
G 2.8 13
Leucine a 4.0 100
Norleucine a 4.0 100
Phenylalanine cx 4.0 100
Glycine methyl ester a 3.8 100
Glycine ethyl a 3.8 100ester
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Table 2.9: Studies using other L-a-amino acids
(Degree of incorporation)
Aminoacid
Glycine
Alanine
position
a
a
G
X of incorporated into stable positions by P. putida in the form of free cells bound cells
18
20
1
79
835
Norvaline
Leucine
Norleucine
Phenylalanine
Glycine methyl ester
Glycine ethyl ester
aG
a
a
a
a
a
12
1
17
21
13
11
11
57 5
46
41
41
63
58
Table 2.10: Biocatalvst regeneration studies 
(Deuteration of methionine)
Sample
1
2
Methionineposition
aG
aG
aG
X ofincorporated into stable positions
77
21
143
48
11
Description of the immobilized Pseudomonas putida
Freshlyprepared
Previouslyused
Regenerated
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Table 2.11: Labelling studies using different 
batches of Pseudomonas putida 
(Deuteration of methionine)
X of *HSample Methionine incorporated into Batch ofposition stable positions Pseudomonas putida
l a  28 A
G 8
2 a 33 BG 9
3 a 25 CG 7
Average a 29G 8
2.3.5 Deuteration of amino acids using 
Pseudomonas putida and pyridoxal hydrochloride.
Table 2.12: Studies using sulphur— containing 
L-a-amino acids 
(Labelling pattern of amino acids from *H nmr spectra)
Amino Chemical Distribution ofacid position shift deuterium
S ppm (X )
Methionine a 3.9 70G 2.2 13G (Keto acid) 2.0 17
Ethionine a 3*9 64G 2.2 36
S-Methylcysteine a 3.9 64G 3.1 36
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Table 2.13: Studies using sulphur-containing
L-a-amino acids 
(Degree of incorporation)
Aminoacid position
% of incorporated into stable positions by P putida in the form of
free cells bound cells
Methionine
Ethionine
S-HethyIcysteine
a
G
aG
aG
92
164
72
184
359
278
Table 2.14: Studies using other L-a-amino acids. 
(Labelling pattern of amino acids from nmr spectra)
Aminoacid position Chemical Distribution ofshift 
S ppm deuterium(%)
Glycine
Alanine
Norvaline
Leucine
Norleucine
Glycine methyl ester
Glycine ethyl ester
a
aG
aG
a
a
a
a
3.5
3.6 1.4
4.02.6
4.0
4.0
3.8
3.8
100
2179
793
100
100
100
100
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Table 2.15* Studies using other L-a-amino acids
(Degree of incorporation)
Aminoacid position
X of Incorporated into stable positions by P. putida in the form of
free cells bound cells
Glycine
Alanine
a
a
G
11
34
22
44
Norvaline
Leucine
Norleucine
Glycine methyl ester
Glycine ethyl ester
aG
a
a
a
a
16
3
3
7
18
5
9
14
19
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2.3.6 Deuteration of amino acids using 
Pseudomonas putida and pyridoxine.
Table 2.16* Studies using sulphur^containing 
L-a-amino acids 
(Labelling pattern of amino acids from nmr spectra)
Aminoacid position Chemical Distribution of shift deuterium 
S ppm (%)
Methionine aG 3.9 66 2.2 34
Eth ion ine aG 3.9 62 2.2 38
S-Methylcyste ine aG 3.9 67 3. 1 33
Table 2.17* Studies using sulphur-containing
L-a-amino acids
(Degree of »H incorporation)
Aminoacid position
X of “H incorporated into stable positions P. putida in the form i
free cells bound cel
Methionine aG 23 67 6 17
Ethionine aG 34 63 10 17
S-MethyIcysteine a 14 52G 13
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Table 2. 18; Studies using other L-oc-aaino acids
(Labelling pattern of amino acids fro* nmr spectra)
Amino Chemical Distribution ofacid position shift deuterium
S ppm (%)
Glycine OL 3.5 100
Alanine OL 3.6 85
a 1.4 15
Norvaline a 4.0 89
a 2.6 11
Leucine OL 4.0 100
Norleucine OL 4.0 100
Phenylalanine OL 4.0 100
Glycine methyl ester OL 3.8 100
Glycine ethyl ester OL 3.8 100
1 92
Table 2.19: Studies using other L-a-amino acids 
(Degree of incorporation)
Aminoacid
Glycine
Alanine
Norvaline
Leucine
Norleucine
Phenylalanine
Glycine methyl ester
Glycine ethyl ester
position
X of *H incorporated into stable positions by P. putida in the form of
a
a
G
aG
a
a
a
a
a
free cells 
15
312
222
25
21
23
18
23
bound cells
57
453
433
48
39
41
47
54
2.3.7 Deuteration of amino acids in sugar solutions.
Table 2.20: Deuteration of methionine in sugar solutions
Sample
1
Methionineposition
aG
X of *H incorporated into stable positions
5314
40X(w/v) sugar solution
Fructose
aG 4412 Sucrose
aG 4710 Glucose
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2.3.8 Labelling studies in semi- and non-aqueous solvents
Aminoacid
Table 2.21: Deuteration of glycine esters
in non-aqueous solvents
X of »HPosition incorporated into Non-aqueousstable positions solvent
Glycineester
Glycineester
Glycineester
Glycineester
Glycineester
Glycineester
Glycineester
Glycineester
Glycineester
Glycineester
methyl
ethyl
methyl
ethyl
methyl
ethyl
methyl
ethyl
methyl
ethyl
a
a
a
a
a
a
a
cx
(X
negative
negative
75
68
67
68
negative
negative
negative
negative
chloroform
DMSO
DMF
ethanol
ethanol
THF
THF
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Table 2.22: Deuteration of amino acids
Amino Position X of »H incorporated intoacid stable positions
Glycine a 47
Alanine a 61G 4
Methionine a 58G 18
Glycine a 53
Alanine a 52G 4
Methionine a 60G 16
Glycine a 35
Alanine a 54G 4
Methionine a 71G 19
Glycine a negative
Alanine oc negativeG negative
Meth ionine OL negativeG negative
Glycine a negative
Alanine <x negativeG negative
Methionine « negativeG negative
Semi-aqueous solution
10% DMSO
10% DMF
40% Glycerol
10% Ethanol
50% Ethanol
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2.3.9 Deutération of amino acids in 10% 
inorganic salt solutions.
Table 2.23: Deuteration of amino acids
in inorganic salt solutions
% of ®HAmino Position incorporated into 10X(u/v) inorganicacid stable positions salt solution
Glycine a 55 F e C U
Alanine a 63 Wa 5
Methionine « 88 H
a 18
Glycine a 63 CaCl»
Alanine oc 54 H13 3
Methionine oc 65 H(3 18
Glycine QL 63 MgCla
Alanine OC 57 u13 3
Methion ine oc 68(3 20
Glycine oc 62 CuClss
Alanine oc 50 If13 4
Methionine oc 73 M(3 16
Glycine oc 59 ZnAcz
Alanine oc 56 H(3 4
Methionine oc 64 H(3 19
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2.3.10 Some kinetic data for the deuteration of 
amino acids by Pseudomonas putida.
Table 2.24: Studies using glycine methyl ester in de-DMSO
Time Change in the(min) chemical shift of the Log* (I-Iœ)«-position integral (I)
0 2.00 0.41810 1.86 0.32220 1.77 0.25530 1.70 0.19940 1.64 0.14850 1.59 0.10460 1.54 0.05870 1.50 0.02080 1.48 0.00090 1.48 0.000100 1.42 -0.062110 1.40 -0.083120 1.40 -0.083130 1.38 -0.105140 1.38 -0.105150 1.36 -0.128160 1.35 -0.139170 1.32 -0.174180 1.33 -0.16210000 (Im) 0.48
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Table 2 . 2 5 : Studies using glycine ethyl ester in d*-DMSO
Time Change in the
(min ) chemica 1 shift of the Log* (I-i
m-posit ion integral (I)
0 2.00 0.444
10 1.87 0.357
20 1.80 0.307
30 1.71 0.239
40 1.65 0. 190
50 1.80 0. 148
60 1.57 0. 122
70 1.52 0.077
80 1.46 0.020
90 1.44 0.000
100 1.43 -0.010
110 1.41 —0.030
120 1.39 -0.051
130 1.39 -0.051
140 1.37 -0.072
150 1.35 -0.094
160 1.34 -0.105
170 1.29 -0.162
180 1.31 -0.139
10000 (7 days) 0.44
Table 2.26: Rates of deuteration of amino acids
Amino acid First Order Rate constant (k) (min-i) ts-i)
Glycine 
methyl ester
Glycine 
ethyl ester
5.21 X 10~® 
4.84 X 10-®
8.68 X 10“® 
7.73 X 10“®
2 0 0
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2.3.11 Some examples of the and nmr spectra 
obtained for deuterated amino a c i d s .
The following pages contain some examples of the and 
®H nmr spectra that have been obtained for the deuterated 
amino acids. Although a complete collection of spectra is 
not shown, it is hoped that those chosen will illustrate the 
results that were obtained using the deuteration methods 
employed.
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Figure 2.3 nmr spectrum of methionine 
(reference sample)
1 O3^4ppm 25
Figure 2.4 *-H nmr spectrum of C2, 3 - ^ H Ü - m e t h lonine 
(pyrldoxal phosphate used as coenzyme)
5 4 3 2 1 0P Pm
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Figure 2.5 nmr spectrum of C2, 3-^H3-methionine 
(pyridoxal phosphate used as c o e n z v m e )
Figure 2.6 nmr spectr um  of [2, 3-^ H3- methion m e .
(pyridoxal hydroc h l o r i d e  used as coenzyme)
P P m
2 05
Figure 2.7 =H nmr spectrum of C2, 3-=H]-methionine 
(labelled in 40% glucose solution)
PPm
Figure 2.8 nmr spectrum of C2, 3-=H]-methionine 
(labelled in 10% FeCls solution)
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Figure 2.9 nmr spectrum of ethionine(referees sample)
12 O3467 58 m
Figure 2.10 nmr spectrum of C2, S-^HH-ethionine.
(pyridoxal phosphate used as coenzyme)
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Figure 2.11 =H nmr spectrum of C2, 3-=H]-ethionine 
(pyridoxal phosphate used as coenzyme)
12345P Pm7 689
Figure 2.12 nmr spectrum of C2, 3-^H3-ethionine. 
(pyridoxine used as coenzyme)
6r 5 38 24 t
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Figure 2.13 nmr spectrum of S-methyIcysteine(reference sample)
Figure 2.14 nmr spectrum of C2, 3-^H3-S“methyIcysteine 
(pyridoxal phosphate used as coenzyme)
36 4PPm78 5 2 1 0
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Figure 2.15 nmr spectrum of C2, 3-^ H]-S-methyicysteine(pyridoxal phosphate used as coenzyme)
? 13é P Pm8 7 5
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Figure 2. 16 '■H nmr spectrum of C2-=H] glycine.(pyridoxal phosphate used as coenzyme)
8 0
8 4P Pm 3 0
2 1 1
Figure 2.18 nmr spectrum of C2, 3- H^Ü-alanine.(pyridoxal phosphate used as coenzyme)
67 5 48 P Pm
Figure 2.19 limr spectrum of C2, 3-=H]-alanine.
(pyridoxal phosphate used as coenzyme)
3 25 04 1P Pm
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Figure 2.20 '-H nmr spectrum of phenylalanine(reference sample)
1237 5 468 P Pm
Figure 2.21 nmr spectrum of C2-^H3~phenylalanine 
(pyridoxal phosphate used as coenzyme)
6 4PPm5 278 1
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Figure 2.22 nmr spectrum of C2-^ H3-phenylalanine(pyridoxal phosphate used as coenzyme)
8 6 4PPm
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2.4 Discussion.
The catalytic deuteration of several amino acids and 
amino acid derivatives using whole cells of Pseudomonas 
put Ida has been shown to be feasible* However, attempts to 
utilize crude and semi-purified extracts of the enzyme 
methionine-T-lyase as catalysts for deuteration of amino 
acids were unsuccessful*
There are several distinct differences between the 
results observed for the deuteration of amino acids and 
their derivatives using whole cells of Pseudomonas putida 
(ATCC 2032) and those reported by Esaki et. al. ® for 
methionine-T-lyase. In the latter case, the a- and (Î- 
positions were deuterated only for L-methionine, L-S- 
alkyIcysteines and linear L-a-amino acids while labelling of 
the a-position occured with glycine, L-phenylalanine and L- 
tryptophan. It was shown by the research described herein 
that the labelling of L-leucine was possible but other 
branched-chain amino acids did not label. The deuteration 
of L-tryptophan using whole cells was not possible. 
Replacing the methyl group of methionine with an ethyl group 
did not affect the ability of the a- and G-protons of the 
amino acid to undergo exchange labelling with deuterium.
It was found that the D- and DL-amino acids did not 
undergo deuteration with Pseudomonas putida. Attempts to 
deuterate N-substituted amino acids, simple dipeptides, OJ - 
amino acids dicarboxylic amino acids and hydroxy amino acids
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were also unsuccessful. These observations were in agreement 
with results obtained by Esaki et. al.® using methionine-T- 
lyase.
There are several possible explanations for the 
differences between the data obtained by Esaki et. al. ® and 
those reported here. Firstly, Esaki et. al.® used a
different strain of Pseudomonas putida than that used for 
this work. A more likely reason is the fact that the whole 
cells will contain a mixture of enzymes and other cellular 
compounds which may affect the deuteration of amino acids. 
It is conceivable that, in addition to methionine-T-lyase, 
several other transaminases might exist in Pseudomonas
putida and these could even promote similar deuteration
reactions. Indeed the latter case would seem quite plausible 
when one considers that Pseudomonas aeruginosa and
Escherichia coli have been shown to contain several
transaminases which overlap in their ability to catalyse 
different biochemical pathways
The investigation of the effects of different coenzymes 
on the deuteration of amino acids has been carried out using 
pyridoxine derivatives. The deuteration of amino acids in 
the presence of either pyridoxal phosphate or pyridoxine led 
to similar labelling patterns for the amino acids (see
Tables 2.6-2,9 and Tables 2.16-2,19). When pyridoxal 
hydrochloride was used as the coenzyme, noticeable
differences in the labelling pattern of the amino acids were 
observed. It can be seen from Table 2.14 that in the case
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of alanine and norvaline the majority of the deuterium was 
incorporated into the 8-positions. The other amino acids 
showed a lower level of deuterium incorporation for
reactions using pyridoxal hydrochloride as coenzyme than
those with pyridoxine and pyridoxal phosphate. The
deuteration of methionine in the presence of pyridoxal 
hydrochloride led to a product that was labelled mainly in 
the a-position. An additional chemical shift at S 2.0 ppm 
was observed in the nmr spectra of labelled methionine
and can be assigned as the 8-methylene group of the 
corresponding a-keto acid.
The above observations for experiments in which
pyridoxal hydrochloride was present as a coenzyme implied
that both transamination and hydrogen isotope exchange 
reactions were competitively occuring. Indeed both reactions 
depend upon a common Schiff's base as an intermediate and so 
it is possible that either reaction pathway can be followed. 
The structure of the coenzyme possibly dictates which
reaction predominates. Esaki et. al ® also reported the
formation of an a-keto acid during the deuteration of
methionine by methionine-r-lyase and pyridoxal phosphate.
Successful immobilization of Pseudomonas putida cells 
was achieved using a biofix C2 ceramic support. The
bacteria cells were loaded directly onto the column of
biofix C2, which had been pre-washed with phosphate buffer 
solution. Although the method of immobilization had not been 
optimized for these studies, it can be seen from plate
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counting results in section 2.3.3 that about 5% of the cells 
were immobilized.
In general, as can be seen from the results given in 
sections 2.3.4, 2.3.5 and 2.3.6, the labelling of amino
acids using immobilized cells resulted in a higher
incorporation of deuterium than the corresponding experiment 
With free cells. Indeed in the case of L-methionine, which 
was labelled in the presence of pyridoxal phosphate as 
coenzyme, an increase in deuterium incorporation of over 50% 
was observed at the a-position. However, it should be
pointed out that the number of bacteria cells used in 
deuteration studies using immobilized cells was 
approximately tenfold that for experiments using free cells.
A study of the reusability of the immobilized 
Pseudomonas putida cells has been carried out. It was found 
that regeneration of the biocatalyst was necessary to 
restore the catalytic activity of the Pseudomonas putida. 
The regeneration of the biocatalyst was achieved by leaving 
the immobilized Pseudomonas putida cells overnight in a 10% 
peptone solution. As can be seen from Table 2.10, the
degree of deuterium incorporation obtained using the 
regenerated biocatalyst was greater than that for 
biocatalyst which had been directly reused but less than
With freshly prepared catalyst. Although the regeneration 
method employed may not have restored the catalyst to its 
full biological activity, the results obtained indicated 
that it was possible to regenerate the immobilized
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Pseudomonas putida cells. The reproducibility of the 
deuteration method was investigated by using three batches 
of Pseudomonas putida to label methionine. It can be seen 
from Table 2.11 that no significant difference in the level 
of ®H incorporated into methionine was observed for the 
different batches of Pseudomonas putida.
The use of semi- and non-aqueous solvent media for
deuteration experiments has been investigated. The 
deuteration of amino acids was found to be possible in 10% 
DMSO, 10% DMF and 40% glycerol (see Section 2.3.8). Attempts
to use aqueous ethanol and chloroform as solvent media were
unsuccessful. There was no overall pattern to the degree of 
incorporated into the amino acids in semi-aqueous 
solvents and thus it is not possible to determine the best 
system to employ. In addition, the deuteration of glycine 
esters in DMSO and DMF was also found possible. The loss of 
the ester groups from the amino acid derivatives did not 
occur in these solvent systems. The retention of the ester 
group implied that the carboxyl group of the amino acid may 
not play a part in the reaction.
Indeed there is some supportive evidence for the 
deuteration of amino acids by Pseudomonas putida in semi- 
and non-aqueous media. For instance, the interconversion of 
glycine and glyoxylate by serineîglyoxylate transaminase is 
induced eightfold in the presence of methanol and 
methyl a m i n e Transamination has also been reported to 
occur in micellar phase*®. Thus, it is conceivable that a
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transaminase would be capable of promoting deuterium 
labelling, since both transamination and hydrogen isotope 
exchange reaction pathways involve a common Schiff’s base.
The ability to deuterate amino acids and and amino acid 
esters in semi- and non-aqueous solvent systems may be 
dictated by the physical properties and toxicity of the 
solvents. Those solvents with high dielectric constants, 
such as water (80.2), DMSO (46.7), DMF (38.7) and glycerol 
(42.5), were found to be suitable media in which to carry 
out deuteration experiments. In solvents with low 
dielectric constants, such as chloroform (4.8), THF (7.8) 
and ethanol (24.8), no deuteration of the amino acids 
occurred. In solvents with high dielectric constants the a- 
carbanion (iminium ion), formed by a-hydrogen abstraction 
from the coenzyme-substrate Schiff's base, may be less 
stable than the resulting deuterated amino acid. In the 
case of solvents such as DMSO and DMF, which have higher 
dipole moments than water, the deuteration of amino acids 
may occur due to the lowering of the activation energy. In 
these cases the nature of the solvents may destabilize the 
iminium ion relative to the products.
The effects of reducing the amount of water in the 
reaction media upon the behaviour of the Pseudomonas putida 
cells and the transaminase must be considered. One aspect 
of increasing the proportion of organic solvent in the 
system will alter the osmotic conditions and this may lead 
to dehydration of the bacteria cells and denaturing of the
2 20
enzyme. Also since DaO was used as the labelling reagent, 
then it was desirable that the organic component of the 
solvent system had a high degree of aqueous miscibility. 
This was important because it was hoped to promote an 
intracellular reaction rather than a free enzyme process. 
In the case of chloroform, which has a poor miscibility with 
water, the attempts to deuterate amino acids with whole 
cells may have been unsuccessful due to the fact that this 
criteria was not met.
The kinetics of the deuteration of amino acids have 
been studied by nmr spectroscopy. However, the first 
order rate constants of deuteration determined using this 
method need to be carefully interpreted. There are several 
processes which make up the overall biochemical reaction. 
Some of these are: (a) the absorption of amino acid into the 
cell and its subsequent excretion; (b) the formation of the 
Schiff's bases between the pyridoxine derivative and the 
enzyme and/ or the amino acid; (c) the isotope exchange of 
deuterium with the protonated enzyme Schiff's base and 
subsequent labelling of the amino acid. The first order rate 
constants for the deuteration of glycine methyl ester and 
glycine ethyl ester in ds-DMSO were found to be 8.68xl0"®s”  ^
and 7.73xl0“®s“ *^ respectively.
In summary, it was found possible to deuterate amino 
acids using whole cells of Pseudomonas putida. The 
deuteration was found to be dependant upon the pyridoxine 
derivative used as the coenzyme. In the case of experiments
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employing pyridoxal hydrochloride as the coenzyme it would 
appear that both transamination and hydrogen isotope 
exchange reactions occur.
It was found that Pseudomonas putida cells could be 
immobilized using a biofix support. The recovery and
regeneration of immobilized bacteria cells has been 
successfully carried out. The deuteration of amino acids 
using immobilized bacteria was more efficient than 
experiments using free cells of Pseudomonas putida.
The deuteration of amino acids in semi-aqueous and non- 
aqueous solvents has been achieved using immobilized
Pseudomonas putida cells. The deuterium labelling of 
glycine esters in DMSO and DMF have been achieved. The
glycine esters did not undergo loss of the ester groups
during the hydrogen isotope exchange reactions. Nmr
spectroscopy has been used to follow the deuteration of 
glycine esters in DMSO.
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